Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:addison disease'
(id=8833609 ; fe=en:addison disease ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=25248 creation date=2017-08-31 touchdate=2025-09-27 14:42:10.000)
≈ 1053 relations sortantes

  1. en:addison disease -- r_associated #0: 258 / 1 -> médecine
    n1=en:addison disease | n2=médecine | rel=r_associated | relid=0 | w=258
  2. en:addison disease -- r_associated #0: 170 / 0.659 -> insuffisance surrénalienne primaire
    n1=en:addison disease | n2=insuffisance surrénalienne primaire | rel=r_associated | relid=0 | w=170
  3. en:addison disease -- r_associated #0: 167 / 0.647 -> insuffisance corticosurrénalienne primitive
    n1=en:addison disease | n2=insuffisance corticosurrénalienne primitive | rel=r_associated | relid=0 | w=167
  4. en:addison disease -- r_associated #0: 167 / 0.647 -> insuffisance surrénale primitive
    n1=en:addison disease | n2=insuffisance surrénale primitive | rel=r_associated | relid=0 | w=167
  5. en:addison disease -- r_associated #0: 166 / 0.643 -> insuffisance corticosurrénalienne chronique
    n1=en:addison disease | n2=insuffisance corticosurrénalienne chronique | rel=r_associated | relid=0 | w=166
  6. en:addison disease -- r_associated #0: 166 / 0.643 -> insuffisance surrénalienne primitive
    n1=en:addison disease | n2=insuffisance surrénalienne primitive | rel=r_associated | relid=0 | w=166
  7. en:addison disease -- r_associated #0: 165 / 0.64 -> maladie bronzée
    n1=en:addison disease | n2=maladie bronzée | rel=r_associated | relid=0 | w=165
  8. en:addison disease -- r_associated #0: 163 / 0.632 -> Addison
    n1=en:addison disease | n2=Addison | rel=r_associated | relid=0 | w=163
  9. en:addison disease -- r_associated #0: 148 / 0.574 -> en:addison's disease
    n1=en:addison disease | n2=en:addison's disease | rel=r_associated | relid=0 | w=148
  10. en:addison disease -- r_associated #0: 146 / 0.566 -> maladies
    n1=en:addison disease | n2=maladies | rel=r_associated | relid=0 | w=146
  11. en:addison disease -- r_associated #0: 144 / 0.558 -> maladie
    n1=en:addison disease | n2=maladie | rel=r_associated | relid=0 | w=144
  12. en:addison disease -- r_associated #0: 143 / 0.554 -> maladie d
    n1=en:addison disease | n2=maladie d | rel=r_associated | relid=0 | w=143
  13. en:addison disease -- r_associated #0: 141 / 0.547 -> amylose
    n1=en:addison disease | n2=amylose | rel=r_associated | relid=0 | w=141
  14. en:addison disease -- r_associated #0: 141 / 0.547 -> atrophie corticosurrénalienne auto-immune
    n1=en:addison disease | n2=atrophie corticosurrénalienne auto-immune | rel=r_associated | relid=0 | w=141
  15. en:addison disease -- r_associated #0: 141 / 0.547 -> insuffisance corticosurrénale primaire
    n1=en:addison disease | n2=insuffisance corticosurrénale primaire | rel=r_associated | relid=0 | w=141
  16. en:addison disease -- r_associated #0: 141 / 0.547 -> insuffisance surrénale
    n1=en:addison disease | n2=insuffisance surrénale | rel=r_associated | relid=0 | w=141
  17. en:addison disease -- r_associated #0: 141 / 0.547 -> maladie rare
    n1=en:addison disease | n2=maladie rare | rel=r_associated | relid=0 | w=141
  18. en:addison disease -- r_associated #0: 141 / 0.547 -> maladie
    (médecine)
    n1=en:addison disease | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=141
  19. en:addison disease -- r_associated #0: 141 / 0.547 -> processus pathologique
    n1=en:addison disease | n2=processus pathologique | rel=r_associated | relid=0 | w=141
  20. en:addison disease -- r_associated #0: 131 / 0.508 -> en:adrenal gland
    n1=en:addison disease | n2=en:adrenal gland | rel=r_associated | relid=0 | w=131
  21. en:addison disease -- r_associated #0: 131 / 0.508 -> en:adrenocortical insufficiency
    n1=en:addison disease | n2=en:adrenocortical insufficiency | rel=r_associated | relid=0 | w=131
  22. en:addison disease -- r_associated #0: 131 / 0.508 -> en:antigen presenting cell
    n1=en:addison disease | n2=en:antigen presenting cell | rel=r_associated | relid=0 | w=131
  23. en:addison disease -- r_associated #0: 131 / 0.508 -> en:autoimmune adrenal insufficiency
    n1=en:addison disease | n2=en:autoimmune adrenal insufficiency | rel=r_associated | relid=0 | w=131
  24. en:addison disease -- r_associated #0: 131 / 0.508 -> en:autoimmune disease
    n1=en:addison disease | n2=en:autoimmune disease | rel=r_associated | relid=0 | w=131
  25. en:addison disease -- r_associated #0: 131 / 0.508 -> en:autoimmune endocrine disease
    n1=en:addison disease | n2=en:autoimmune endocrine disease | rel=r_associated | relid=0 | w=131
  26. en:addison disease -- r_associated #0: 131 / 0.508 -> en:autoimmune hemolytic anemia
    n1=en:addison disease | n2=en:autoimmune hemolytic anemia | rel=r_associated | relid=0 | w=131
  27. en:addison disease -- r_associated #0: 131 / 0.508 -> en:complement
    n1=en:addison disease | n2=en:complement | rel=r_associated | relid=0 | w=131
  28. en:addison disease -- r_associated #0: 131 / 0.508 -> en:diffuse endocrine system
    n1=en:addison disease | n2=en:diffuse endocrine system | rel=r_associated | relid=0 | w=131
  29. en:addison disease -- r_associated #0: 131 / 0.508 -> en:disorder of pineal gland
    n1=en:addison disease | n2=en:disorder of pineal gland | rel=r_associated | relid=0 | w=131
  30. en:addison disease -- r_associated #0: 131 / 0.508 -> en:endocrine features
    n1=en:addison disease | n2=en:endocrine features | rel=r_associated | relid=0 | w=131
  31. en:addison disease -- r_associated #0: 131 / 0.508 -> en:endocrine system
    n1=en:addison disease | n2=en:endocrine system | rel=r_associated | relid=0 | w=131
  32. en:addison disease -- r_associated #0: 131 / 0.508 -> en:endocrine system disorders, general, polyglandular and nec
    n1=en:addison disease | n2=en:endocrine system disorders, general, polyglandular and nec | rel=r_associated | relid=0 | w=131
  33. en:addison disease -- r_associated #0: 131 / 0.508 -> en:experimental allergic encephalomyelitis
    n1=en:addison disease | n2=en:experimental allergic encephalomyelitis | rel=r_associated | relid=0 | w=131
  34. en:addison disease -- r_associated #0: 131 / 0.508 -> en:lymphatic system
    n1=en:addison disease | n2=en:lymphatic system | rel=r_associated | relid=0 | w=131
  35. en:addison disease -- r_associated #0: 131 / 0.508 -> en:neuroendocrine system
    n1=en:addison disease | n2=en:neuroendocrine system | rel=r_associated | relid=0 | w=131
  36. en:addison disease -- r_associated #0: 131 / 0.508 -> en:other disorders of adrenal gland
    n1=en:addison disease | n2=en:other disorders of adrenal gland | rel=r_associated | relid=0 | w=131
  37. en:addison disease -- r_associated #0: 131 / 0.508 -> en:parathyroid gland
    n1=en:addison disease | n2=en:parathyroid gland | rel=r_associated | relid=0 | w=131
  38. en:addison disease -- r_associated #0: 131 / 0.508 -> en:pituitary gland
    n1=en:addison disease | n2=en:pituitary gland | rel=r_associated | relid=0 | w=131
  39. en:addison disease -- r_associated #0: 131 / 0.508 -> en:testicular disorder
    n1=en:addison disease | n2=en:testicular disorder | rel=r_associated | relid=0 | w=131
  40. en:addison disease -- r_associated #0: 131 / 0.508 -> en:thyroid gland
    n1=en:addison disease | n2=en:thyroid gland | rel=r_associated | relid=0 | w=131
  41. en:addison disease -- r_associated #0: 131 / 0.508 -> en:type iii hypersensitivity
    n1=en:addison disease | n2=en:type iii hypersensitivity | rel=r_associated | relid=0 | w=131
  42. en:addison disease -- r_associated #0: 126 / 0.488 -> en:hypoaldosteronemia
    n1=en:addison disease | n2=en:hypoaldosteronemia | rel=r_associated | relid=0 | w=126
  43. en:addison disease -- r_associated #0: 126 / 0.488 -> en:hypoaldosteronism, hyporeninemic
    n1=en:addison disease | n2=en:hypoaldosteronism, hyporeninemic | rel=r_associated | relid=0 | w=126
  44. en:addison disease -- r_associated #0: 126 / 0.488 -> en:multiple sclerosis
    n1=en:addison disease | n2=en:multiple sclerosis | rel=r_associated | relid=0 | w=126
  45. en:addison disease -- r_associated #0: 126 / 0.488 -> en:phagocytic cell
    n1=en:addison disease | n2=en:phagocytic cell | rel=r_associated | relid=0 | w=126
  46. en:addison disease -- r_associated #0: 126 / 0.488 -> en:pituitary thyroid axis
    n1=en:addison disease | n2=en:pituitary thyroid axis | rel=r_associated | relid=0 | w=126
  47. en:addison disease -- r_associated #0: 126 / 0.488 -> en:placenta
    n1=en:addison disease | n2=en:placenta | rel=r_associated | relid=0 | w=126
  48. en:addison disease -- r_associated #0: 126 / 0.488 -> en:rheumatoid arthritis
    n1=en:addison disease | n2=en:rheumatoid arthritis | rel=r_associated | relid=0 | w=126
  49. en:addison disease -- r_associated #0: 126 / 0.488 -> en:secondary adrenal insufficiency
    n1=en:addison disease | n2=en:secondary adrenal insufficiency | rel=r_associated | relid=0 | w=126
  50. en:addison disease -- r_associated #0: 126 / 0.488 -> en:splenic disorder
    n1=en:addison disease | n2=en:splenic disorder | rel=r_associated | relid=0 | w=126
  51. en:addison disease -- r_associated #0: 126 / 0.488 -> en:syndrome
    n1=en:addison disease | n2=en:syndrome | rel=r_associated | relid=0 | w=126
  52. en:addison disease -- r_associated #0: 126 / 0.488 -> en:systemic lupus erythematosus
    n1=en:addison disease | n2=en:systemic lupus erythematosus | rel=r_associated | relid=0 | w=126
  53. en:addison disease -- r_associated #0: 126 / 0.488 -> en:thyroid gland disorder
    n1=en:addison disease | n2=en:thyroid gland disorder | rel=r_associated | relid=0 | w=126
  54. en:addison disease -- r_associated #0: 126 / 0.488 -> insuffisance surrénale lente
    n1=en:addison disease | n2=insuffisance surrénale lente | rel=r_associated | relid=0 | w=126
  55. en:addison disease -- r_associated #0: 121 / 0.469 -> en:gonad
    n1=en:addison disease | n2=en:gonad | rel=r_associated | relid=0 | w=121
  56. en:addison disease -- r_associated #0: 121 / 0.469 -> en:hashimoto thyroiditis
    n1=en:addison disease | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=121
  57. en:addison disease -- r_associated #0: 121 / 0.469 -> en:parathyroid gland disorder
    n1=en:addison disease | n2=en:parathyroid gland disorder | rel=r_associated | relid=0 | w=121
  58. en:addison disease -- r_associated #0: 116 / 0.45 -> chien
    n1=en:addison disease | n2=chien | rel=r_associated | relid=0 | w=116
  59. en:addison disease -- r_associated #0: 116 / 0.45 -> hormones surrénaliennes
    n1=en:addison disease | n2=hormones surrénaliennes | rel=r_associated | relid=0 | w=116
  60. en:addison disease -- r_associated #0: 109 / 0.422 -> maladie d'Addison
    n1=en:addison disease | n2=maladie d'Addison | rel=r_associated | relid=0 | w=109
  61. en:addison disease -- r_associated #0: 106 / 0.411 -> maladie d'addison
    n1=en:addison disease | n2=maladie d'addison | rel=r_associated | relid=0 | w=106
  62. en:addison disease -- r_associated #0: 105 / 0.407 -> glandes surrénales
    n1=en:addison disease | n2=glandes surrénales | rel=r_associated | relid=0 | w=105
  63. en:addison disease -- r_associated #0: 105 / 0.407 -> insuffisance corticosurrénalienne primaire
    n1=en:addison disease | n2=insuffisance corticosurrénalienne primaire | rel=r_associated | relid=0 | w=105
  64. en:addison disease -- r_associated #0: 105 / 0.407 -> insuffisance surrénalienne
    n1=en:addison disease | n2=insuffisance surrénalienne | rel=r_associated | relid=0 | w=105
  65. en:addison disease -- r_associated #0: 101 / 0.391 -> achalasie et insuffisance surrénalienne
    n1=en:addison disease | n2=achalasie et insuffisance surrénalienne | rel=r_associated | relid=0 | w=101
  66. en:addison disease -- r_associated #0: 101 / 0.391 -> en:autoimmune primary adrenal insufficiency
    n1=en:addison disease | n2=en:autoimmune primary adrenal insufficiency | rel=r_associated | relid=0 | w=101
  67. en:addison disease -- r_associated #0: 101 / 0.391 -> syndrome de Allgrove
    n1=en:addison disease | n2=syndrome de Allgrove | rel=r_associated | relid=0 | w=101
  68. en:addison disease -- r_associated #0: 96 / 0.372 -> ACTH
    n1=en:addison disease | n2=ACTH | rel=r_associated | relid=0 | w=96
  69. en:addison disease -- r_associated #0: 96 / 0.372 -> activité rénine plasmatique
    n1=en:addison disease | n2=activité rénine plasmatique | rel=r_associated | relid=0 | w=96
  70. en:addison disease -- r_associated #0: 96 / 0.372 -> adrénoleucodystrophie
    n1=en:addison disease | n2=adrénoleucodystrophie | rel=r_associated | relid=0 | w=96
  71. en:addison disease -- r_associated #0: 96 / 0.372 -> aldostérone
    n1=en:addison disease | n2=aldostérone | rel=r_associated | relid=0 | w=96
  72. en:addison disease -- r_associated #0: 96 / 0.372 -> anticorps anti21-hydroxylase
    n1=en:addison disease | n2=anticorps anti21-hydroxylase | rel=r_associated | relid=0 | w=96
  73. en:addison disease -- r_associated #0: 96 / 0.372 -> cortisol
    n1=en:addison disease | n2=cortisol | rel=r_associated | relid=0 | w=96
  74. en:addison disease -- r_associated #0: 96 / 0.372 -> DAX1
    n1=en:addison disease | n2=DAX1 | rel=r_associated | relid=0 | w=96
  75. en:addison disease -- r_associated #0: 96 / 0.372 -> DHA
    n1=en:addison disease | n2=DHA | rel=r_associated | relid=0 | w=96
  76. en:addison disease -- r_associated #0: 96 / 0.372 -> insuffisance de la corticale surrénalienne
    n1=en:addison disease | n2=insuffisance de la corticale surrénalienne | rel=r_associated | relid=0 | w=96
  77. en:addison disease -- r_associated #0: 96 / 0.372 -> insuffisance surrénale aigüe
    n1=en:addison disease | n2=insuffisance surrénale aigüe | rel=r_associated | relid=0 | w=96
  78. en:addison disease -- r_associated #0: 96 / 0.372 -> maladie de Wolman
    n1=en:addison disease | n2=maladie de Wolman | rel=r_associated | relid=0 | w=96
  79. en:addison disease -- r_associated #0: 96 / 0.372 -> polyendocrinopathies auto-immunes
    n1=en:addison disease | n2=polyendocrinopathies auto-immunes | rel=r_associated | relid=0 | w=96
  80. en:addison disease -- r_associated #0: 96 / 0.372 -> rénine
    n1=en:addison disease | n2=rénine | rel=r_associated | relid=0 | w=96
  81. en:addison disease -- r_associated #0: 91 / 0.353 -> chat
    n1=en:addison disease | n2=chat | rel=r_associated | relid=0 | w=91
  82. en:addison disease -- r_associated #0: 86 / 0.333 -> en:Addison's disease
    n1=en:addison disease | n2=en:Addison's disease | rel=r_associated | relid=0 | w=86
  83. en:addison disease -- r_associated #0: 86 / 0.333 -> surrénalite auto-immune
    n1=en:addison disease | n2=surrénalite auto-immune | rel=r_associated | relid=0 | w=86
  84. en:addison disease -- r_associated #0: 80 / 0.31 -> en:adrenal cortical hypofunction
    n1=en:addison disease | n2=en:adrenal cortical hypofunction | rel=r_associated | relid=0 | w=80
  85. en:addison disease -- r_associated #0: 80 / 0.31 -> en:anatomic structures
    n1=en:addison disease | n2=en:anatomic structures | rel=r_associated | relid=0 | w=80
  86. en:addison disease -- r_associated #0: 80 / 0.31 -> en:aspects of mortality statistics
    n1=en:addison disease | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=80
  87. en:addison disease -- r_associated #0: 80 / 0.31 -> en:aspects of radionuclide imaging
    n1=en:addison disease | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=80
  88. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune encephalitis
    n1=en:addison disease | n2=en:autoimmune encephalitis | rel=r_associated | relid=0 | w=80
  89. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune hypoparathyroidism
    n1=en:addison disease | n2=en:autoimmune hypoparathyroidism | rel=r_associated | relid=0 | w=80
  90. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune hypophysitis
    n1=en:addison disease | n2=en:autoimmune hypophysitis | rel=r_associated | relid=0 | w=80
  91. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune pancreatitis
    n1=en:addison disease | n2=en:autoimmune pancreatitis | rel=r_associated | relid=0 | w=80
  92. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune parathyroiditis
    n1=en:addison disease | n2=en:autoimmune parathyroiditis | rel=r_associated | relid=0 | w=80
  93. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune polyendocrine syndrome type 3
    n1=en:addison disease | n2=en:autoimmune polyendocrine syndrome type 3 | rel=r_associated | relid=0 | w=80
  94. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune polyendocrinopathy syndrome
    n1=en:addison disease | n2=en:autoimmune polyendocrinopathy syndrome | rel=r_associated | relid=0 | w=80
  95. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune primary ovarian failure
    n1=en:addison disease | n2=en:autoimmune primary ovarian failure | rel=r_associated | relid=0 | w=80
  96. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune syndrome type ii, polyglandular
    n1=en:addison disease | n2=en:autoimmune syndrome type ii, polyglandular | rel=r_associated | relid=0 | w=80
  97. en:addison disease -- r_associated #0: 80 / 0.31 -> en:autoimmune thyroiditis
    n1=en:addison disease | n2=en:autoimmune thyroiditis | rel=r_associated | relid=0 | w=80
  98. en:addison disease -- r_associated #0: 80 / 0.31 -> en:chemically induced
    n1=en:addison disease | n2=en:chemically induced | rel=r_associated | relid=0 | w=80
  99. en:addison disease -- r_associated #0: 80 / 0.31 -> en:complication aspects
    n1=en:addison disease | n2=en:complication aspects | rel=r_associated | relid=0 | w=80
  100. en:addison disease -- r_associated #0: 80 / 0.31 -> en:congenital absence of adrenal gland
    n1=en:addison disease | n2=en:congenital absence of adrenal gland | rel=r_associated | relid=0 | w=80
  101. en:addison disease -- r_associated #0: 80 / 0.31 -> en:congenital mesh qualifier
    n1=en:addison disease | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=80
  102. en:addison disease -- r_associated #0: 80 / 0.31 -> en:dermatitis herpetiformis
    n1=en:addison disease | n2=en:dermatitis herpetiformis | rel=r_associated | relid=0 | w=80
  103. en:addison disease -- r_associated #0: 80 / 0.31 -> en:dermatomyositis
    n1=en:addison disease | n2=en:dermatomyositis | rel=r_associated | relid=0 | w=80
  104. en:addison disease -- r_associated #0: 80 / 0.31 -> en:diabetes complication
    n1=en:addison disease | n2=en:diabetes complication | rel=r_associated | relid=0 | w=80
  105. en:addison disease -- r_associated #0: 80 / 0.31 -> en:diabetic mastopathy
    n1=en:addison disease | n2=en:diabetic mastopathy | rel=r_associated | relid=0 | w=80
  106. en:addison disease -- r_associated #0: 80 / 0.31 -> en:diagnosis aspect
    n1=en:addison disease | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=80
  107. en:addison disease -- r_associated #0: 80 / 0.31 -> en:embryologic
    n1=en:addison disease | n2=en:embryologic | rel=r_associated | relid=0 | w=80
  108. en:addison disease -- r_associated #0: 80 / 0.31 -> en:endocrine system disorder
    n1=en:addison disease | n2=en:endocrine system disorder | rel=r_associated | relid=0 | w=80
  109. en:addison disease -- r_associated #0: 80 / 0.31 -> en:enzymology
    n1=en:addison disease | n2=en:enzymology | rel=r_associated | relid=0 | w=80
  110. en:addison disease -- r_associated #0: 80 / 0.31 -> en:epidemiologic
    n1=en:addison disease | n2=en:epidemiologic | rel=r_associated | relid=0 | w=80
  111. en:addison disease -- r_associated #0: 80 / 0.31 -> en:ethnologic
    n1=en:addison disease | n2=en:ethnologic | rel=r_associated | relid=0 | w=80
  112. en:addison disease -- r_associated #0: 80 / 0.31 -> en:etiology aspects
    n1=en:addison disease | n2=en:etiology aspects | rel=r_associated | relid=0 | w=80
  113. en:addison disease -- r_associated #0: 80 / 0.31 -> en:exposure as collected domain
    n1=en:addison disease | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=80
  114. en:addison disease -- r_associated #0: 80 / 0.31 -> en:genetic aspects
    n1=en:addison disease | n2=en:genetic aspects | rel=r_associated | relid=0 | w=80
  115. en:addison disease -- r_associated #0: 80 / 0.31 -> en:glucocorticoid deficiency
    n1=en:addison disease | n2=en:glucocorticoid deficiency | rel=r_associated | relid=0 | w=80
  116. en:addison disease -- r_associated #0: 80 / 0.31 -> en:graves disease
    n1=en:addison disease | n2=en:graves disease | rel=r_associated | relid=0 | w=80
  117. en:addison disease -- r_associated #0: 80 / 0.31 -> en:hashitoxicosis
    n1=en:addison disease | n2=en:hashitoxicosis | rel=r_associated | relid=0 | w=80
  118. en:addison disease -- r_associated #0: 80 / 0.31 -> en:historical aspects qualifier
    n1=en:addison disease | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=80
  119. en:addison disease -- r_associated #0: 80 / 0.31 -> en:hypocortisolemia
    n1=en:addison disease | n2=en:hypocortisolemia | rel=r_associated | relid=0 | w=80
  120. en:addison disease -- r_associated #0: 80 / 0.31 -> en:hypothyroidism, autoimmune
    n1=en:addison disease | n2=en:hypothyroidism, autoimmune | rel=r_associated | relid=0 | w=80
  121. en:addison disease -- r_associated #0: 80 / 0.31 -> en:idiopathic atrophic hypothyroidism
    n1=en:addison disease | n2=en:idiopathic atrophic hypothyroidism | rel=r_associated | relid=0 | w=80
  122. en:addison disease -- r_associated #0: 80 / 0.31 -> en:immune system disorder
    n1=en:addison disease | n2=en:immune system disorder | rel=r_associated | relid=0 | w=80
  123. en:addison disease -- r_associated #0: 80 / 0.31 -> en:immunology aspects
    n1=en:addison disease | n2=en:immunology aspects | rel=r_associated | relid=0 | w=80
  124. en:addison disease -- r_associated #0: 80 / 0.31 -> en:in blood
    n1=en:addison disease | n2=en:in blood | rel=r_associated | relid=0 | w=80
  125. en:addison disease -- r_associated #0: 80 / 0.31 -> en:in cerebrospinal fluid
    n1=en:addison disease | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=80
  126. en:addison disease -- r_associated #0: 80 / 0.31 -> en:in urine
    n1=en:addison disease | n2=en:in urine | rel=r_associated | relid=0 | w=80
  127. en:addison disease -- r_associated #0: 80 / 0.31 -> en:infectious disorder
    n1=en:addison disease | n2=en:infectious disorder | rel=r_associated | relid=0 | w=80
  128. en:addison disease -- r_associated #0: 80 / 0.31 -> en:insulin autoimmune syndrome
    n1=en:addison disease | n2=en:insulin autoimmune syndrome | rel=r_associated | relid=0 | w=80
  129. en:addison disease -- r_associated #0: 80 / 0.31 -> en:kawasaki disease
    n1=en:addison disease | n2=en:kawasaki disease | rel=r_associated | relid=0 | w=80
  130. en:addison disease -- r_associated #0: 80 / 0.31 -> en:latent autoimmune diabetes in adults
    n1=en:addison disease | n2=en:latent autoimmune diabetes in adults | rel=r_associated | relid=0 | w=80
  131. en:addison disease -- r_associated #0: 80 / 0.31 -> en:localized scleroderma
    n1=en:addison disease | n2=en:localized scleroderma | rel=r_associated | relid=0 | w=80
  132. en:addison disease -- r_associated #0: 80 / 0.31 -> en:lupus erythematosus
    n1=en:addison disease | n2=en:lupus erythematosus | rel=r_associated | relid=0 | w=80
  133. en:addison disease -- r_associated #0: 80 / 0.31 -> en:lymphatic diseases
    n1=en:addison disease | n2=en:lymphatic diseases | rel=r_associated | relid=0 | w=80
  134. en:addison disease -- r_associated #0: 80 / 0.31 -> en:lymphocytic hypopituitarism
    n1=en:addison disease | n2=en:lymphocytic hypopituitarism | rel=r_associated | relid=0 | w=80
  135. en:addison disease -- r_associated #0: 80 / 0.31 -> en:marine lenhart syndrome
    n1=en:addison disease | n2=en:marine lenhart syndrome | rel=r_associated | relid=0 | w=80
  136. en:addison disease -- r_associated #0: 80 / 0.31 -> en:metabolic aspects
    n1=en:addison disease | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=80
  137. en:addison disease -- r_associated #0: 80 / 0.31 -> en:metabolic disorder
    n1=en:addison disease | n2=en:metabolic disorder | rel=r_associated | relid=0 | w=80
  138. en:addison disease -- r_associated #0: 80 / 0.31 -> en:microbiological
    n1=en:addison disease | n2=en:microbiological | rel=r_associated | relid=0 | w=80
  139. en:addison disease -- r_associated #0: 80 / 0.31 -> en:nursing therapy
    n1=en:addison disease | n2=en:nursing therapy | rel=r_associated | relid=0 | w=80
  140. en:addison disease -- r_associated #0: 80 / 0.31 -> en:nutritional management
    n1=en:addison disease | n2=en:nutritional management | rel=r_associated | relid=0 | w=80
  141. en:addison disease -- r_associated #0: 80 / 0.31 -> en:parasitology
    n1=en:addison disease | n2=en:parasitology | rel=r_associated | relid=0 | w=80
  142. en:addison disease -- r_associated #0: 80 / 0.31 -> en:pathological aspects
    n1=en:addison disease | n2=en:pathological aspects | rel=r_associated | relid=0 | w=80
  143. en:addison disease -- r_associated #0: 80 / 0.31 -> en:pemphigus
    n1=en:addison disease | n2=en:pemphigus | rel=r_associated | relid=0 | w=80
  144. en:addison disease -- r_associated #0: 80 / 0.31 -> en:pharmacotherapeutic
    n1=en:addison disease | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=80
  145. en:addison disease -- r_associated #0: 80 / 0.31 -> en:physiopathological
    n1=en:addison disease | n2=en:physiopathological | rel=r_associated | relid=0 | w=80
  146. en:addison disease -- r_associated #0: 80 / 0.31 -> en:polyglandular type i autoimmune syndrome
    n1=en:addison disease | n2=en:polyglandular type i autoimmune syndrome | rel=r_associated | relid=0 | w=80
  147. en:addison disease -- r_associated #0: 80 / 0.31 -> en:psychology qualifier
    n1=en:addison disease | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=80
  148. en:addison disease -- r_associated #0: 80 / 0.31 -> en:radiotherapeutic
    n1=en:addison disease | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=80
  149. en:addison disease -- r_associated #0: 80 / 0.31 -> en:rehabilitation aspects
    n1=en:addison disease | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=80
  150. en:addison disease -- r_associated #0: 80 / 0.31 -> en:reiter syndrome
    n1=en:addison disease | n2=en:reiter syndrome | rel=r_associated | relid=0 | w=80
  151. en:addison disease -- r_associated #0: 80 / 0.31 -> en:roentgenographic
    n1=en:addison disease | n2=en:roentgenographic | rel=r_associated | relid=0 | w=80
  152. en:addison disease -- r_associated #0: 80 / 0.31 -> en:scleroderma
    n1=en:addison disease | n2=en:scleroderma | rel=r_associated | relid=0 | w=80
  153. en:addison disease -- r_associated #0: 80 / 0.31 -> en:surgical aspects
    n1=en:addison disease | n2=en:surgical aspects | rel=r_associated | relid=0 | w=80
  154. en:addison disease -- r_associated #0: 80 / 0.31 -> en:systemic scleroderma
    n1=en:addison disease | n2=en:systemic scleroderma | rel=r_associated | relid=0 | w=80
  155. en:addison disease -- r_associated #0: 80 / 0.31 -> en:taxonomic
    n1=en:addison disease | n2=en:taxonomic | rel=r_associated | relid=0 | w=80
  156. en:addison disease -- r_associated #0: 80 / 0.31 -> en:therapeutic aspects
    n1=en:addison disease | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=80
  157. en:addison disease -- r_associated #0: 80 / 0.31 -> en:thyroid associated opthalmopathies
    n1=en:addison disease | n2=en:thyroid associated opthalmopathies | rel=r_associated | relid=0 | w=80
  158. en:addison disease -- r_associated #0: 80 / 0.31 -> en:tuberculosis
    n1=en:addison disease | n2=en:tuberculosis | rel=r_associated | relid=0 | w=80
  159. en:addison disease -- r_associated #0: 80 / 0.31 -> en:tuberculous addison's disease
    n1=en:addison disease | n2=en:tuberculous addison's disease | rel=r_associated | relid=0 | w=80
  160. en:addison disease -- r_associated #0: 80 / 0.31 -> en:type 1 diabetes mellitus
    n1=en:addison disease | n2=en:type 1 diabetes mellitus | rel=r_associated | relid=0 | w=80
  161. en:addison disease -- r_associated #0: 80 / 0.31 -> en:urticaria
    n1=en:addison disease | n2=en:urticaria | rel=r_associated | relid=0 | w=80
  162. en:addison disease -- r_associated #0: 80 / 0.31 -> en:use of ultrasonography
    n1=en:addison disease | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=80
  163. en:addison disease -- r_associated #0: 80 / 0.31 -> en:veterinary aspects
    n1=en:addison disease | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=80
  164. en:addison disease -- r_associated #0: 80 / 0.31 -> en:viruses
    n1=en:addison disease | n2=en:viruses | rel=r_associated | relid=0 | w=80
  165. en:addison disease -- r_associated #0: 76 / 0.295 -> destruction des cellules des glandes surrénales
    n1=en:addison disease | n2=destruction des cellules des glandes surrénales | rel=r_associated | relid=0 | w=76
  166. en:addison disease -- r_associated #0: 76 / 0.295 -> en:Addison disease
    n1=en:addison disease | n2=en:Addison disease | rel=r_associated | relid=0 | w=76
  167. en:addison disease -- r_associated #0: 76 / 0.295 -> en:addison's disease due to autoimmunity
    n1=en:addison disease | n2=en:addison's disease due to autoimmunity | rel=r_associated | relid=0 | w=76
  168. en:addison disease -- r_associated #0: 76 / 0.295 -> insuffisance de production des hormones surrénaliennes
    n1=en:addison disease | n2=insuffisance de production des hormones surrénaliennes | rel=r_associated | relid=0 | w=76
  169. en:addison disease -- r_associated #0: 76 / 0.295 -> maladie d'addison d'origine auto-immune
    n1=en:addison disease | n2=maladie d'addison d'origine auto-immune | rel=r_associated | relid=0 | w=76
  170. en:addison disease -- r_associated #0: 71 / 0.275 -> insuffisance corticosurrénalienne lente
    n1=en:addison disease | n2=insuffisance corticosurrénalienne lente | rel=r_associated | relid=0 | w=71
  171. en:addison disease -- r_associated #0: 69 / 0.267 -> en:ovary
    n1=en:addison disease | n2=en:ovary | rel=r_associated | relid=0 | w=69
  172. en:addison disease -- r_associated #0: 69 / 0.267 -> en:secondary amenorrhea
    n1=en:addison disease | n2=en:secondary amenorrhea | rel=r_associated | relid=0 | w=69
  173. en:addison disease -- r_associated #0: 68 / 0.264 -> en:hypercatabolism
    n1=en:addison disease | n2=en:hypercatabolism | rel=r_associated | relid=0 | w=68
  174. en:addison disease -- r_associated #0: 68 / 0.264 -> en:lymphoma
    n1=en:addison disease | n2=en:lymphoma | rel=r_associated | relid=0 | w=68
  175. en:addison disease -- r_associated #0: 67 / 0.26 -> en:entire immune system
    n1=en:addison disease | n2=en:entire immune system | rel=r_associated | relid=0 | w=67
  176. en:addison disease -- r_associated #0: 67 / 0.26 -> en:low luteinizing hormone (lh)
    n1=en:addison disease | n2=en:low luteinizing hormone (lh) | rel=r_associated | relid=0 | w=67
  177. en:addison disease -- r_associated #0: 67 / 0.26 -> en:low urinary cortols-to-cortolone ratio
    n1=en:addison disease | n2=en:low urinary cortols-to-cortolone ratio | rel=r_associated | relid=0 | w=67
  178. en:addison disease -- r_associated #0: 67 / 0.26 -> en:mixed connective tissue disease
    n1=en:addison disease | n2=en:mixed connective tissue disease | rel=r_associated | relid=0 | w=67
  179. en:addison disease -- r_associated #0: 67 / 0.26 -> en:neonatal hypoparathyroidism
    n1=en:addison disease | n2=en:neonatal hypoparathyroidism | rel=r_associated | relid=0 | w=67
  180. en:addison disease -- r_associated #0: 67 / 0.26 -> en:pituitary hormone deficiencies (in some patients)
    n1=en:addison disease | n2=en:pituitary hormone deficiencies (in some patients) | rel=r_associated | relid=0 | w=67
  181. en:addison disease -- r_associated #0: 66 / 0.256 -> en:adrenal hyperplasia, bilateral
    n1=en:addison disease | n2=en:adrenal hyperplasia, bilateral | rel=r_associated | relid=0 | w=66
  182. en:addison disease -- r_associated #0: 66 / 0.256 -> en:aldosterone synthase deficiency
    n1=en:addison disease | n2=en:aldosterone synthase deficiency | rel=r_associated | relid=0 | w=66
  183. en:addison disease -- r_associated #0: 66 / 0.256 -> en:childhood leukemia
    n1=en:addison disease | n2=en:childhood leukemia | rel=r_associated | relid=0 | w=66
  184. en:addison disease -- r_associated #0: 66 / 0.256 -> en:cushingoid
    n1=en:addison disease | n2=en:cushingoid | rel=r_associated | relid=0 | w=66
  185. en:addison disease -- r_associated #0: 66 / 0.256 -> en:diabetic foot
    n1=en:addison disease | n2=en:diabetic foot | rel=r_associated | relid=0 | w=66
  186. en:addison disease -- r_associated #0: 66 / 0.256 -> en:high fsh secondary to androgen insensitivity
    n1=en:addison disease | n2=en:high fsh secondary to androgen insensitivity | rel=r_associated | relid=0 | w=66
  187. en:addison disease -- r_associated #0: 66 / 0.256 -> en:hypertension
    n1=en:addison disease | n2=en:hypertension | rel=r_associated | relid=0 | w=66
  188. en:addison disease -- r_associated #0: 66 / 0.256 -> en:hypothyroidism (less common)
    n1=en:addison disease | n2=en:hypothyroidism (less common) | rel=r_associated | relid=0 | w=66
  189. en:addison disease -- r_associated #0: 66 / 0.256 -> en:mikulicz disease
    n1=en:addison disease | n2=en:mikulicz disease | rel=r_associated | relid=0 | w=66
  190. en:addison disease -- r_associated #0: 66 / 0.256 -> en:small adrenal gland
    n1=en:addison disease | n2=en:small adrenal gland | rel=r_associated | relid=0 | w=66
  191. en:addison disease -- r_associated #0: 66 / 0.256 -> en:thyroxin binding globulin normal
    n1=en:addison disease | n2=en:thyroxin binding globulin normal | rel=r_associated | relid=0 | w=66
  192. en:addison disease -- r_associated #0: 66 / 0.256 -> en:type 2 diabetes (in some)
    n1=en:addison disease | n2=en:type 2 diabetes (in some) | rel=r_associated | relid=0 | w=66
  193. en:addison disease -- r_associated #0: 66 / 0.256 -> en:type 2 diabetes mellitus
    n1=en:addison disease | n2=en:type 2 diabetes mellitus | rel=r_associated | relid=0 | w=66
  194. en:addison disease -- r_associated #0: 65 / 0.252 -> en:acral overgrowth
    n1=en:addison disease | n2=en:acral overgrowth | rel=r_associated | relid=0 | w=65
  195. en:addison disease -- r_associated #0: 65 / 0.252 -> en:adrenal gland pheochromocytoma
    n1=en:addison disease | n2=en:adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=65
  196. en:addison disease -- r_associated #0: 65 / 0.252 -> en:adrenal medullary insufficiency
    n1=en:addison disease | n2=en:adrenal medullary insufficiency | rel=r_associated | relid=0 | w=65
  197. en:addison disease -- r_associated #0: 65 / 0.252 -> en:autoimmune liver disease
    n1=en:addison disease | n2=en:autoimmune liver disease | rel=r_associated | relid=0 | w=65
  198. en:addison disease -- r_associated #0: 65 / 0.252 -> en:autoimmune vasculitis
    n1=en:addison disease | n2=en:autoimmune vasculitis | rel=r_associated | relid=0 | w=65
  199. en:addison disease -- r_associated #0: 65 / 0.252 -> en:delayed pubertal development (rare)
    n1=en:addison disease | n2=en:delayed pubertal development (rare) | rel=r_associated | relid=0 | w=65
  200. en:addison disease -- r_associated #0: 65 / 0.252 -> en:elevated follicle stimulating hormone (fsh)
    n1=en:addison disease | n2=en:elevated follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=65
  201. en:addison disease -- r_associated #0: 65 / 0.252 -> en:goiter
    n1=en:addison disease | n2=en:goiter | rel=r_associated | relid=0 | w=65
  202. en:addison disease -- r_associated #0: 65 / 0.252 -> en:hyperphosphatasaemia
    n1=en:addison disease | n2=en:hyperphosphatasaemia | rel=r_associated | relid=0 | w=65
  203. en:addison disease -- r_associated #0: 65 / 0.252 -> en:hypersensitivity
    n1=en:addison disease | n2=en:hypersensitivity | rel=r_associated | relid=0 | w=65
  204. en:addison disease -- r_associated #0: 65 / 0.252 -> en:magnesium sulfate 40meq/5gm pwdr
    n1=en:addison disease | n2=en:magnesium sulfate 40meq/5gm pwdr | rel=r_associated | relid=0 | w=65
  205. en:addison disease -- r_associated #0: 65 / 0.252 -> en:menstruation
    n1=en:addison disease | n2=en:menstruation | rel=r_associated | relid=0 | w=65
  206. en:addison disease -- r_associated #0: 65 / 0.252 -> en:mineralocorticoid insufficiency (in 15%)
    n1=en:addison disease | n2=en:mineralocorticoid insufficiency (in 15%) | rel=r_associated | relid=0 | w=65
  207. en:addison disease -- r_associated #0: 65 / 0.252 -> en:mononuclear phagocyte system
    n1=en:addison disease | n2=en:mononuclear phagocyte system | rel=r_associated | relid=0 | w=65
  208. en:addison disease -- r_associated #0: 65 / 0.252 -> en:myasthenia gravis
    n1=en:addison disease | n2=en:myasthenia gravis | rel=r_associated | relid=0 | w=65
  209. en:addison disease -- r_associated #0: 65 / 0.252 -> en:no insulin-dependent diabetes mellitus
    n1=en:addison disease | n2=en:no insulin-dependent diabetes mellitus | rel=r_associated | relid=0 | w=65
  210. en:addison disease -- r_associated #0: 65 / 0.252 -> en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome
    n1=en:addison disease | n2=en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome | rel=r_associated | relid=0 | w=65
  211. en:addison disease -- r_associated #0: 65 / 0.252 -> en:pituitary hormone deficiency
    n1=en:addison disease | n2=en:pituitary hormone deficiency | rel=r_associated | relid=0 | w=65
  212. en:addison disease -- r_associated #0: 65 / 0.252 -> en:potassium acetate 0.2 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium acetate 0.2 meq/ml injectable solution | rel=r_associated | relid=0 | w=65
  213. en:addison disease -- r_associated #0: 65 / 0.252 -> en:potassium chloride 10 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 10 meq extended release oral tablet | rel=r_associated | relid=0 | w=65
  214. en:addison disease -- r_associated #0: 65 / 0.252 -> en:potassium chloride 2.67 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium chloride 2.67 meq/ml oral solution | rel=r_associated | relid=0 | w=65
  215. en:addison disease -- r_associated #0: 65 / 0.252 -> en:potassium chloride 6.7 meq delayed release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 6.7 meq delayed release oral tablet | rel=r_associated | relid=0 | w=65
  216. en:addison disease -- r_associated #0: 65 / 0.252 -> en:primary hypogonadism (in 2 male patients)
    n1=en:addison disease | n2=en:primary hypogonadism (in 2 male patients) | rel=r_associated | relid=0 | w=65
  217. en:addison disease -- r_associated #0: 65 / 0.252 -> en:thyroid function normal
    n1=en:addison disease | n2=en:thyroid function normal | rel=r_associated | relid=0 | w=65
  218. en:addison disease -- r_associated #0: 65 / 0.252 -> en:type 1 diabetes mellitus developed in some patients
    n1=en:addison disease | n2=en:type 1 diabetes mellitus developed in some patients | rel=r_associated | relid=0 | w=65
  219. en:addison disease -- r_associated #0: 64 / 0.248 -> en:abnormal glucose tolerance
    n1=en:addison disease | n2=en:abnormal glucose tolerance | rel=r_associated | relid=0 | w=64
  220. en:addison disease -- r_associated #0: 64 / 0.248 -> en:absent or minimal increase in pregnanetriol after hcg stimulation
    n1=en:addison disease | n2=en:absent or minimal increase in pregnanetriol after hcg stimulation | rel=r_associated | relid=0 | w=64
  221. en:addison disease -- r_associated #0: 64 / 0.248 -> en:adrenal atrophy
    n1=en:addison disease | n2=en:adrenal atrophy | rel=r_associated | relid=0 | w=64
  222. en:addison disease -- r_associated #0: 64 / 0.248 -> en:adrenoleukodystrophy
    n1=en:addison disease | n2=en:adrenoleukodystrophy | rel=r_associated | relid=0 | w=64
  223. en:addison disease -- r_associated #0: 64 / 0.248 -> en:anhydrous citric acid
    n1=en:addison disease | n2=en:anhydrous citric acid | rel=r_associated | relid=0 | w=64
  224. en:addison disease -- r_associated #0: 64 / 0.248 -> en:autoimmune hematologic disorder
    n1=en:addison disease | n2=en:autoimmune hematologic disorder | rel=r_associated | relid=0 | w=64
  225. en:addison disease -- r_associated #0: 64 / 0.248 -> en:citric acid granules
    n1=en:addison disease | n2=en:citric acid granules | rel=r_associated | relid=0 | w=64
  226. en:addison disease -- r_associated #0: 64 / 0.248 -> en:cushing disease
    n1=en:addison disease | n2=en:cushing disease | rel=r_associated | relid=0 | w=64
  227. en:addison disease -- r_associated #0: 64 / 0.248 -> en:cushingoid appearance (2 patients)
    n1=en:addison disease | n2=en:cushingoid appearance (2 patients) | rel=r_associated | relid=0 | w=64
  228. en:addison disease -- r_associated #0: 64 / 0.248 -> en:diabetes in children and teens
    n1=en:addison disease | n2=en:diabetes in children and teens | rel=r_associated | relid=0 | w=64
  229. en:addison disease -- r_associated #0: 64 / 0.248 -> en:elevated insulin
    n1=en:addison disease | n2=en:elevated insulin | rel=r_associated | relid=0 | w=64
  230. en:addison disease -- r_associated #0: 64 / 0.248 -> en:euthyroidism
    n1=en:addison disease | n2=en:euthyroidism | rel=r_associated | relid=0 | w=64
  231. en:addison disease -- r_associated #0: 64 / 0.248 -> en:female infertility
    n1=en:addison disease | n2=en:female infertility | rel=r_associated | relid=0 | w=64
  232. en:addison disease -- r_associated #0: 64 / 0.248 -> en:growth hormone deficiency
    n1=en:addison disease | n2=en:growth hormone deficiency | rel=r_associated | relid=0 | w=64
  233. en:addison disease -- r_associated #0: 64 / 0.248 -> en:hypercreatinaemia
    n1=en:addison disease | n2=en:hypercreatinaemia | rel=r_associated | relid=0 | w=64
  234. en:addison disease -- r_associated #0: 64 / 0.248 -> en:hyperoxalaemia
    n1=en:addison disease | n2=en:hyperoxalaemia | rel=r_associated | relid=0 | w=64
  235. en:addison disease -- r_associated #0: 64 / 0.248 -> en:hypoadrenalism (rare)
    n1=en:addison disease | n2=en:hypoadrenalism (rare) | rel=r_associated | relid=0 | w=64
  236. en:addison disease -- r_associated #0: 64 / 0.248 -> en:hypocalcemia
    n1=en:addison disease | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=64
  237. en:addison disease -- r_associated #0: 64 / 0.248 -> en:hypogonadism
    n1=en:addison disease | n2=en:hypogonadism | rel=r_associated | relid=0 | w=64
  238. en:addison disease -- r_associated #0: 64 / 0.248 -> en:hypothyroidism (30% patients)
    n1=en:addison disease | n2=en:hypothyroidism (30% patients) | rel=r_associated | relid=0 | w=64
  239. en:addison disease -- r_associated #0: 64 / 0.248 -> en:hypothyroidism, congenital (1 patient)
    n1=en:addison disease | n2=en:hypothyroidism, congenital (1 patient) | rel=r_associated | relid=0 | w=64
  240. en:addison disease -- r_associated #0: 64 / 0.248 -> en:increased serum pth, mild
    n1=en:addison disease | n2=en:increased serum pth, mild | rel=r_associated | relid=0 | w=64
  241. en:addison disease -- r_associated #0: 64 / 0.248 -> en:insensitivity to growth hormone therapy
    n1=en:addison disease | n2=en:insensitivity to growth hormone therapy | rel=r_associated | relid=0 | w=64
  242. en:addison disease -- r_associated #0: 64 / 0.248 -> en:insulin resistance (in some patients)
    n1=en:addison disease | n2=en:insulin resistance (in some patients) | rel=r_associated | relid=0 | w=64
  243. en:addison disease -- r_associated #0: 64 / 0.248 -> en:insulin-like growth factor slightly low
    n1=en:addison disease | n2=en:insulin-like growth factor slightly low | rel=r_associated | relid=0 | w=64
  244. en:addison disease -- r_associated #0: 64 / 0.248 -> en:insulin-resistant diabetes mellitus in adulthood
    n1=en:addison disease | n2=en:insulin-resistant diabetes mellitus in adulthood | rel=r_associated | relid=0 | w=64
  245. en:addison disease -- r_associated #0: 64 / 0.248 -> en:juvenile arthritis
    n1=en:addison disease | n2=en:juvenile arthritis | rel=r_associated | relid=0 | w=64
  246. en:addison disease -- r_associated #0: 64 / 0.248 -> en:kearns-sayre syndrome
    n1=en:addison disease | n2=en:kearns-sayre syndrome | rel=r_associated | relid=0 | w=64
  247. en:addison disease -- r_associated #0: 64 / 0.248 -> en:left adrenal gland
    n1=en:addison disease | n2=en:left adrenal gland | rel=r_associated | relid=0 | w=64
  248. en:addison disease -- r_associated #0: 64 / 0.248 -> en:leukocyte
    n1=en:addison disease | n2=en:leukocyte | rel=r_associated | relid=0 | w=64
  249. en:addison disease -- r_associated #0: 64 / 0.248 -> en:low adh (in some patients)
    n1=en:addison disease | n2=en:low adh (in some patients) | rel=r_associated | relid=0 | w=64
  250. en:addison disease -- r_associated #0: 64 / 0.248 -> en:low cortols-to-cortolone ratio
    n1=en:addison disease | n2=en:low cortols-to-cortolone ratio | rel=r_associated | relid=0 | w=64
  251. en:addison disease -- r_associated #0: 64 / 0.248 -> en:low or absent growth hormone (in some patients)
    n1=en:addison disease | n2=en:low or absent growth hormone (in some patients) | rel=r_associated | relid=0 | w=64
  252. en:addison disease -- r_associated #0: 64 / 0.248 -> en:low prolactin (prl) levels (in some patients)
    n1=en:addison disease | n2=en:low prolactin (prl) levels (in some patients) | rel=r_associated | relid=0 | w=64
  253. en:addison disease -- r_associated #0: 64 / 0.248 -> en:low serum gonadotropins
    n1=en:addison disease | n2=en:low serum gonadotropins | rel=r_associated | relid=0 | w=64
  254. en:addison disease -- r_associated #0: 64 / 0.248 -> en:low testosterone levels
    n1=en:addison disease | n2=en:low testosterone levels | rel=r_associated | relid=0 | w=64
  255. en:addison disease -- r_associated #0: 64 / 0.248 -> en:low to normal level of cortisol metabolites
    n1=en:addison disease | n2=en:low to normal level of cortisol metabolites | rel=r_associated | relid=0 | w=64
  256. en:addison disease -- r_associated #0: 64 / 0.248 -> en:macronodular adrenal hyperplasia
    n1=en:addison disease | n2=en:macronodular adrenal hyperplasia | rel=r_associated | relid=0 | w=64
  257. en:addison disease -- r_associated #0: 64 / 0.248 -> en:muscular autoimmune disorders
    n1=en:addison disease | n2=en:muscular autoimmune disorders | rel=r_associated | relid=0 | w=64
  258. en:addison disease -- r_associated #0: 64 / 0.248 -> en:myelodysplastic syndrome
    n1=en:addison disease | n2=en:myelodysplastic syndrome | rel=r_associated | relid=0 | w=64
  259. en:addison disease -- r_associated #0: 64 / 0.248 -> en:parathyroid hyperplasia, benign
    n1=en:addison disease | n2=en:parathyroid hyperplasia, benign | rel=r_associated | relid=0 | w=64
  260. en:addison disease -- r_associated #0: 64 / 0.248 -> en:patients have normal pituitary function
    n1=en:addison disease | n2=en:patients have normal pituitary function | rel=r_associated | relid=0 | w=64
  261. en:addison disease -- r_associated #0: 64 / 0.248 -> en:pigmented micronodular adrenal dysplasia
    n1=en:addison disease | n2=en:pigmented micronodular adrenal dysplasia | rel=r_associated | relid=0 | w=64
  262. en:addison disease -- r_associated #0: 64 / 0.248 -> en:pituitary defects
    n1=en:addison disease | n2=en:pituitary defects | rel=r_associated | relid=0 | w=64
  263. en:addison disease -- r_associated #0: 64 / 0.248 -> en:potassium bicarbonate 20 meq effervescent oral tablet
    n1=en:addison disease | n2=en:potassium bicarbonate 20 meq effervescent oral tablet | rel=r_associated | relid=0 | w=64
  264. en:addison disease -- r_associated #0: 64 / 0.248 -> en:potassium citrate
    n1=en:addison disease | n2=en:potassium citrate | rel=r_associated | relid=0 | w=64
  265. en:addison disease -- r_associated #0: 64 / 0.248 -> en:potassium citrate 15 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium citrate 15 meq extended release oral tablet | rel=r_associated | relid=0 | w=64
  266. en:addison disease -- r_associated #0: 64 / 0.248 -> en:premature menopause (in a subset of patients)
    n1=en:addison disease | n2=en:premature menopause (in a subset of patients) | rel=r_associated | relid=0 | w=64
  267. en:addison disease -- r_associated #0: 64 / 0.248 -> en:premature thelarche
    n1=en:addison disease | n2=en:premature thelarche | rel=r_associated | relid=0 | w=64
  268. en:addison disease -- r_associated #0: 64 / 0.248 -> en:primary amenorrhea
    n1=en:addison disease | n2=en:primary amenorrhea | rel=r_associated | relid=0 | w=64
  269. en:addison disease -- r_associated #0: 64 / 0.248 -> en:progesterone undetectable
    n1=en:addison disease | n2=en:progesterone undetectable | rel=r_associated | relid=0 | w=64
  270. en:addison disease -- r_associated #0: 64 / 0.248 -> en:rheumatoid arthritis and associated conditions
    n1=en:addison disease | n2=en:rheumatoid arthritis and associated conditions | rel=r_associated | relid=0 | w=64
  271. en:addison disease -- r_associated #0: 64 / 0.248 -> en:susac syndrome
    n1=en:addison disease | n2=en:susac syndrome | rel=r_associated | relid=0 | w=64
  272. en:addison disease -- r_associated #0: 64 / 0.248 -> en:type 2 diabetes mellitus (t2d)
    n1=en:addison disease | n2=en:type 2 diabetes mellitus (t2d) | rel=r_associated | relid=0 | w=64
  273. en:addison disease -- r_associated #0: 64 / 0.248 -> en:undervirilization
    n1=en:addison disease | n2=en:undervirilization | rel=r_associated | relid=0 | w=64
  274. en:addison disease -- r_associated #0: 63 / 0.244 -> en:abcd1, 1-bp del, 2204g
    n1=en:addison disease | n2=en:abcd1, 1-bp del, 2204g | rel=r_associated | relid=0 | w=63
  275. en:addison disease -- r_associated #0: 63 / 0.244 -> en:adrenal hemangiomas
    n1=en:addison disease | n2=en:adrenal hemangiomas | rel=r_associated | relid=0 | w=63
  276. en:addison disease -- r_associated #0: 63 / 0.244 -> en:adrenal insufficiency neonatal
    n1=en:addison disease | n2=en:adrenal insufficiency neonatal | rel=r_associated | relid=0 | w=63
  277. en:addison disease -- r_associated #0: 63 / 0.244 -> en:autoimmune cholangitis
    n1=en:addison disease | n2=en:autoimmune cholangitis | rel=r_associated | relid=0 | w=63
  278. en:addison disease -- r_associated #0: 63 / 0.244 -> en:autoimmune necrotizing myopathy
    n1=en:addison disease | n2=en:autoimmune necrotizing myopathy | rel=r_associated | relid=0 | w=63
  279. en:addison disease -- r_associated #0: 63 / 0.244 -> en:autoimmune neutropenia
    n1=en:addison disease | n2=en:autoimmune neutropenia | rel=r_associated | relid=0 | w=63
  280. en:addison disease -- r_associated #0: 63 / 0.244 -> en:central hypothyroidism
    n1=en:addison disease | n2=en:central hypothyroidism | rel=r_associated | relid=0 | w=63
  281. en:addison disease -- r_associated #0: 63 / 0.244 -> en:congenital absence of thymus
    n1=en:addison disease | n2=en:congenital absence of thymus | rel=r_associated | relid=0 | w=63
  282. en:addison disease -- r_associated #0: 63 / 0.244 -> en:decreased fertility in females
    n1=en:addison disease | n2=en:decreased fertility in females | rel=r_associated | relid=0 | w=63
  283. en:addison disease -- r_associated #0: 63 / 0.244 -> en:decreased growth hormone secretion (1 patient)
    n1=en:addison disease | n2=en:decreased growth hormone secretion (1 patient) | rel=r_associated | relid=0 | w=63
  284. en:addison disease -- r_associated #0: 63 / 0.244 -> en:diabetes insipidus (in some patients)
    n1=en:addison disease | n2=en:diabetes insipidus (in some patients) | rel=r_associated | relid=0 | w=63
  285. en:addison disease -- r_associated #0: 63 / 0.244 -> en:diabetic nephropathy
    n1=en:addison disease | n2=en:diabetic nephropathy | rel=r_associated | relid=0 | w=63
  286. en:addison disease -- r_associated #0: 63 / 0.244 -> en:enteroendocrine cell
    n1=en:addison disease | n2=en:enteroendocrine cell | rel=r_associated | relid=0 | w=63
  287. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hiv/aids
    n1=en:addison disease | n2=en:hiv/aids | rel=r_associated | relid=0 | w=63
  288. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hyperactive renin-angiotensin system
    n1=en:addison disease | n2=en:hyperactive renin-angiotensin system | rel=r_associated | relid=0 | w=63
  289. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hyperamylasemia
    n1=en:addison disease | n2=en:hyperamylasemia | rel=r_associated | relid=0 | w=63
  290. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hyperinsulinemia
    n1=en:addison disease | n2=en:hyperinsulinemia | rel=r_associated | relid=0 | w=63
  291. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hyperlipasaemia
    n1=en:addison disease | n2=en:hyperlipasaemia | rel=r_associated | relid=0 | w=63
  292. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hypothalamic and/or pituitary defect
    n1=en:addison disease | n2=en:hypothalamic and/or pituitary defect | rel=r_associated | relid=0 | w=63
  293. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hypothyroidism (if untreated)
    n1=en:addison disease | n2=en:hypothyroidism (if untreated) | rel=r_associated | relid=0 | w=63
  294. en:addison disease -- r_associated #0: 63 / 0.244 -> en:hypothyroidism, autoantibody-positive (in some patients)
    n1=en:addison disease | n2=en:hypothyroidism, autoantibody-positive (in some patients) | rel=r_associated | relid=0 | w=63
  295. en:addison disease -- r_associated #0: 63 / 0.244 -> en:iatrogenic adrenal insufficiency
    n1=en:addison disease | n2=en:iatrogenic adrenal insufficiency | rel=r_associated | relid=0 | w=63
  296. en:addison disease -- r_associated #0: 63 / 0.244 -> en:increased baseline gonadotropins
    n1=en:addison disease | n2=en:increased baseline gonadotropins | rel=r_associated | relid=0 | w=63
  297. en:addison disease -- r_associated #0: 63 / 0.244 -> en:increased serum gonadotropins
    n1=en:addison disease | n2=en:increased serum gonadotropins | rel=r_associated | relid=0 | w=63
  298. en:addison disease -- r_associated #0: 63 / 0.244 -> en:insulin-resistant diabetes mellitus
    n1=en:addison disease | n2=en:insulin-resistant diabetes mellitus | rel=r_associated | relid=0 | w=63
  299. en:addison disease -- r_associated #0: 63 / 0.244 -> en:low insulin-like growth factor-i (igf1 147440) levels
    n1=en:addison disease | n2=en:low insulin-like growth factor-i (igf1 147440) levels | rel=r_associated | relid=0 | w=63
  300. en:addison disease -- r_associated #0: 63 / 0.244 -> en:low testosterone in males
    n1=en:addison disease | n2=en:low testosterone in males | rel=r_associated | relid=0 | w=63
  301. en:addison disease -- r_associated #0: 63 / 0.244 -> en:magnesium carbonate
    n1=en:addison disease | n2=en:magnesium carbonate | rel=r_associated | relid=0 | w=63
  302. en:addison disease -- r_associated #0: 63 / 0.244 -> en:magnesium oxide
    n1=en:addison disease | n2=en:magnesium oxide | rel=r_associated | relid=0 | w=63
  303. en:addison disease -- r_associated #0: 63 / 0.244 -> en:malignant ovarian neoplasm
    n1=en:addison disease | n2=en:malignant ovarian neoplasm | rel=r_associated | relid=0 | w=63
  304. en:addison disease -- r_associated #0: 63 / 0.244 -> en:maturity-onset diabetes of the young (rare)
    n1=en:addison disease | n2=en:maturity-onset diabetes of the young (rare) | rel=r_associated | relid=0 | w=63
  305. en:addison disease -- r_associated #0: 63 / 0.244 -> en:metabolic syndrome
    n1=en:addison disease | n2=en:metabolic syndrome | rel=r_associated | relid=0 | w=63
  306. en:addison disease -- r_associated #0: 63 / 0.244 -> en:no adrenal insufficiency
    n1=en:addison disease | n2=en:no adrenal insufficiency | rel=r_associated | relid=0 | w=63
  307. en:addison disease -- r_associated #0: 63 / 0.244 -> en:normal thyroid-stimulating hormone level
    n1=en:addison disease | n2=en:normal thyroid-stimulating hormone level | rel=r_associated | relid=0 | w=63
  308. en:addison disease -- r_associated #0: 63 / 0.244 -> en:other and unspecified adrenocortical insufficiency
    n1=en:addison disease | n2=en:other and unspecified adrenocortical insufficiency | rel=r_associated | relid=0 | w=63
  309. en:addison disease -- r_associated #0: 63 / 0.244 -> en:oxalosis
    n1=en:addison disease | n2=en:oxalosis | rel=r_associated | relid=0 | w=63
  310. en:addison disease -- r_associated #0: 63 / 0.244 -> en:parathyroid hormone decreased
    n1=en:addison disease | n2=en:parathyroid hormone decreased | rel=r_associated | relid=0 | w=63
  311. en:addison disease -- r_associated #0: 63 / 0.244 -> en:pituitary gonadal axis
    n1=en:addison disease | n2=en:pituitary gonadal axis | rel=r_associated | relid=0 | w=63
  312. en:addison disease -- r_associated #0: 63 / 0.244 -> en:plasma testosterone is normal or increased
    n1=en:addison disease | n2=en:plasma testosterone is normal or increased | rel=r_associated | relid=0 | w=63
  313. en:addison disease -- r_associated #0: 63 / 0.244 -> en:potassium bicarbonate
    n1=en:addison disease | n2=en:potassium bicarbonate | rel=r_associated | relid=0 | w=63
  314. en:addison disease -- r_associated #0: 63 / 0.244 -> en:primary hypothyroidism (reported in 2 patients)
    n1=en:addison disease | n2=en:primary hypothyroidism (reported in 2 patients) | rel=r_associated | relid=0 | w=63
  315. en:addison disease -- r_associated #0: 63 / 0.244 -> en:pulmonary alveolar proteinosis, acquired
    n1=en:addison disease | n2=en:pulmonary alveolar proteinosis, acquired | rel=r_associated | relid=0 | w=63
  316. en:addison disease -- r_associated #0: 63 / 0.244 -> en:thin pituitary stalk
    n1=en:addison disease | n2=en:thin pituitary stalk | rel=r_associated | relid=0 | w=63
  317. en:addison disease -- r_associated #0: 63 / 0.244 -> en:thyroid defect in oxidation and organification of iodide
    n1=en:addison disease | n2=en:thyroid defect in oxidation and organification of iodide | rel=r_associated | relid=0 | w=63
  318. en:addison disease -- r_associated #0: 63 / 0.244 -> en:thyroid dysplasia/aplasia
    n1=en:addison disease | n2=en:thyroid dysplasia/aplasia | rel=r_associated | relid=0 | w=63
  319. en:addison disease -- r_associated #0: 63 / 0.244 -> en:undifferentiated connective tissue disease
    n1=en:addison disease | n2=en:undifferentiated connective tissue disease | rel=r_associated | relid=0 | w=63
  320. en:addison disease -- r_associated #0: 62 / 0.24 -> en:abnormal growth hormone (139250) response to stimulus
    n1=en:addison disease | n2=en:abnormal growth hormone (139250) response to stimulus | rel=r_associated | relid=0 | w=62
  321. en:addison disease -- r_associated #0: 62 / 0.24 -> en:acromegaly
    n1=en:addison disease | n2=en:acromegaly | rel=r_associated | relid=0 | w=62
  322. en:addison disease -- r_associated #0: 62 / 0.24 -> en:acute lymphoblastic leukemia
    n1=en:addison disease | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=62
  323. en:addison disease -- r_associated #0: 62 / 0.24 -> en:adrenal crisis
    n1=en:addison disease | n2=en:adrenal crisis | rel=r_associated | relid=0 | w=62
  324. en:addison disease -- r_associated #0: 62 / 0.24 -> en:adrenal gland dysgenesis
    n1=en:addison disease | n2=en:adrenal gland dysgenesis | rel=r_associated | relid=0 | w=62
  325. en:addison disease -- r_associated #0: 62 / 0.24 -> en:adrenal hypoplasia
    n1=en:addison disease | n2=en:adrenal hypoplasia | rel=r_associated | relid=0 | w=62
  326. en:addison disease -- r_associated #0: 62 / 0.24 -> en:adrenal insufficiency due to adrenal metastasis
    n1=en:addison disease | n2=en:adrenal insufficiency due to adrenal metastasis | rel=r_associated | relid=0 | w=62
  327. en:addison disease -- r_associated #0: 62 / 0.24 -> en:autoimmune disorders nec
    n1=en:addison disease | n2=en:autoimmune disorders nec | rel=r_associated | relid=0 | w=62
  328. en:addison disease -- r_associated #0: 62 / 0.24 -> en:autoimmune lymphoproliferative syndrome
    n1=en:addison disease | n2=en:autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=62
  329. en:addison disease -- r_associated #0: 62 / 0.24 -> en:c-cell hyperplasia
    n1=en:addison disease | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=62
  330. en:addison disease -- r_associated #0: 62 / 0.24 -> en:citric acid
    n1=en:addison disease | n2=en:citric acid | rel=r_associated | relid=0 | w=62
  331. en:addison disease -- r_associated #0: 62 / 0.24 -> en:congenital hypoplasia of thymus
    n1=en:addison disease | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=62
  332. en:addison disease -- r_associated #0: 62 / 0.24 -> en:delayed puberty (in some patients)
    n1=en:addison disease | n2=en:delayed puberty (in some patients) | rel=r_associated | relid=0 | w=62
  333. en:addison disease -- r_associated #0: 62 / 0.24 -> en:early-onset type ii diabetes (rare)
    n1=en:addison disease | n2=en:early-onset type ii diabetes (rare) | rel=r_associated | relid=0 | w=62
  334. en:addison disease -- r_associated #0: 62 / 0.24 -> en:elevated igf1 levels
    n1=en:addison disease | n2=en:elevated igf1 levels | rel=r_associated | relid=0 | w=62
  335. en:addison disease -- r_associated #0: 62 / 0.24 -> en:endocrine abnormalities, variable, (less common)
    n1=en:addison disease | n2=en:endocrine abnormalities, variable, (less common) | rel=r_associated | relid=0 | w=62
  336. en:addison disease -- r_associated #0: 62 / 0.24 -> en:endocrine pancreatic adenoma
    n1=en:addison disease | n2=en:endocrine pancreatic adenoma | rel=r_associated | relid=0 | w=62
  337. en:addison disease -- r_associated #0: 62 / 0.24 -> en:enlarged thyroid gland (rare)
    n1=en:addison disease | n2=en:enlarged thyroid gland (rare) | rel=r_associated | relid=0 | w=62
  338. en:addison disease -- r_associated #0: 62 / 0.24 -> en:eosinophilic disorder
    n1=en:addison disease | n2=en:eosinophilic disorder | rel=r_associated | relid=0 | w=62
  339. en:addison disease -- r_associated #0: 62 / 0.24 -> en:euthyroid (compensated hypothyroidism)
    n1=en:addison disease | n2=en:euthyroid (compensated hypothyroidism) | rel=r_associated | relid=0 | w=62
  340. en:addison disease -- r_associated #0: 62 / 0.24 -> en:family history of addison disease
    n1=en:addison disease | n2=en:family history of addison disease | rel=r_associated | relid=0 | w=62
  341. en:addison disease -- r_associated #0: 62 / 0.24 -> en:glomerulonephritis
    n1=en:addison disease | n2=en:glomerulonephritis | rel=r_associated | relid=0 | w=62
  342. en:addison disease -- r_associated #0: 62 / 0.24 -> en:goiter may occur
    n1=en:addison disease | n2=en:goiter may occur | rel=r_associated | relid=0 | w=62
  343. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hepatic autoimmune disorders
    n1=en:addison disease | n2=en:hepatic autoimmune disorders | rel=r_associated | relid=0 | w=62
  344. en:addison disease -- r_associated #0: 62 / 0.24 -> en:high absolute level of cortisone metabolites
    n1=en:addison disease | n2=en:high absolute level of cortisone metabolites | rel=r_associated | relid=0 | w=62
  345. en:addison disease -- r_associated #0: 62 / 0.24 -> en:high level of cortisone metabolites
    n1=en:addison disease | n2=en:high level of cortisone metabolites | rel=r_associated | relid=0 | w=62
  346. en:addison disease -- r_associated #0: 62 / 0.24 -> en:high luteinizing hormone levels
    n1=en:addison disease | n2=en:high luteinizing hormone levels | rel=r_associated | relid=0 | w=62
  347. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hiv/aids in women
    n1=en:addison disease | n2=en:hiv/aids in women | rel=r_associated | relid=0 | w=62
  348. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hyperaldosteronism
    n1=en:addison disease | n2=en:hyperaldosteronism | rel=r_associated | relid=0 | w=62
  349. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hyperglycemia
    n1=en:addison disease | n2=en:hyperglycemia | rel=r_associated | relid=0 | w=62
  350. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hyperglycemia (in some patients)
    n1=en:addison disease | n2=en:hyperglycemia (in some patients) | rel=r_associated | relid=0 | w=62
  351. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hypergonadotropic hypogonadism (rare)
    n1=en:addison disease | n2=en:hypergonadotropic hypogonadism (rare) | rel=r_associated | relid=0 | w=62
  352. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hyperinsulinemic hypoglycemia
    n1=en:addison disease | n2=en:hyperinsulinemic hypoglycemia | rel=r_associated | relid=0 | w=62
  353. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hypermetabolism
    n1=en:addison disease | n2=en:hypermetabolism | rel=r_associated | relid=0 | w=62
  354. en:addison disease -- r_associated #0: 62 / 0.24 -> en:hypogonadism (reported in 1 patient)
    n1=en:addison disease | n2=en:hypogonadism (reported in 1 patient) | rel=r_associated | relid=0 | w=62
  355. en:addison disease -- r_associated #0: 62 / 0.24 -> en:increased gonadotropin levels (in female patients)
    n1=en:addison disease | n2=en:increased gonadotropin levels (in female patients) | rel=r_associated | relid=0 | w=62
  356. en:addison disease -- r_associated #0: 62 / 0.24 -> en:increased serum tsh (2 patients)
    n1=en:addison disease | n2=en:increased serum tsh (2 patients) | rel=r_associated | relid=0 | w=62
  357. en:addison disease -- r_associated #0: 62 / 0.24 -> en:increased testosterone
    n1=en:addison disease | n2=en:increased testosterone | rel=r_associated | relid=0 | w=62
  358. en:addison disease -- r_associated #0: 62 / 0.24 -> en:insulin-resistant diabetes mellitus at puberty
    n1=en:addison disease | n2=en:insulin-resistant diabetes mellitus at puberty | rel=r_associated | relid=0 | w=62
  359. en:addison disease -- r_associated #0: 62 / 0.24 -> en:latex allergy
    n1=en:addison disease | n2=en:latex allergy | rel=r_associated | relid=0 | w=62
  360. en:addison disease -- r_associated #0: 62 / 0.24 -> en:low free-t4 levels
    n1=en:addison disease | n2=en:low free-t4 levels | rel=r_associated | relid=0 | w=62
  361. en:addison disease -- r_associated #0: 62 / 0.24 -> en:low to normal serum gonadotropins
    n1=en:addison disease | n2=en:low to normal serum gonadotropins | rel=r_associated | relid=0 | w=62
  362. en:addison disease -- r_associated #0: 62 / 0.24 -> en:low urinary estrogens
    n1=en:addison disease | n2=en:low urinary estrogens | rel=r_associated | relid=0 | w=62
  363. en:addison disease -- r_associated #0: 62 / 0.24 -> en:magnesium 192mg tab
    n1=en:addison disease | n2=en:magnesium 192mg tab | rel=r_associated | relid=0 | w=62
  364. en:addison disease -- r_associated #0: 62 / 0.24 -> en:magnesium oxide 200 mg oral tablet
    n1=en:addison disease | n2=en:magnesium oxide 200 mg oral tablet | rel=r_associated | relid=0 | w=62
  365. en:addison disease -- r_associated #0: 62 / 0.24 -> en:magnesium oxide 500 mg oral tablet
    n1=en:addison disease | n2=en:magnesium oxide 500 mg oral tablet | rel=r_associated | relid=0 | w=62
  366. en:addison disease -- r_associated #0: 62 / 0.24 -> en:malignant adrenal gland neoplasm
    n1=en:addison disease | n2=en:malignant adrenal gland neoplasm | rel=r_associated | relid=0 | w=62
  367. en:addison disease -- r_associated #0: 62 / 0.24 -> en:malignant pancreatic neoplasm
    n1=en:addison disease | n2=en:malignant pancreatic neoplasm | rel=r_associated | relid=0 | w=62
  368. en:addison disease -- r_associated #0: 62 / 0.24 -> en:malignant testicular neoplasm
    n1=en:addison disease | n2=en:malignant testicular neoplasm | rel=r_associated | relid=0 | w=62
  369. en:addison disease -- r_associated #0: 62 / 0.24 -> en:malignant thymus neoplasm
    n1=en:addison disease | n2=en:malignant thymus neoplasm | rel=r_associated | relid=0 | w=62
  370. en:addison disease -- r_associated #0: 62 / 0.24 -> en:normal adrenal function
    n1=en:addison disease | n2=en:normal adrenal function | rel=r_associated | relid=0 | w=62
  371. en:addison disease -- r_associated #0: 62 / 0.24 -> en:normal growth hormone studies
    n1=en:addison disease | n2=en:normal growth hormone studies | rel=r_associated | relid=0 | w=62
  372. en:addison disease -- r_associated #0: 62 / 0.24 -> en:normal or mildly elevated serum phosphate
    n1=en:addison disease | n2=en:normal or mildly elevated serum phosphate | rel=r_associated | relid=0 | w=62
  373. en:addison disease -- r_associated #0: 62 / 0.24 -> en:oligomenorrhea
    n1=en:addison disease | n2=en:oligomenorrhea | rel=r_associated | relid=0 | w=62
  374. en:addison disease -- r_associated #0: 62 / 0.24 -> en:other adrenocortical overactivity
    n1=en:addison disease | n2=en:other adrenocortical overactivity | rel=r_associated | relid=0 | w=62
  375. en:addison disease -- r_associated #0: 62 / 0.24 -> en:pancreas transplantation
    n1=en:addison disease | n2=en:pancreas transplantation | rel=r_associated | relid=0 | w=62
  376. en:addison disease -- r_associated #0: 62 / 0.24 -> en:pituitary amphophil hyperplasia
    n1=en:addison disease | n2=en:pituitary amphophil hyperplasia | rel=r_associated | relid=0 | w=62
  377. en:addison disease -- r_associated #0: 62 / 0.24 -> en:post-adrenalectomy adrenal insufficiency
    n1=en:addison disease | n2=en:post-adrenalectomy adrenal insufficiency | rel=r_associated | relid=0 | w=62
  378. en:addison disease -- r_associated #0: 62 / 0.24 -> en:potassium acetate 2 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium acetate 2 meq/ml injectable solution | rel=r_associated | relid=0 | w=62
  379. en:addison disease -- r_associated #0: 62 / 0.24 -> en:potassium bicarbonate pwdr
    n1=en:addison disease | n2=en:potassium bicarbonate pwdr | rel=r_associated | relid=0 | w=62
  380. en:addison disease -- r_associated #0: 62 / 0.24 -> en:potassium chloride 10 meq extended release oral capsule
    n1=en:addison disease | n2=en:potassium chloride 10 meq extended release oral capsule | rel=r_associated | relid=0 | w=62
  381. en:addison disease -- r_associated #0: 62 / 0.24 -> en:potassium chloride 15 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 15 meq extended release oral tablet | rel=r_associated | relid=0 | w=62
  382. en:addison disease -- r_associated #0: 62 / 0.24 -> en:potassium citrate 5 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium citrate 5 meq extended release oral tablet | rel=r_associated | relid=0 | w=62
  383. en:addison disease -- r_associated #0: 62 / 0.24 -> en:primary adrenal insufficiency
    n1=en:addison disease | n2=en:primary adrenal insufficiency | rel=r_associated | relid=0 | w=62
  384. en:addison disease -- r_associated #0: 62 / 0.24 -> en:primary testicular failure
    n1=en:addison disease | n2=en:primary testicular failure | rel=r_associated | relid=0 | w=62
  385. en:addison disease -- r_associated #0: 62 / 0.24 -> en:renal diseases (endocrine only)
    n1=en:addison disease | n2=en:renal diseases (endocrine only) | rel=r_associated | relid=0 | w=62
  386. en:addison disease -- r_associated #0: 62 / 0.24 -> en:scleroderma and associated disorders
    n1=en:addison disease | n2=en:scleroderma and associated disorders | rel=r_associated | relid=0 | w=62
  387. en:addison disease -- r_associated #0: 62 / 0.24 -> en:seasonal allergic rhinitis
    n1=en:addison disease | n2=en:seasonal allergic rhinitis | rel=r_associated | relid=0 | w=62
  388. en:addison disease -- r_associated #0: 62 / 0.24 -> en:secondary sexual characteristics lacking
    n1=en:addison disease | n2=en:secondary sexual characteristics lacking | rel=r_associated | relid=0 | w=62
  389. en:addison disease -- r_associated #0: 62 / 0.24 -> en:serum estrogen decreased
    n1=en:addison disease | n2=en:serum estrogen decreased | rel=r_associated | relid=0 | w=62
  390. en:addison disease -- r_associated #0: 62 / 0.24 -> en:structure of left inferior parathyroid gland
    n1=en:addison disease | n2=en:structure of left inferior parathyroid gland | rel=r_associated | relid=0 | w=62
  391. en:addison disease -- r_associated #0: 62 / 0.24 -> en:superior parathyroid gland
    n1=en:addison disease | n2=en:superior parathyroid gland | rel=r_associated | relid=0 | w=62
  392. en:addison disease -- r_associated #0: 62 / 0.24 -> en:syndrome of inappropriate antidiuretic hormone secretion
    n1=en:addison disease | n2=en:syndrome of inappropriate antidiuretic hormone secretion | rel=r_associated | relid=0 | w=62
  393. en:addison disease -- r_associated #0: 62 / 0.24 -> en:thyroid gland carcinoma
    n1=en:addison disease | n2=en:thyroid gland carcinoma | rel=r_associated | relid=0 | w=62
  394. en:addison disease -- r_associated #0: 62 / 0.24 -> en:thyroid gland papillary carcinoma
    n1=en:addison disease | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=62
  395. en:addison disease -- r_associated #0: 62 / 0.24 -> en:thyroid lymphangiectasia
    n1=en:addison disease | n2=en:thyroid lymphangiectasia | rel=r_associated | relid=0 | w=62
  396. en:addison disease -- r_associated #0: 62 / 0.24 -> en:turner syndrome
    n1=en:addison disease | n2=en:turner syndrome | rel=r_associated | relid=0 | w=62
  397. en:addison disease -- r_associated #0: 61 / 0.236 -> en:50 ml magnesium sulfate 40 mg/ml injection
    n1=en:addison disease | n2=en:50 ml magnesium sulfate 40 mg/ml injection | rel=r_associated | relid=0 | w=61
  398. en:addison disease -- r_associated #0: 61 / 0.236 -> en:accessory thyroid tissue
    n1=en:addison disease | n2=en:accessory thyroid tissue | rel=r_associated | relid=0 | w=61
  399. en:addison disease -- r_associated #0: 61 / 0.236 -> en:addison melanoderma (disorder)
    n1=en:addison disease | n2=en:addison melanoderma (disorder) | rel=r_associated | relid=0 | w=61
  400. en:addison disease -- r_associated #0: 61 / 0.236 -> en:adrenal
    n1=en:addison disease | n2=en:adrenal | rel=r_associated | relid=0 | w=61
  401. en:addison disease -- r_associated #0: 61 / 0.236 -> en:adrenal crisis in neonatal period
    n1=en:addison disease | n2=en:adrenal crisis in neonatal period | rel=r_associated | relid=0 | w=61
  402. en:addison disease -- r_associated #0: 61 / 0.236 -> en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency
    n1=en:addison disease | n2=en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency | rel=r_associated | relid=0 | w=61
  403. en:addison disease -- r_associated #0: 61 / 0.236 -> en:amenorrhea
    n1=en:addison disease | n2=en:amenorrhea | rel=r_associated | relid=0 | w=61
  404. en:addison disease -- r_associated #0: 61 / 0.236 -> en:autoimmune hepatitis
    n1=en:addison disease | n2=en:autoimmune hepatitis | rel=r_associated | relid=0 | w=61
  405. en:addison disease -- r_associated #0: 61 / 0.236 -> en:bone marrow disorder
    n1=en:addison disease | n2=en:bone marrow disorder | rel=r_associated | relid=0 | w=61
  406. en:addison disease -- r_associated #0: 61 / 0.236 -> en:bullous pemphigoid
    n1=en:addison disease | n2=en:bullous pemphigoid | rel=r_associated | relid=0 | w=61
  407. en:addison disease -- r_associated #0: 61 / 0.236 -> en:catabolic state
    n1=en:addison disease | n2=en:catabolic state | rel=r_associated | relid=0 | w=61
  408. en:addison disease -- r_associated #0: 61 / 0.236 -> en:chromaffin system
    n1=en:addison disease | n2=en:chromaffin system | rel=r_associated | relid=0 | w=61
  409. en:addison disease -- r_associated #0: 61 / 0.236 -> en:congenital adrenal hyperplasia
    n1=en:addison disease | n2=en:congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=61
  410. en:addison disease -- r_associated #0: 61 / 0.236 -> en:congenital hypoparathyroidism
    n1=en:addison disease | n2=en:congenital hypoparathyroidism | rel=r_associated | relid=0 | w=61
  411. en:addison disease -- r_associated #0: 61 / 0.236 -> en:cortisol deficiency
    n1=en:addison disease | n2=en:cortisol deficiency | rel=r_associated | relid=0 | w=61
  412. en:addison disease -- r_associated #0: 61 / 0.236 -> en:cushing disease due to increased acth secretion (less common)
    n1=en:addison disease | n2=en:cushing disease due to increased acth secretion (less common) | rel=r_associated | relid=0 | w=61
  413. en:addison disease -- r_associated #0: 61 / 0.236 -> en:decreased growth hormone (in some patients)
    n1=en:addison disease | n2=en:decreased growth hormone (in some patients) | rel=r_associated | relid=0 | w=61
  414. en:addison disease -- r_associated #0: 61 / 0.236 -> en:decreased testosterone (in some patients)
    n1=en:addison disease | n2=en:decreased testosterone (in some patients) | rel=r_associated | relid=0 | w=61
  415. en:addison disease -- r_associated #0: 61 / 0.236 -> en:defective dht formation
    n1=en:addison disease | n2=en:defective dht formation | rel=r_associated | relid=0 | w=61
  416. en:addison disease -- r_associated #0: 61 / 0.236 -> en:diabetes mellitus
    n1=en:addison disease | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=61
  417. en:addison disease -- r_associated #0: 61 / 0.236 -> en:diabetes mellitus, insulin-dependent (1 patient)
    n1=en:addison disease | n2=en:diabetes mellitus, insulin-dependent (1 patient) | rel=r_associated | relid=0 | w=61
  418. en:addison disease -- r_associated #0: 61 / 0.236 -> en:diabetic diet
    n1=en:addison disease | n2=en:diabetic diet | rel=r_associated | relid=0 | w=61
  419. en:addison disease -- r_associated #0: 61 / 0.236 -> en:drug-induced adrenocortical insufficiency
    n1=en:addison disease | n2=en:drug-induced adrenocortical insufficiency | rel=r_associated | relid=0 | w=61
  420. en:addison disease -- r_associated #0: 61 / 0.236 -> en:early-onset puberty (menarche about 2 years early)
    n1=en:addison disease | n2=en:early-onset puberty (menarche about 2 years early) | rel=r_associated | relid=0 | w=61
  421. en:addison disease -- r_associated #0: 61 / 0.236 -> en:ectopic or absent posterior pituitary
    n1=en:addison disease | n2=en:ectopic or absent posterior pituitary | rel=r_associated | relid=0 | w=61
  422. en:addison disease -- r_associated #0: 61 / 0.236 -> en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect)
    n1=en:addison disease | n2=en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect) | rel=r_associated | relid=0 | w=61
  423. en:addison disease -- r_associated #0: 61 / 0.236 -> en:elevated serum estradiol (in male and female patients)
    n1=en:addison disease | n2=en:elevated serum estradiol (in male and female patients) | rel=r_associated | relid=0 | w=61
  424. en:addison disease -- r_associated #0: 61 / 0.236 -> en:endocrine gland
    n1=en:addison disease | n2=en:endocrine gland | rel=r_associated | relid=0 | w=61
  425. en:addison disease -- r_associated #0: 61 / 0.236 -> en:entire endocrine system
    n1=en:addison disease | n2=en:entire endocrine system | rel=r_associated | relid=0 | w=61
  426. en:addison disease -- r_associated #0: 61 / 0.236 -> en:estradiol undetectable
    n1=en:addison disease | n2=en:estradiol undetectable | rel=r_associated | relid=0 | w=61
  427. en:addison disease -- r_associated #0: 61 / 0.236 -> en:familial hypoaldosteronism
    n1=en:addison disease | n2=en:familial hypoaldosteronism | rel=r_associated | relid=0 | w=61
  428. en:addison disease -- r_associated #0: 61 / 0.236 -> en:fisher syndrome
    n1=en:addison disease | n2=en:fisher syndrome | rel=r_associated | relid=0 | w=61
  429. en:addison disease -- r_associated #0: 61 / 0.236 -> en:free thyroxine to free triiodothyronine ratio markedly low
    n1=en:addison disease | n2=en:free thyroxine to free triiodothyronine ratio markedly low | rel=r_associated | relid=0 | w=61
  430. en:addison disease -- r_associated #0: 61 / 0.236 -> en:gastrin-producing neuroendocrine tumor
    n1=en:addison disease | n2=en:gastrin-producing neuroendocrine tumor | rel=r_associated | relid=0 | w=61
  431. en:addison disease -- r_associated #0: 61 / 0.236 -> en:growth hormone deficiency (hcs)
    n1=en:addison disease | n2=en:growth hormone deficiency (hcs) | rel=r_associated | relid=0 | w=61
  432. en:addison disease -- r_associated #0: 61 / 0.236 -> en:growth hormone deficiency (reported in 1 patient)
    n1=en:addison disease | n2=en:growth hormone deficiency (reported in 1 patient) | rel=r_associated | relid=0 | w=61
  433. en:addison disease -- r_associated #0: 61 / 0.236 -> en:growth hormone deficiency in some individuals
    n1=en:addison disease | n2=en:growth hormone deficiency in some individuals | rel=r_associated | relid=0 | w=61
  434. en:addison disease -- r_associated #0: 61 / 0.236 -> en:high serum leptin levels (rare)
    n1=en:addison disease | n2=en:high serum leptin levels (rare) | rel=r_associated | relid=0 | w=61
  435. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hormone
    n1=en:addison disease | n2=en:hormone | rel=r_associated | relid=0 | w=61
  436. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hypercalcemia
    n1=en:addison disease | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=61
  437. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hyperinsulinemia (in some patients)
    n1=en:addison disease | n2=en:hyperinsulinemia (in some patients) | rel=r_associated | relid=0 | w=61
  438. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hypoadrenocorticism, familial
    n1=en:addison disease | n2=en:hypoadrenocorticism, familial | rel=r_associated | relid=0 | w=61
  439. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hypoglycemia, fasting
    n1=en:addison disease | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=61
  440. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hypogonadaism
    n1=en:addison disease | n2=en:hypogonadaism | rel=r_associated | relid=0 | w=61
  441. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hypogonadism (1 patient)
    n1=en:addison disease | n2=en:hypogonadism (1 patient) | rel=r_associated | relid=0 | w=61
  442. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hypokalemia (rare)
    n1=en:addison disease | n2=en:hypokalemia (rare) | rel=r_associated | relid=0 | w=61
  443. en:addison disease -- r_associated #0: 61 / 0.236 -> en:hypothalamic insufficiency
    n1=en:addison disease | n2=en:hypothalamic insufficiency | rel=r_associated | relid=0 | w=61
  444. en:addison disease -- r_associated #0: 61 / 0.236 -> en:immunological synapses
    n1=en:addison disease | n2=en:immunological synapses | rel=r_associated | relid=0 | w=61
  445. en:addison disease -- r_associated #0: 61 / 0.236 -> en:impaired glucose tolerance (in some patients)
    n1=en:addison disease | n2=en:impaired glucose tolerance (in some patients) | rel=r_associated | relid=0 | w=61
  446. en:addison disease -- r_associated #0: 61 / 0.236 -> en:increased sweating at early age
    n1=en:addison disease | n2=en:increased sweating at early age | rel=r_associated | relid=0 | w=61
  447. en:addison disease -- r_associated #0: 61 / 0.236 -> en:increased thyroxine level
    n1=en:addison disease | n2=en:increased thyroxine level | rel=r_associated | relid=0 | w=61
  448. en:addison disease -- r_associated #0: 61 / 0.236 -> en:infectious mononucleosis
    n1=en:addison disease | n2=en:infectious mononucleosis | rel=r_associated | relid=0 | w=61
  449. en:addison disease -- r_associated #0: 61 / 0.236 -> en:insulin deficiency (may develop later in life)
    n1=en:addison disease | n2=en:insulin deficiency (may develop later in life) | rel=r_associated | relid=0 | w=61
  450. en:addison disease -- r_associated #0: 61 / 0.236 -> en:insulin resistance
    n1=en:addison disease | n2=en:insulin resistance | rel=r_associated | relid=0 | w=61
  451. en:addison disease -- r_associated #0: 61 / 0.236 -> en:insulin-dependent but ketosis-resistant diabetes
    n1=en:addison disease | n2=en:insulin-dependent but ketosis-resistant diabetes | rel=r_associated | relid=0 | w=61
  452. en:addison disease -- r_associated #0: 61 / 0.236 -> en:intermittent severe hypoglycemia
    n1=en:addison disease | n2=en:intermittent severe hypoglycemia | rel=r_associated | relid=0 | w=61
  453. en:addison disease -- r_associated #0: 61 / 0.236 -> en:lack of secondary sex characteristics
    n1=en:addison disease | n2=en:lack of secondary sex characteristics | rel=r_associated | relid=0 | w=61
  454. en:addison disease -- r_associated #0: 61 / 0.236 -> en:lambert eaton myasthenic syndrome
    n1=en:addison disease | n2=en:lambert eaton myasthenic syndrome | rel=r_associated | relid=0 | w=61
  455. en:addison disease -- r_associated #0: 61 / 0.236 -> en:low anti-mullerian hormone (amh) level
    n1=en:addison disease | n2=en:low anti-mullerian hormone (amh) level | rel=r_associated | relid=0 | w=61
  456. en:addison disease -- r_associated #0: 61 / 0.236 -> en:low estradiol levels
    n1=en:addison disease | n2=en:low estradiol levels | rel=r_associated | relid=0 | w=61
  457. en:addison disease -- r_associated #0: 61 / 0.236 -> en:low follicle-stimulating hormone (fsh)
    n1=en:addison disease | n2=en:low follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=61
  458. en:addison disease -- r_associated #0: 61 / 0.236 -> en:low inhibin b level
    n1=en:addison disease | n2=en:low inhibin b level | rel=r_associated | relid=0 | w=61
  459. en:addison disease -- r_associated #0: 61 / 0.236 -> en:low serum estradiol levels
    n1=en:addison disease | n2=en:low serum estradiol levels | rel=r_associated | relid=0 | w=61
  460. en:addison disease -- r_associated #0: 61 / 0.236 -> en:luteinizing hormone levels elevated
    n1=en:addison disease | n2=en:luteinizing hormone levels elevated | rel=r_associated | relid=0 | w=61
  461. en:addison disease -- r_associated #0: 61 / 0.236 -> en:magnesium sulfate 10gm/1000ml intravenous
    n1=en:addison disease | n2=en:magnesium sulfate 10gm/1000ml intravenous | rel=r_associated | relid=0 | w=61
  462. en:addison disease -- r_associated #0: 61 / 0.236 -> en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial
    n1=en:addison disease | n2=en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial | rel=r_associated | relid=0 | w=61
  463. en:addison disease -- r_associated #0: 61 / 0.236 -> en:mineralocorticoid deficiency
    n1=en:addison disease | n2=en:mineralocorticoid deficiency | rel=r_associated | relid=0 | w=61
  464. en:addison disease -- r_associated #0: 61 / 0.236 -> en:modestly low estradiol
    n1=en:addison disease | n2=en:modestly low estradiol | rel=r_associated | relid=0 | w=61
  465. en:addison disease -- r_associated #0: 61 / 0.236 -> en:multiple hormone resistance
    n1=en:addison disease | n2=en:multiple hormone resistance | rel=r_associated | relid=0 | w=61
  466. en:addison disease -- r_associated #0: 61 / 0.236 -> en:neurogenic diabetes insipidus
    n1=en:addison disease | n2=en:neurogenic diabetes insipidus | rel=r_associated | relid=0 | w=61
  467. en:addison disease -- r_associated #0: 61 / 0.236 -> en:normal anterior pituitary function
    n1=en:addison disease | n2=en:normal anterior pituitary function | rel=r_associated | relid=0 | w=61
  468. en:addison disease -- r_associated #0: 61 / 0.236 -> en:normal pituitary function
    n1=en:addison disease | n2=en:normal pituitary function | rel=r_associated | relid=0 | w=61
  469. en:addison disease -- r_associated #0: 61 / 0.236 -> en:normal sized thyroid gland
    n1=en:addison disease | n2=en:normal sized thyroid gland | rel=r_associated | relid=0 | w=61
  470. en:addison disease -- r_associated #0: 61 / 0.236 -> en:other specified disorders of adrenal gland
    n1=en:addison disease | n2=en:other specified disorders of adrenal gland | rel=r_associated | relid=0 | w=61
  471. en:addison disease -- r_associated #0: 61 / 0.236 -> en:paraganglion
    n1=en:addison disease | n2=en:paraganglion | rel=r_associated | relid=0 | w=61
  472. en:addison disease -- r_associated #0: 61 / 0.236 -> en:parathyroid gland adenoma
    n1=en:addison disease | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=61
  473. en:addison disease -- r_associated #0: 61 / 0.236 -> en:parathyroid hormone levels low to low-normal
    n1=en:addison disease | n2=en:parathyroid hormone levels low to low-normal | rel=r_associated | relid=0 | w=61
  474. en:addison disease -- r_associated #0: 61 / 0.236 -> en:parathyroid hyperplasia
    n1=en:addison disease | n2=en:parathyroid hyperplasia | rel=r_associated | relid=0 | w=61
  475. en:addison disease -- r_associated #0: 61 / 0.236 -> en:pituitary gland adenoma
    n1=en:addison disease | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=61
  476. en:addison disease -- r_associated #0: 61 / 0.236 -> en:plasma dihydrotestosterone (dht) is decreased
    n1=en:addison disease | n2=en:plasma dihydrotestosterone (dht) is decreased | rel=r_associated | relid=0 | w=61
  477. en:addison disease -- r_associated #0: 61 / 0.236 -> en:poor secondary sexual development (1 family)
    n1=en:addison disease | n2=en:poor secondary sexual development (1 family) | rel=r_associated | relid=0 | w=61
  478. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium acetate
    n1=en:addison disease | n2=en:potassium acetate | rel=r_associated | relid=0 | w=61
  479. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium acetate 4 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium acetate 4 meq/ml injectable solution | rel=r_associated | relid=0 | w=61
  480. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium bicarbonate 99 mg oral capsule
    n1=en:addison disease | n2=en:potassium bicarbonate 99 mg oral capsule | rel=r_associated | relid=0 | w=61
  481. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium bitartrate
    n1=en:addison disease | n2=en:potassium bitartrate | rel=r_associated | relid=0 | w=61
  482. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium chloride 0.125 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium chloride 0.125 meq/ml oral solution | rel=r_associated | relid=0 | w=61
  483. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium chloride 0.67 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 0.67 meq/ml injectable solution | rel=r_associated | relid=0 | w=61
  484. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium chloride 1.33 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium chloride 1.33 meq/ml oral solution | rel=r_associated | relid=0 | w=61
  485. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium chloride 10 meq extended release oral tablet [k-dur]
    n1=en:addison disease | n2=en:potassium chloride 10 meq extended release oral tablet [k-dur] | rel=r_associated | relid=0 | w=61
  486. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium chloride 3 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 3 meq/ml injectable solution | rel=r_associated | relid=0 | w=61
  487. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium chloride 4 meq delayed release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 4 meq delayed release oral tablet | rel=r_associated | relid=0 | w=61
  488. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium chloride 6.7 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 6.7 meq extended release oral tablet | rel=r_associated | relid=0 | w=61
  489. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium gluconate
    n1=en:addison disease | n2=en:potassium gluconate | rel=r_associated | relid=0 | w=61
  490. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium gluconate 2.5 meq oral tablet
    n1=en:addison disease | n2=en:potassium gluconate 2.5 meq oral tablet | rel=r_associated | relid=0 | w=61
  491. en:addison disease -- r_associated #0: 61 / 0.236 -> en:potassium gluconate 5 meq oral tablet
    n1=en:addison disease | n2=en:potassium gluconate 5 meq oral tablet | rel=r_associated | relid=0 | w=61
  492. en:addison disease -- r_associated #0: 61 / 0.236 -> en:precocious puberty in males
    n1=en:addison disease | n2=en:precocious puberty in males | rel=r_associated | relid=0 | w=61
  493. en:addison disease -- r_associated #0: 61 / 0.236 -> en:pregnanetriolone (ptl) present in urine
    n1=en:addison disease | n2=en:pregnanetriolone (ptl) present in urine | rel=r_associated | relid=0 | w=61
  494. en:addison disease -- r_associated #0: 61 / 0.236 -> en:premature menopause
    n1=en:addison disease | n2=en:premature menopause | rel=r_associated | relid=0 | w=61
  495. en:addison disease -- r_associated #0: 61 / 0.236 -> en:premature ovarian failure in female carriers
    n1=en:addison disease | n2=en:premature ovarian failure in female carriers | rel=r_associated | relid=0 | w=61
  496. en:addison disease -- r_associated #0: 61 / 0.236 -> en:premature pubertal basal levels of luteinizing hormone (lh)
    n1=en:addison disease | n2=en:premature pubertal basal levels of luteinizing hormone (lh) | rel=r_associated | relid=0 | w=61
  497. en:addison disease -- r_associated #0: 61 / 0.236 -> en:premature pubertal stimulated levels of lh
    n1=en:addison disease | n2=en:premature pubertal stimulated levels of lh | rel=r_associated | relid=0 | w=61
  498. en:addison disease -- r_associated #0: 61 / 0.236 -> en:primary amenorrhea (in a subset of patients)
    n1=en:addison disease | n2=en:primary amenorrhea (in a subset of patients) | rel=r_associated | relid=0 | w=61
  499. en:addison disease -- r_associated #0: 61 / 0.236 -> en:pseudohypoaldosteronism type 1
    n1=en:addison disease | n2=en:pseudohypoaldosteronism type 1 | rel=r_associated | relid=0 | w=61
  500. en:addison disease -- r_associated #0: 61 / 0.236 -> en:renal resistance to pth
    n1=en:addison disease | n2=en:renal resistance to pth | rel=r_associated | relid=0 | w=61
  501. en:addison disease -- r_associated #0: 61 / 0.236 -> en:subclinical hypothyroidism
    n1=en:addison disease | n2=en:subclinical hypothyroidism | rel=r_associated | relid=0 | w=61
  502. en:addison disease -- r_associated #0: 61 / 0.236 -> en:subset of patients with ovarioleukodystrophy have primary amenorrhea
    n1=en:addison disease | n2=en:subset of patients with ovarioleukodystrophy have primary amenorrhea | rel=r_associated | relid=0 | w=61
  503. en:addison disease -- r_associated #0: 61 / 0.236 -> en:testicular hypofunction due to defect in adrenocortical hormone synthesis
    n1=en:addison disease | n2=en:testicular hypofunction due to defect in adrenocortical hormone synthesis | rel=r_associated | relid=0 | w=61
  504. en:addison disease -- r_associated #0: 61 / 0.236 -> en:thymus disorder
    n1=en:addison disease | n2=en:thymus disorder | rel=r_associated | relid=0 | w=61
  505. en:addison disease -- r_associated #0: 61 / 0.236 -> en:thyroid hyperplasia
    n1=en:addison disease | n2=en:thyroid hyperplasia | rel=r_associated | relid=0 | w=61
  506. en:addison disease -- r_associated #0: 61 / 0.236 -> en:thyroid storm
    n1=en:addison disease | n2=en:thyroid storm | rel=r_associated | relid=0 | w=61
  507. en:addison disease -- r_associated #0: 61 / 0.236 -> en:thyroid volume 22-66ml (adults)
    n1=en:addison disease | n2=en:thyroid volume 22-66ml (adults) | rel=r_associated | relid=0 | w=61
  508. en:addison disease -- r_associated #0: 61 / 0.236 -> en:total and free triiodothyronine high-normal or elevated
    n1=en:addison disease | n2=en:total and free triiodothyronine high-normal or elevated | rel=r_associated | relid=0 | w=61
  509. en:addison disease -- r_associated #0: 61 / 0.236 -> en:trivalent influenza vaccine
    n1=en:addison disease | n2=en:trivalent influenza vaccine | rel=r_associated | relid=0 | w=61
  510. en:addison disease -- r_associated #0: 60 / 0.233 -> en:50 ml magnesium sulfate 80 mg/ml injection
    n1=en:addison disease | n2=en:50 ml magnesium sulfate 80 mg/ml injection | rel=r_associated | relid=0 | w=60
  511. en:addison disease -- r_associated #0: 60 / 0.233 -> en:abnormal glucose tolerance test
    n1=en:addison disease | n2=en:abnormal glucose tolerance test | rel=r_associated | relid=0 | w=60
  512. en:addison disease -- r_associated #0: 60 / 0.233 -> en:absent or delayed puberty
    n1=en:addison disease | n2=en:absent or delayed puberty | rel=r_associated | relid=0 | w=60
  513. en:addison disease -- r_associated #0: 60 / 0.233 -> en:acquired porphyria
    n1=en:addison disease | n2=en:acquired porphyria | rel=r_associated | relid=0 | w=60
  514. en:addison disease -- r_associated #0: 60 / 0.233 -> en:adrenal adenomas, bilateral
    n1=en:addison disease | n2=en:adrenal adenomas, bilateral | rel=r_associated | relid=0 | w=60
  515. en:addison disease -- r_associated #0: 60 / 0.233 -> en:adrenal gland disorder
    n1=en:addison disease | n2=en:adrenal gland disorder | rel=r_associated | relid=0 | w=60
  516. en:addison disease -- r_associated #0: 60 / 0.233 -> en:adrenocortical cytomegaly
    n1=en:addison disease | n2=en:adrenocortical cytomegaly | rel=r_associated | relid=0 | w=60
  517. en:addison disease -- r_associated #0: 60 / 0.233 -> en:adrenocorticotropin deficiency
    n1=en:addison disease | n2=en:adrenocorticotropin deficiency | rel=r_associated | relid=0 | w=60
  518. en:addison disease -- r_associated #0: 60 / 0.233 -> en:adrenogenital syndrome
    n1=en:addison disease | n2=en:adrenogenital syndrome | rel=r_associated | relid=0 | w=60
  519. en:addison disease -- r_associated #0: 60 / 0.233 -> en:age at natural menopause qtl
    n1=en:addison disease | n2=en:age at natural menopause qtl | rel=r_associated | relid=0 | w=60
  520. en:addison disease -- r_associated #0: 60 / 0.233 -> en:aldosterone level increased above normal
    n1=en:addison disease | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=60
  521. en:addison disease -- r_associated #0: 60 / 0.233 -> en:anti-glomerular basement membrane disease
    n1=en:addison disease | n2=en:anti-glomerular basement membrane disease | rel=r_associated | relid=0 | w=60
  522. en:addison disease -- r_associated #0: 60 / 0.233 -> en:antisynthetase syndrome
    n1=en:addison disease | n2=en:antisynthetase syndrome | rel=r_associated | relid=0 | w=60
  523. en:addison disease -- r_associated #0: 60 / 0.233 -> en:aplastic anemia
    n1=en:addison disease | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=60
  524. en:addison disease -- r_associated #0: 60 / 0.233 -> en:argentaffin cell
    n1=en:addison disease | n2=en:argentaffin cell | rel=r_associated | relid=0 | w=60
  525. en:addison disease -- r_associated #0: 60 / 0.233 -> en:autoimmune disease, nec in mdr
    n1=en:addison disease | n2=en:autoimmune disease, nec in mdr | rel=r_associated | relid=0 | w=60
  526. en:addison disease -- r_associated #0: 60 / 0.233 -> en:autoimmune disease:find:pt:^family member:nom:phenx
    n1=en:addison disease | n2=en:autoimmune disease:find:pt:^family member:nom:phenx | rel=r_associated | relid=0 | w=60
  527. en:addison disease -- r_associated #0: 60 / 0.233 -> en:carotenemia
    n1=en:addison disease | n2=en:carotenemia | rel=r_associated | relid=0 | w=60
  528. en:addison disease -- r_associated #0: 60 / 0.233 -> en:central hyperthyroidism
    n1=en:addison disease | n2=en:central hyperthyroidism | rel=r_associated | relid=0 | w=60
  529. en:addison disease -- r_associated #0: 60 / 0.233 -> en:cervical neuroendocrine carcinoma
    n1=en:addison disease | n2=en:cervical neuroendocrine carcinoma | rel=r_associated | relid=0 | w=60
  530. en:addison disease -- r_associated #0: 60 / 0.233 -> en:childhood asthma
    n1=en:addison disease | n2=en:childhood asthma | rel=r_associated | relid=0 | w=60
  531. en:addison disease -- r_associated #0: 60 / 0.233 -> en:congenital absence of parathyroid gland
    n1=en:addison disease | n2=en:congenital absence of parathyroid gland | rel=r_associated | relid=0 | w=60
  532. en:addison disease -- r_associated #0: 60 / 0.233 -> en:cortisol insufficiency
    n1=en:addison disease | n2=en:cortisol insufficiency | rel=r_associated | relid=0 | w=60
  533. en:addison disease -- r_associated #0: 60 / 0.233 -> en:crystal arthropathy
    n1=en:addison disease | n2=en:crystal arthropathy | rel=r_associated | relid=0 | w=60
  534. en:addison disease -- r_associated #0: 60 / 0.233 -> en:decreased circulating renin level
    n1=en:addison disease | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=60
  535. en:addison disease -- r_associated #0: 60 / 0.233 -> en:decreased testosterone in males
    n1=en:addison disease | n2=en:decreased testosterone in males | rel=r_associated | relid=0 | w=60
  536. en:addison disease -- r_associated #0: 60 / 0.233 -> en:deficient growth hormone response to insulin, arginine, or levodopa
    n1=en:addison disease | n2=en:deficient growth hormone response to insulin, arginine, or levodopa | rel=r_associated | relid=0 | w=60
  537. en:addison disease -- r_associated #0: 60 / 0.233 -> en:delayed or incomplete puberty (1 family)
    n1=en:addison disease | n2=en:delayed or incomplete puberty (1 family) | rel=r_associated | relid=0 | w=60
  538. en:addison disease -- r_associated #0: 60 / 0.233 -> en:delayed puberty
    n1=en:addison disease | n2=en:delayed puberty | rel=r_associated | relid=0 | w=60
  539. en:addison disease -- r_associated #0: 60 / 0.233 -> en:delayed testosterone increase at puberty
    n1=en:addison disease | n2=en:delayed testosterone increase at puberty | rel=r_associated | relid=0 | w=60
  540. en:addison disease -- r_associated #0: 60 / 0.233 -> en:diabetes mellitus (in some patients)
    n1=en:addison disease | n2=en:diabetes mellitus (in some patients) | rel=r_associated | relid=0 | w=60
  541. en:addison disease -- r_associated #0: 60 / 0.233 -> en:diabetes mellitus, type 1 (rare)
    n1=en:addison disease | n2=en:diabetes mellitus, type 1 (rare) | rel=r_associated | relid=0 | w=60
  542. en:addison disease -- r_associated #0: 60 / 0.233 -> en:diabetes mellitus, type 2 (rare)
    n1=en:addison disease | n2=en:diabetes mellitus, type 2 (rare) | rel=r_associated | relid=0 | w=60
  543. en:addison disease -- r_associated #0: 60 / 0.233 -> en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx
    n1=en:addison disease | n2=en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx | rel=r_associated | relid=0 | w=60
  544. en:addison disease -- r_associated #0: 60 / 0.233 -> en:ectopic endocrine structure
    n1=en:addison disease | n2=en:ectopic endocrine structure | rel=r_associated | relid=0 | w=60
  545. en:addison disease -- r_associated #0: 60 / 0.233 -> en:ectopic posterior pituitary
    n1=en:addison disease | n2=en:ectopic posterior pituitary | rel=r_associated | relid=0 | w=60
  546. en:addison disease -- r_associated #0: 60 / 0.233 -> en:elevated fasting glucose
    n1=en:addison disease | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=60
  547. en:addison disease -- r_associated #0: 60 / 0.233 -> en:elevated prepubertal levels of estradiol
    n1=en:addison disease | n2=en:elevated prepubertal levels of estradiol | rel=r_associated | relid=0 | w=60
  548. en:addison disease -- r_associated #0: 60 / 0.233 -> en:elevated serum luteinizing hormone (in male and female patients)
    n1=en:addison disease | n2=en:elevated serum luteinizing hormone (in male and female patients) | rel=r_associated | relid=0 | w=60
  549. en:addison disease -- r_associated #0: 60 / 0.233 -> en:endocrine pancreas disorder
    n1=en:addison disease | n2=en:endocrine pancreas disorder | rel=r_associated | relid=0 | w=60
  550. en:addison disease -- r_associated #0: 60 / 0.233 -> en:endocrine tissue
    n1=en:addison disease | n2=en:endocrine tissue | rel=r_associated | relid=0 | w=60
  551. en:addison disease -- r_associated #0: 60 / 0.233 -> en:enzyme induction
    n1=en:addison disease | n2=en:enzyme induction | rel=r_associated | relid=0 | w=60
  552. en:addison disease -- r_associated #0: 60 / 0.233 -> en:few and small islets of langerhans
    n1=en:addison disease | n2=en:few and small islets of langerhans | rel=r_associated | relid=0 | w=60
  553. en:addison disease -- r_associated #0: 60 / 0.233 -> en:glucagonoma syndrome
    n1=en:addison disease | n2=en:glucagonoma syndrome | rel=r_associated | relid=0 | w=60
  554. en:addison disease -- r_associated #0: 60 / 0.233 -> en:gonadotrophin levels low
    n1=en:addison disease | n2=en:gonadotrophin levels low | rel=r_associated | relid=0 | w=60
  555. en:addison disease -- r_associated #0: 60 / 0.233 -> en:growth disorders
    n1=en:addison disease | n2=en:growth disorders | rel=r_associated | relid=0 | w=60
  556. en:addison disease -- r_associated #0: 60 / 0.233 -> en:high follicle-stimulating hormone levels
    n1=en:addison disease | n2=en:high follicle-stimulating hormone levels | rel=r_associated | relid=0 | w=60
  557. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hodgkin lymphoma
    n1=en:addison disease | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=60
  558. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hypergonadotrophic hypogonadism (in females in adolescence)
    n1=en:addison disease | n2=en:hypergonadotrophic hypogonadism (in females in adolescence) | rel=r_associated | relid=0 | w=60
  559. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hypergonadotropic hypogonadism (reported in 1 female)
    n1=en:addison disease | n2=en:hypergonadotropic hypogonadism (reported in 1 female) | rel=r_associated | relid=0 | w=60
  560. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hyperparathyroidism
    n1=en:addison disease | n2=en:hyperparathyroidism | rel=r_associated | relid=0 | w=60
  561. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hyperprolactinemia
    n1=en:addison disease | n2=en:hyperprolactinemia | rel=r_associated | relid=0 | w=60
  562. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hyperthyroidism
    n1=en:addison disease | n2=en:hyperthyroidism | rel=r_associated | relid=0 | w=60
  563. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hypogonadotropic hypogonadism (in some patients)
    n1=en:addison disease | n2=en:hypogonadotropic hypogonadism (in some patients) | rel=r_associated | relid=0 | w=60
  564. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hypoplasia of the thyroid gland in some patients
    n1=en:addison disease | n2=en:hypoplasia of the thyroid gland in some patients | rel=r_associated | relid=0 | w=60
  565. en:addison disease -- r_associated #0: 60 / 0.233 -> en:hypothyroidic goitre
    n1=en:addison disease | n2=en:hypothyroidic goitre | rel=r_associated | relid=0 | w=60
  566. en:addison disease -- r_associated #0: 60 / 0.233 -> en:idiopathic thrombocytopenic purpura
    n1=en:addison disease | n2=en:idiopathic thrombocytopenic purpura | rel=r_associated | relid=0 | w=60
  567. en:addison disease -- r_associated #0: 60 / 0.233 -> en:immune system
    n1=en:addison disease | n2=en:immune system | rel=r_associated | relid=0 | w=60
  568. en:addison disease -- r_associated #0: 60 / 0.233 -> en:immunization
    n1=en:addison disease | n2=en:immunization | rel=r_associated | relid=0 | w=60
  569. en:addison disease -- r_associated #0: 60 / 0.233 -> en:increased cortisol excretion rate
    n1=en:addison disease | n2=en:increased cortisol excretion rate | rel=r_associated | relid=0 | w=60
  570. en:addison disease -- r_associated #0: 60 / 0.233 -> en:increased prolactin level
    n1=en:addison disease | n2=en:increased prolactin level | rel=r_associated | relid=0 | w=60
  571. en:addison disease -- r_associated #0: 60 / 0.233 -> en:lack of growth hormone (gh) response to stimulation
    n1=en:addison disease | n2=en:lack of growth hormone (gh) response to stimulation | rel=r_associated | relid=0 | w=60
  572. en:addison disease -- r_associated #0: 60 / 0.233 -> en:lack of secondary sexual characteristics (in 1 family)
    n1=en:addison disease | n2=en:lack of secondary sexual characteristics (in 1 family) | rel=r_associated | relid=0 | w=60
  573. en:addison disease -- r_associated #0: 60 / 0.233 -> en:low estradiol in females
    n1=en:addison disease | n2=en:low estradiol in females | rel=r_associated | relid=0 | w=60
  574. en:addison disease -- r_associated #0: 60 / 0.233 -> en:low estrogen and progesterone
    n1=en:addison disease | n2=en:low estrogen and progesterone | rel=r_associated | relid=0 | w=60
  575. en:addison disease -- r_associated #0: 60 / 0.233 -> en:low to undetectable insulin levels in the presence of hyperglycemia
    n1=en:addison disease | n2=en:low to undetectable insulin levels in the presence of hyperglycemia | rel=r_associated | relid=0 | w=60
  576. en:addison disease -- r_associated #0: 60 / 0.233 -> en:lupus erythematosus and associated conditions
    n1=en:addison disease | n2=en:lupus erythematosus and associated conditions | rel=r_associated | relid=0 | w=60
  577. en:addison disease -- r_associated #0: 60 / 0.233 -> en:magnesium oxide 140 mg oral capsule
    n1=en:addison disease | n2=en:magnesium oxide 140 mg oral capsule | rel=r_associated | relid=0 | w=60
  578. en:addison disease -- r_associated #0: 60 / 0.233 -> en:magnesium oxide 250 mg oral tablet
    n1=en:addison disease | n2=en:magnesium oxide 250 mg oral tablet | rel=r_associated | relid=0 | w=60
  579. en:addison disease -- r_associated #0: 60 / 0.233 -> en:magnesium oxide 500 mg oral capsule
    n1=en:addison disease | n2=en:magnesium oxide 500 mg oral capsule | rel=r_associated | relid=0 | w=60
  580. en:addison disease -- r_associated #0: 60 / 0.233 -> en:magnesium sulfate 10 mg/ml injection
    n1=en:addison disease | n2=en:magnesium sulfate 10 mg/ml injection | rel=r_associated | relid=0 | w=60
  581. en:addison disease -- r_associated #0: 60 / 0.233 -> en:magnesium sulfate 1000 mg oral granules
    n1=en:addison disease | n2=en:magnesium sulfate 1000 mg oral granules | rel=r_associated | relid=0 | w=60
  582. en:addison disease -- r_associated #0: 60 / 0.233 -> en:masculinization at puberty
    n1=en:addison disease | n2=en:masculinization at puberty | rel=r_associated | relid=0 | w=60
  583. en:addison disease -- r_associated #0: 60 / 0.233 -> en:mineralocorticoid insufficiency
    n1=en:addison disease | n2=en:mineralocorticoid insufficiency | rel=r_associated | relid=0 | w=60
  584. en:addison disease -- r_associated #0: 60 / 0.233 -> en:necrosis adrenal cortex
    n1=en:addison disease | n2=en:necrosis adrenal cortex | rel=r_associated | relid=0 | w=60
  585. en:addison disease -- r_associated #0: 60 / 0.233 -> en:neonatal hyperbilirubinemia
    n1=en:addison disease | n2=en:neonatal hyperbilirubinemia | rel=r_associated | relid=0 | w=60
  586. en:addison disease -- r_associated #0: 60 / 0.233 -> en:nonautoimmune insulin-dependent diabetes in second decade of life
    n1=en:addison disease | n2=en:nonautoimmune insulin-dependent diabetes in second decade of life | rel=r_associated | relid=0 | w=60
  587. en:addison disease -- r_associated #0: 60 / 0.233 -> en:normal female secondary sexual characteristics
    n1=en:addison disease | n2=en:normal female secondary sexual characteristics | rel=r_associated | relid=0 | w=60
  588. en:addison disease -- r_associated #0: 60 / 0.233 -> en:normal follicle-stimulating hormone (fsh)
    n1=en:addison disease | n2=en:normal follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=60
  589. en:addison disease -- r_associated #0: 60 / 0.233 -> en:normal luteinizing hormone (lh)
    n1=en:addison disease | n2=en:normal luteinizing hormone (lh) | rel=r_associated | relid=0 | w=60
  590. en:addison disease -- r_associated #0: 60 / 0.233 -> en:ophthalmia, sympathetic
    n1=en:addison disease | n2=en:ophthalmia, sympathetic | rel=r_associated | relid=0 | w=60
  591. en:addison disease -- r_associated #0: 60 / 0.233 -> en:ovarian cyst
    n1=en:addison disease | n2=en:ovarian cyst | rel=r_associated | relid=0 | w=60
  592. en:addison disease -- r_associated #0: 60 / 0.233 -> en:parathyroid hypoplasia
    n1=en:addison disease | n2=en:parathyroid hypoplasia | rel=r_associated | relid=0 | w=60
  593. en:addison disease -- r_associated #0: 60 / 0.233 -> en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections
    n1=en:addison disease | n2=en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections | rel=r_associated | relid=0 | w=60
  594. en:addison disease -- r_associated #0: 60 / 0.233 -> en:pituitary anomalies
    n1=en:addison disease | n2=en:pituitary anomalies | rel=r_associated | relid=0 | w=60
  595. en:addison disease -- r_associated #0: 60 / 0.233 -> en:plasma cell myeloma
    n1=en:addison disease | n2=en:plasma cell myeloma | rel=r_associated | relid=0 | w=60
  596. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium chloride 0.167 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium chloride 0.167 meq/ml oral solution | rel=r_associated | relid=0 | w=60
  597. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium chloride 0.2 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 0.2 meq/ml injectable solution | rel=r_associated | relid=0 | w=60
  598. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium chloride 1.5 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 1.5 meq/ml injectable solution | rel=r_associated | relid=0 | w=60
  599. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium chloride 10 meq oral tablet
    n1=en:addison disease | n2=en:potassium chloride 10 meq oral tablet | rel=r_associated | relid=0 | w=60
  600. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium chloride 2 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium chloride 2 meq/ml oral solution | rel=r_associated | relid=0 | w=60
  601. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium chloride 20 meq extended release oral tablet [k-dur]
    n1=en:addison disease | n2=en:potassium chloride 20 meq extended release oral tablet [k-dur] | rel=r_associated | relid=0 | w=60
  602. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium chloride 8 meq delayed release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 8 meq delayed release oral tablet | rel=r_associated | relid=0 | w=60
  603. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium gluconate 1.33 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium gluconate 1.33 meq/ml oral solution | rel=r_associated | relid=0 | w=60
  604. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium gluconate 2 meq oral tablet
    n1=en:addison disease | n2=en:potassium gluconate 2 meq oral tablet | rel=r_associated | relid=0 | w=60
  605. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium gluconate 2.35 meq oral tablet
    n1=en:addison disease | n2=en:potassium gluconate 2.35 meq oral tablet | rel=r_associated | relid=0 | w=60
  606. en:addison disease -- r_associated #0: 60 / 0.233 -> en:potassium,chelated 99 mg oral tablet
    n1=en:addison disease | n2=en:potassium,chelated 99 mg oral tablet | rel=r_associated | relid=0 | w=60
  607. en:addison disease -- r_associated #0: 60 / 0.233 -> en:precocious puberty with sertoli cell tumor
    n1=en:addison disease | n2=en:precocious puberty with sertoli cell tumor | rel=r_associated | relid=0 | w=60
  608. en:addison disease -- r_associated #0: 60 / 0.233 -> en:prevention & control
    n1=en:addison disease | n2=en:prevention & control | rel=r_associated | relid=0 | w=60
  609. en:addison disease -- r_associated #0: 60 / 0.233 -> en:prolactin-producing pituitary gland adenoma
    n1=en:addison disease | n2=en:prolactin-producing pituitary gland adenoma | rel=r_associated | relid=0 | w=60
  610. en:addison disease -- r_associated #0: 60 / 0.233 -> en:reticuloendothelial system
    n1=en:addison disease | n2=en:reticuloendothelial system | rel=r_associated | relid=0 | w=60
  611. en:addison disease -- r_associated #0: 60 / 0.233 -> en:serum aldosterone elevated
    n1=en:addison disease | n2=en:serum aldosterone elevated | rel=r_associated | relid=0 | w=60
  612. en:addison disease -- r_associated #0: 60 / 0.233 -> en:steroid withdrawal syndrome
    n1=en:addison disease | n2=en:steroid withdrawal syndrome | rel=r_associated | relid=0 | w=60
  613. en:addison disease -- r_associated #0: 60 / 0.233 -> en:structure of left superior parathyroid gland
    n1=en:addison disease | n2=en:structure of left superior parathyroid gland | rel=r_associated | relid=0 | w=60
  614. en:addison disease -- r_associated #0: 60 / 0.233 -> en:thyroid follicular hyperplasia
    n1=en:addison disease | n2=en:thyroid follicular hyperplasia | rel=r_associated | relid=0 | w=60
  615. en:addison disease -- r_associated #0: 60 / 0.233 -> en:truncal obesity (rare)
    n1=en:addison disease | n2=en:truncal obesity (rare) | rel=r_associated | relid=0 | w=60
  616. en:addison disease -- r_associated #0: 60 / 0.233 -> en:viral infection
    n1=en:addison disease | n2=en:viral infection | rel=r_associated | relid=0 | w=60
  617. en:addison disease -- r_associated #0: 59 / 0.229 -> en:absent or low response to gonadotropin-releasing hormone stimulation
    n1=en:addison disease | n2=en:absent or low response to gonadotropin-releasing hormone stimulation | rel=r_associated | relid=0 | w=59
  618. en:addison disease -- r_associated #0: 59 / 0.229 -> en:accessory parathyroid gland
    n1=en:addison disease | n2=en:accessory parathyroid gland | rel=r_associated | relid=0 | w=59
  619. en:addison disease -- r_associated #0: 59 / 0.229 -> en:adrenal cortex adenoma
    n1=en:addison disease | n2=en:adrenal cortex adenoma | rel=r_associated | relid=0 | w=59
  620. en:addison disease -- r_associated #0: 59 / 0.229 -> en:adrenal failure (in some patients)
    n1=en:addison disease | n2=en:adrenal failure (in some patients) | rel=r_associated | relid=0 | w=59
  621. en:addison disease -- r_associated #0: 59 / 0.229 -> en:adrenal insufficiency, congenital (300200) in 'complex' form
    n1=en:addison disease | n2=en:adrenal insufficiency, congenital (300200) in 'complex' form | rel=r_associated | relid=0 | w=59
  622. en:addison disease -- r_associated #0: 59 / 0.229 -> en:adrenocortical hypofunction, chronic primary congenital
    n1=en:addison disease | n2=en:adrenocortical hypofunction, chronic primary congenital | rel=r_associated | relid=0 | w=59
  623. en:addison disease -- r_associated #0: 59 / 0.229 -> en:alcohol-induced pseudo-cushing's syndrome
    n1=en:addison disease | n2=en:alcohol-induced pseudo-cushing's syndrome | rel=r_associated | relid=0 | w=59
  624. en:addison disease -- r_associated #0: 59 / 0.229 -> en:androgen excess
    n1=en:addison disease | n2=en:androgen excess | rel=r_associated | relid=0 | w=59
  625. en:addison disease -- r_associated #0: 59 / 0.229 -> en:anterior pituitary enlargement
    n1=en:addison disease | n2=en:anterior pituitary enlargement | rel=r_associated | relid=0 | w=59
  626. en:addison disease -- r_associated #0: 59 / 0.229 -> en:antiphospholipid syndrome
    n1=en:addison disease | n2=en:antiphospholipid syndrome | rel=r_associated | relid=0 | w=59
  627. en:addison disease -- r_associated #0: 59 / 0.229 -> en:asthma
    n1=en:addison disease | n2=en:asthma | rel=r_associated | relid=0 | w=59
  628. en:addison disease -- r_associated #0: 59 / 0.229 -> en:autoimmune leukopenia
    n1=en:addison disease | n2=en:autoimmune leukopenia | rel=r_associated | relid=0 | w=59
  629. en:addison disease -- r_associated #0: 59 / 0.229 -> en:autoimmune skin disease
    n1=en:addison disease | n2=en:autoimmune skin disease | rel=r_associated | relid=0 | w=59
  630. en:addison disease -- r_associated #0: 59 / 0.229 -> en:benign lymphoepithelial lesion of the salivary gland
    n1=en:addison disease | n2=en:benign lymphoepithelial lesion of the salivary gland | rel=r_associated | relid=0 | w=59
  631. en:addison disease -- r_associated #0: 59 / 0.229 -> en:brain diseases, metabolic
    n1=en:addison disease | n2=en:brain diseases, metabolic | rel=r_associated | relid=0 | w=59
  632. en:addison disease -- r_associated #0: 59 / 0.229 -> en:calcitonin decreased
    n1=en:addison disease | n2=en:calcitonin decreased | rel=r_associated | relid=0 | w=59
  633. en:addison disease -- r_associated #0: 59 / 0.229 -> en:childhood immunization
    n1=en:addison disease | n2=en:childhood immunization | rel=r_associated | relid=0 | w=59
  634. en:addison disease -- r_associated #0: 59 / 0.229 -> en:citric acid monohydrate
    n1=en:addison disease | n2=en:citric acid monohydrate | rel=r_associated | relid=0 | w=59
  635. en:addison disease -- r_associated #0: 59 / 0.229 -> en:citrus naringinine
    n1=en:addison disease | n2=en:citrus naringinine | rel=r_associated | relid=0 | w=59
  636. en:addison disease -- r_associated #0: 59 / 0.229 -> en:corticosteroid deficiency
    n1=en:addison disease | n2=en:corticosteroid deficiency | rel=r_associated | relid=0 | w=59
  637. en:addison disease -- r_associated #0: 59 / 0.229 -> en:cushing syndrome
    n1=en:addison disease | n2=en:cushing syndrome | rel=r_associated | relid=0 | w=59
  638. en:addison disease -- r_associated #0: 59 / 0.229 -> en:decreased secondary sexual characteristics (in a subset of patients)
    n1=en:addison disease | n2=en:decreased secondary sexual characteristics (in a subset of patients) | rel=r_associated | relid=0 | w=59
  639. en:addison disease -- r_associated #0: 59 / 0.229 -> en:decreased testosterone level
    n1=en:addison disease | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=59
  640. en:addison disease -- r_associated #0: 59 / 0.229 -> en:diabetes insipidus
    n1=en:addison disease | n2=en:diabetes insipidus | rel=r_associated | relid=0 | w=59
  641. en:addison disease -- r_associated #0: 59 / 0.229 -> en:disorders of bilirubin excretion
    n1=en:addison disease | n2=en:disorders of bilirubin excretion | rel=r_associated | relid=0 | w=59
  642. en:addison disease -- r_associated #0: 59 / 0.229 -> en:dysfunction of hypothalamo-pituitary-gonadal axis
    n1=en:addison disease | n2=en:dysfunction of hypothalamo-pituitary-gonadal axis | rel=r_associated | relid=0 | w=59
  643. en:addison disease -- r_associated #0: 59 / 0.229 -> en:early-onset puberty (in 2 of 3 patients)
    n1=en:addison disease | n2=en:early-onset puberty (in 2 of 3 patients) | rel=r_associated | relid=0 | w=59
  644. en:addison disease -- r_associated #0: 59 / 0.229 -> en:elevated 18-oxocortisol
    n1=en:addison disease | n2=en:elevated 18-oxocortisol | rel=r_associated | relid=0 | w=59
  645. en:addison disease -- r_associated #0: 59 / 0.229 -> en:elevated androgen metabolite excretion level
    n1=en:addison disease | n2=en:elevated androgen metabolite excretion level | rel=r_associated | relid=0 | w=59
  646. en:addison disease -- r_associated #0: 59 / 0.229 -> en:elevated growth hormone (gh) levels
    n1=en:addison disease | n2=en:elevated growth hormone (gh) levels | rel=r_associated | relid=0 | w=59
  647. en:addison disease -- r_associated #0: 59 / 0.229 -> en:elevated serum estrone (in male and female patients)
    n1=en:addison disease | n2=en:elevated serum estrone (in male and female patients) | rel=r_associated | relid=0 | w=59
  648. en:addison disease -- r_associated #0: 59 / 0.229 -> en:endocrine system subdivision
    n1=en:addison disease | n2=en:endocrine system subdivision | rel=r_associated | relid=0 | w=59
  649. en:addison disease -- r_associated #0: 59 / 0.229 -> en:enhanced insulin sensitivity
    n1=en:addison disease | n2=en:enhanced insulin sensitivity | rel=r_associated | relid=0 | w=59
  650. en:addison disease -- r_associated #0: 59 / 0.229 -> en:enzyme inhibition disorder
    n1=en:addison disease | n2=en:enzyme inhibition disorder | rel=r_associated | relid=0 | w=59
  651. en:addison disease -- r_associated #0: 59 / 0.229 -> en:episodic asymptomatic severe hypoglycemia in childhood
    n1=en:addison disease | n2=en:episodic asymptomatic severe hypoglycemia in childhood | rel=r_associated | relid=0 | w=59
  652. en:addison disease -- r_associated #0: 59 / 0.229 -> en:eunuchoid appearance of males
    n1=en:addison disease | n2=en:eunuchoid appearance of males | rel=r_associated | relid=0 | w=59
  653. en:addison disease -- r_associated #0: 59 / 0.229 -> en:euthyroid (finding)
    n1=en:addison disease | n2=en:euthyroid (finding) | rel=r_associated | relid=0 | w=59
  654. en:addison disease -- r_associated #0: 59 / 0.229 -> en:glucocorticoid insufficiency
    n1=en:addison disease | n2=en:glucocorticoid insufficiency | rel=r_associated | relid=0 | w=59
  655. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hereditary adrenal unresponsiveness to corticotropin
    n1=en:addison disease | n2=en:hereditary adrenal unresponsiveness to corticotropin | rel=r_associated | relid=0 | w=59
  656. en:addison disease -- r_associated #0: 59 / 0.229 -> en:high to high-normal cortisol secretion rate
    n1=en:addison disease | n2=en:high to high-normal cortisol secretion rate | rel=r_associated | relid=0 | w=59
  657. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hiv/aids and infections
    n1=en:addison disease | n2=en:hiv/aids and infections | rel=r_associated | relid=0 | w=59
  658. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hiv/aids medicines
    n1=en:addison disease | n2=en:hiv/aids medicines | rel=r_associated | relid=0 | w=59
  659. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hyperbilirubinemia
    n1=en:addison disease | n2=en:hyperbilirubinemia | rel=r_associated | relid=0 | w=59
  660. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypercortisolemia
    n1=en:addison disease | n2=en:hypercortisolemia | rel=r_associated | relid=0 | w=59
  661. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypercortisolism, mild (in some patients)
    n1=en:addison disease | n2=en:hypercortisolism, mild (in some patients) | rel=r_associated | relid=0 | w=59
  662. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypercreatininaemia
    n1=en:addison disease | n2=en:hypercreatininaemia | rel=r_associated | relid=0 | w=59
  663. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypergonadotropic hypogonadism
    n1=en:addison disease | n2=en:hypergonadotropic hypogonadism | rel=r_associated | relid=0 | w=59
  664. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hyperproinsulinemia (asymptomatic in some patients)
    n1=en:addison disease | n2=en:hyperproinsulinemia (asymptomatic in some patients) | rel=r_associated | relid=0 | w=59
  665. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hyperreninemia (rare)
    n1=en:addison disease | n2=en:hyperreninemia (rare) | rel=r_associated | relid=0 | w=59
  666. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypocalcemia, mild or severe
    n1=en:addison disease | n2=en:hypocalcemia, mild or severe | rel=r_associated | relid=0 | w=59
  667. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypoglycemia
    n1=en:addison disease | n2=en:hypoglycemia | rel=r_associated | relid=0 | w=59
  668. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypogonadism (less common)
    n1=en:addison disease | n2=en:hypogonadism (less common) | rel=r_associated | relid=0 | w=59
  669. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypogonadotropic hypogonadism
    n1=en:addison disease | n2=en:hypogonadotropic hypogonadism | rel=r_associated | relid=0 | w=59
  670. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypogondotropic hypogonadism (1 patient)
    n1=en:addison disease | n2=en:hypogondotropic hypogonadism (1 patient) | rel=r_associated | relid=0 | w=59
  671. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypoparathyroidism
    n1=en:addison disease | n2=en:hypoparathyroidism | rel=r_associated | relid=0 | w=59
  672. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypophyseal agenesis
    n1=en:addison disease | n2=en:hypophyseal agenesis | rel=r_associated | relid=0 | w=59
  673. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypopituitarism (in some patients)
    n1=en:addison disease | n2=en:hypopituitarism (in some patients) | rel=r_associated | relid=0 | w=59
  674. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypothyroidism (20% of adults)
    n1=en:addison disease | n2=en:hypothyroidism (20% of adults) | rel=r_associated | relid=0 | w=59
  675. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypothyroidism (in 1 of 3 siblings)
    n1=en:addison disease | n2=en:hypothyroidism (in 1 of 3 siblings) | rel=r_associated | relid=0 | w=59
  676. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypothyroidism (in 2/4 patients)
    n1=en:addison disease | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=59
  677. en:addison disease -- r_associated #0: 59 / 0.229 -> en:hypothyroidism (in some patients)
    n1=en:addison disease | n2=en:hypothyroidism (in some patients) | rel=r_associated | relid=0 | w=59
  678. en:addison disease -- r_associated #0: 59 / 0.229 -> en:increase in pregnanediol and pregnanetriol after acth stimulation
    n1=en:addison disease | n2=en:increase in pregnanediol and pregnanetriol after acth stimulation | rel=r_associated | relid=0 | w=59
  679. en:addison disease -- r_associated #0: 59 / 0.229 -> en:insulin resistance - type b
    n1=en:addison disease | n2=en:insulin resistance - type b | rel=r_associated | relid=0 | w=59
  680. en:addison disease -- r_associated #0: 59 / 0.229 -> en:intermittent thrombocytopenia
    n1=en:addison disease | n2=en:intermittent thrombocytopenia | rel=r_associated | relid=0 | w=59
  681. en:addison disease -- r_associated #0: 59 / 0.229 -> en:klinefelter syndrome
    n1=en:addison disease | n2=en:klinefelter syndrome | rel=r_associated | relid=0 | w=59
  682. en:addison disease -- r_associated #0: 59 / 0.229 -> en:lack of lh pulsatility
    n1=en:addison disease | n2=en:lack of lh pulsatility | rel=r_associated | relid=0 | w=59
  683. en:addison disease -- r_associated #0: 59 / 0.229 -> en:late menarche
    n1=en:addison disease | n2=en:late menarche | rel=r_associated | relid=0 | w=59
  684. en:addison disease -- r_associated #0: 59 / 0.229 -> en:low estradiol levels in females
    n1=en:addison disease | n2=en:low estradiol levels in females | rel=r_associated | relid=0 | w=59
  685. en:addison disease -- r_associated #0: 59 / 0.229 -> en:low follicle-stimulating hormone levels
    n1=en:addison disease | n2=en:low follicle-stimulating hormone levels | rel=r_associated | relid=0 | w=59
  686. en:addison disease -- r_associated #0: 59 / 0.229 -> en:low insulin-like growth factor-1 (igf1) concentration
    n1=en:addison disease | n2=en:low insulin-like growth factor-1 (igf1) concentration | rel=r_associated | relid=0 | w=59
  687. en:addison disease -- r_associated #0: 59 / 0.229 -> en:low or absent prolactin
    n1=en:addison disease | n2=en:low or absent prolactin | rel=r_associated | relid=0 | w=59
  688. en:addison disease -- r_associated #0: 59 / 0.229 -> en:low to normal absolute level of cortisol metabolites
    n1=en:addison disease | n2=en:low to normal absolute level of cortisol metabolites | rel=r_associated | relid=0 | w=59
  689. en:addison disease -- r_associated #0: 59 / 0.229 -> en:magnesium sulfate 500 mg/ml injection
    n1=en:addison disease | n2=en:magnesium sulfate 500 mg/ml injection | rel=r_associated | relid=0 | w=59
  690. en:addison disease -- r_associated #0: 59 / 0.229 -> en:membranous glomerulonephritis
    n1=en:addison disease | n2=en:membranous glomerulonephritis | rel=r_associated | relid=0 | w=59
  691. en:addison disease -- r_associated #0: 59 / 0.229 -> en:multinodular goiter
    n1=en:addison disease | n2=en:multinodular goiter | rel=r_associated | relid=0 | w=59
  692. en:addison disease -- r_associated #0: 59 / 0.229 -> en:neonatal diabetes mellitus
    n1=en:addison disease | n2=en:neonatal diabetes mellitus | rel=r_associated | relid=0 | w=59
  693. en:addison disease -- r_associated #0: 59 / 0.229 -> en:neuroimmune system
    n1=en:addison disease | n2=en:neuroimmune system | rel=r_associated | relid=0 | w=59
  694. en:addison disease -- r_associated #0: 59 / 0.229 -> en:no goiter
    n1=en:addison disease | n2=en:no goiter | rel=r_associated | relid=0 | w=59
  695. en:addison disease -- r_associated #0: 59 / 0.229 -> en:normal testosterone level
    n1=en:addison disease | n2=en:normal testosterone level | rel=r_associated | relid=0 | w=59
  696. en:addison disease -- r_associated #0: 59 / 0.229 -> en:pancreas
    n1=en:addison disease | n2=en:pancreas | rel=r_associated | relid=0 | w=59
  697. en:addison disease -- r_associated #0: 59 / 0.229 -> en:pancreatitis
    n1=en:addison disease | n2=en:pancreatitis | rel=r_associated | relid=0 | w=59
  698. en:addison disease -- r_associated #0: 59 / 0.229 -> en:parathyroid hormone concentration low or low-normal
    n1=en:addison disease | n2=en:parathyroid hormone concentration low or low-normal | rel=r_associated | relid=0 | w=59
  699. en:addison disease -- r_associated #0: 59 / 0.229 -> en:pituitary hypoplasia (in some patients)
    n1=en:addison disease | n2=en:pituitary hypoplasia (in some patients) | rel=r_associated | relid=0 | w=59
  700. en:addison disease -- r_associated #0: 59 / 0.229 -> en:pituitary hypothyroidism
    n1=en:addison disease | n2=en:pituitary hypothyroidism | rel=r_associated | relid=0 | w=59
  701. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium bicarbonate 25 meq effervescent oral tablet
    n1=en:addison disease | n2=en:potassium bicarbonate 25 meq effervescent oral tablet | rel=r_associated | relid=0 | w=59
  702. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium chloride 25meq tablet
    n1=en:addison disease | n2=en:potassium chloride 25meq tablet | rel=r_associated | relid=0 | w=59
  703. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium chloride 3.2 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 3.2 meq/ml injectable solution | rel=r_associated | relid=0 | w=59
  704. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium chloride 4 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium chloride 4 meq/ml oral solution | rel=r_associated | relid=0 | w=59
  705. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium chloride 7.5% syrup
    n1=en:addison disease | n2=en:potassium chloride 7.5% syrup | rel=r_associated | relid=0 | w=59
  706. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium chloride 8 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 8 meq extended release oral tablet | rel=r_associated | relid=0 | w=59
  707. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium chloride 8 meq oral tablet
    n1=en:addison disease | n2=en:potassium chloride 8 meq oral tablet | rel=r_associated | relid=0 | w=59
  708. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium citrate 10 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium citrate 10 meq extended release oral tablet | rel=r_associated | relid=0 | w=59
  709. en:addison disease -- r_associated #0: 59 / 0.229 -> en:potassium gluconate 6.66 meq oral tablet
    n1=en:addison disease | n2=en:potassium gluconate 6.66 meq oral tablet | rel=r_associated | relid=0 | w=59
  710. en:addison disease -- r_associated #0: 59 / 0.229 -> en:prediabetes
    n1=en:addison disease | n2=en:prediabetes | rel=r_associated | relid=0 | w=59
  711. en:addison disease -- r_associated #0: 59 / 0.229 -> en:premature adrenarche
    n1=en:addison disease | n2=en:premature adrenarche | rel=r_associated | relid=0 | w=59
  712. en:addison disease -- r_associated #0: 59 / 0.229 -> en:prolactin, increased
    n1=en:addison disease | n2=en:prolactin, increased | rel=r_associated | relid=0 | w=59
  713. en:addison disease -- r_associated #0: 59 / 0.229 -> en:prominent body odor
    n1=en:addison disease | n2=en:prominent body odor | rel=r_associated | relid=0 | w=59
  714. en:addison disease -- r_associated #0: 59 / 0.229 -> en:secondary amenorrhea (in a subset of patients)
    n1=en:addison disease | n2=en:secondary amenorrhea (in a subset of patients) | rel=r_associated | relid=0 | w=59
  715. en:addison disease -- r_associated #0: 59 / 0.229 -> en:serum phosphorus normal or mildly elevated
    n1=en:addison disease | n2=en:serum phosphorus normal or mildly elevated | rel=r_associated | relid=0 | w=59
  716. en:addison disease -- r_associated #0: 59 / 0.229 -> en:serum prolactin decreased
    n1=en:addison disease | n2=en:serum prolactin decreased | rel=r_associated | relid=0 | w=59
  717. en:addison disease -- r_associated #0: 59 / 0.229 -> en:sjogren syndrome
    n1=en:addison disease | n2=en:sjogren syndrome | rel=r_associated | relid=0 | w=59
  718. en:addison disease -- r_associated #0: 59 / 0.229 -> en:solitary parathyroid adenomas (rarely multiple)
    n1=en:addison disease | n2=en:solitary parathyroid adenomas (rarely multiple) | rel=r_associated | relid=0 | w=59
  719. en:addison disease -- r_associated #0: 59 / 0.229 -> en:stimulation of the renin/angiotensin/aldosterone axis
    n1=en:addison disease | n2=en:stimulation of the renin/angiotensin/aldosterone axis | rel=r_associated | relid=0 | w=59
  720. en:addison disease -- r_associated #0: 59 / 0.229 -> en:structure of right superior parathyroid gland
    n1=en:addison disease | n2=en:structure of right superior parathyroid gland | rel=r_associated | relid=0 | w=59
  721. en:addison disease -- r_associated #0: 59 / 0.229 -> en:thyroid stimulating hormone normal
    n1=en:addison disease | n2=en:thyroid stimulating hormone normal | rel=r_associated | relid=0 | w=59
  722. en:addison disease -- r_associated #0: 59 / 0.229 -> en:thyroiditis
    n1=en:addison disease | n2=en:thyroiditis | rel=r_associated | relid=0 | w=59
  723. en:addison disease -- r_associated #0: 59 / 0.229 -> en:tonsil and adenoid structure
    n1=en:addison disease | n2=en:tonsil and adenoid structure | rel=r_associated | relid=0 | w=59
  724. en:addison disease -- r_associated #0: 59 / 0.229 -> en:total and free thyroxine low-normal or subnormal
    n1=en:addison disease | n2=en:total and free thyroxine low-normal or subnormal | rel=r_associated | relid=0 | w=59
  725. en:addison disease -- r_associated #0: 59 / 0.229 -> en:toxic nodular goiter
    n1=en:addison disease | n2=en:toxic nodular goiter | rel=r_associated | relid=0 | w=59
  726. en:addison disease -- r_associated #0: 58 / 0.225 -> en:abcd1, ser606leu
    n1=en:addison disease | n2=en:abcd1, ser606leu | rel=r_associated | relid=0 | w=58
  727. en:addison disease -- r_associated #0: 58 / 0.225 -> en:adrenal glands may be normal, atrophic, or slightly enlarged
    n1=en:addison disease | n2=en:adrenal glands may be normal, atrophic, or slightly enlarged | rel=r_associated | relid=0 | w=58
  728. en:addison disease -- r_associated #0: 58 / 0.225 -> en:adrenocortical insufficiency (uncommon)
    n1=en:addison disease | n2=en:adrenocortical insufficiency (uncommon) | rel=r_associated | relid=0 | w=58
  729. en:addison disease -- r_associated #0: 58 / 0.225 -> en:allergic arthritis
    n1=en:addison disease | n2=en:allergic arthritis | rel=r_associated | relid=0 | w=58
  730. en:addison disease -- r_associated #0: 58 / 0.225 -> en:autoimmune disorder of inner ear
    n1=en:addison disease | n2=en:autoimmune disorder of inner ear | rel=r_associated | relid=0 | w=58
  731. en:addison disease -- r_associated #0: 58 / 0.225 -> en:autoimmune nervous system disorder
    n1=en:addison disease | n2=en:autoimmune nervous system disorder | rel=r_associated | relid=0 | w=58
  732. en:addison disease -- r_associated #0: 58 / 0.225 -> en:citrate toxicity
    n1=en:addison disease | n2=en:citrate toxicity | rel=r_associated | relid=0 | w=58
  733. en:addison disease -- r_associated #0: 58 / 0.225 -> en:congenital hypothyroidism
    n1=en:addison disease | n2=en:congenital hypothyroidism | rel=r_associated | relid=0 | w=58
  734. en:addison disease -- r_associated #0: 58 / 0.225 -> en:decreased fertility
    n1=en:addison disease | n2=en:decreased fertility | rel=r_associated | relid=0 | w=58
  735. en:addison disease -- r_associated #0: 58 / 0.225 -> en:decreased thyroxine level
    n1=en:addison disease | n2=en:decreased thyroxine level | rel=r_associated | relid=0 | w=58
  736. en:addison disease -- r_associated #0: 58 / 0.225 -> en:elevated aldosterone
    n1=en:addison disease | n2=en:elevated aldosterone | rel=r_associated | relid=0 | w=58
  737. en:addison disease -- r_associated #0: 58 / 0.225 -> en:elevated serum follicle-stimulating hormone (in male and female patients)
    n1=en:addison disease | n2=en:elevated serum follicle-stimulating hormone (in male and female patients) | rel=r_associated | relid=0 | w=58
  738. en:addison disease -- r_associated #0: 58 / 0.225 -> en:growth hormone deficiency (in 1/4 patients)
    n1=en:addison disease | n2=en:growth hormone deficiency (in 1/4 patients) | rel=r_associated | relid=0 | w=58
  739. en:addison disease -- r_associated #0: 58 / 0.225 -> en:hypergonadotropic hypogonadism (hcs)
    n1=en:addison disease | n2=en:hypergonadotropic hypogonadism (hcs) | rel=r_associated | relid=0 | w=58
  740. en:addison disease -- r_associated #0: 58 / 0.225 -> en:hypergonadotropic hypogonadism (in a subset of patients)
    n1=en:addison disease | n2=en:hypergonadotropic hypogonadism (in a subset of patients) | rel=r_associated | relid=0 | w=58
  741. en:addison disease -- r_associated #0: 58 / 0.225 -> en:hyperinsulinemia (in male patient)
    n1=en:addison disease | n2=en:hyperinsulinemia (in male patient) | rel=r_associated | relid=0 | w=58
  742. en:addison disease -- r_associated #0: 58 / 0.225 -> en:impaired temperature regulation
    n1=en:addison disease | n2=en:impaired temperature regulation | rel=r_associated | relid=0 | w=58
  743. en:addison disease -- r_associated #0: 58 / 0.225 -> en:increased circulating renin level
    n1=en:addison disease | n2=en:increased circulating renin level | rel=r_associated | relid=0 | w=58
  744. en:addison disease -- r_associated #0: 58 / 0.225 -> en:insulin insensitivity
    n1=en:addison disease | n2=en:insulin insensitivity | rel=r_associated | relid=0 | w=58
  745. en:addison disease -- r_associated #0: 58 / 0.225 -> en:lingual thyroid
    n1=en:addison disease | n2=en:lingual thyroid | rel=r_associated | relid=0 | w=58
  746. en:addison disease -- r_associated #0: 58 / 0.225 -> en:low adrenocorticotropic hormone (acth)
    n1=en:addison disease | n2=en:low adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=58
  747. en:addison disease -- r_associated #0: 58 / 0.225 -> en:low igf1 and igfbp3
    n1=en:addison disease | n2=en:low igf1 and igfbp3 | rel=r_associated | relid=0 | w=58
  748. en:addison disease -- r_associated #0: 58 / 0.225 -> en:low serum leptin levels (in most patients)
    n1=en:addison disease | n2=en:low serum leptin levels (in most patients) | rel=r_associated | relid=0 | w=58
  749. en:addison disease -- r_associated #0: 58 / 0.225 -> en:mast cell
    n1=en:addison disease | n2=en:mast cell | rel=r_associated | relid=0 | w=58
  750. en:addison disease -- r_associated #0: 58 / 0.225 -> en:other adrenal hypofunction
    n1=en:addison disease | n2=en:other adrenal hypofunction | rel=r_associated | relid=0 | w=58
  751. en:addison disease -- r_associated #0: 58 / 0.225 -> en:ovarian failure, premature
    n1=en:addison disease | n2=en:ovarian failure, premature | rel=r_associated | relid=0 | w=58
  752. en:addison disease -- r_associated #0: 58 / 0.225 -> en:pituitary gland neoplasm
    n1=en:addison disease | n2=en:pituitary gland neoplasm | rel=r_associated | relid=0 | w=58
  753. en:addison disease -- r_associated #0: 58 / 0.225 -> en:potassium chloride strong 15% injection solution 10ml ampule
    n1=en:addison disease | n2=en:potassium chloride strong 15% injection solution 10ml ampule | rel=r_associated | relid=0 | w=58
  754. en:addison disease -- r_associated #0: 58 / 0.225 -> en:potassium citrate 260 mg oral tablet
    n1=en:addison disease | n2=en:potassium citrate 260 mg oral tablet | rel=r_associated | relid=0 | w=58
  755. en:addison disease -- r_associated #0: 58 / 0.225 -> en:premature pubarche (in 1 female patient)
    n1=en:addison disease | n2=en:premature pubarche (in 1 female patient) | rel=r_associated | relid=0 | w=58
  756. en:addison disease -- r_associated #0: 58 / 0.225 -> en:pseudophaeochromocytoma
    n1=en:addison disease | n2=en:pseudophaeochromocytoma | rel=r_associated | relid=0 | w=58
  757. en:addison disease -- r_associated #0: 58 / 0.225 -> en:right adrenal gland
    n1=en:addison disease | n2=en:right adrenal gland | rel=r_associated | relid=0 | w=58
  758. en:addison disease -- r_associated #0: 58 / 0.225 -> en:sequential loss of anterior pituitary tropic hormones
    n1=en:addison disease | n2=en:sequential loss of anterior pituitary tropic hormones | rel=r_associated | relid=0 | w=58
  759. en:addison disease -- r_associated #0: 58 / 0.225 -> en:thyroid failure (in some patients)
    n1=en:addison disease | n2=en:thyroid failure (in some patients) | rel=r_associated | relid=0 | w=58
  760. en:addison disease -- r_associated #0: 58 / 0.225 -> en:thyroid gland follicular adenoma
    n1=en:addison disease | n2=en:thyroid gland follicular adenoma | rel=r_associated | relid=0 | w=58
  761. en:addison disease -- r_associated #0: 58 / 0.225 -> en:toxic goiter
    n1=en:addison disease | n2=en:toxic goiter | rel=r_associated | relid=0 | w=58
  762. en:addison disease -- r_associated #0: 58 / 0.225 -> en:urinary 17-hydroxycorticoids normal
    n1=en:addison disease | n2=en:urinary 17-hydroxycorticoids normal | rel=r_associated | relid=0 | w=58
  763. en:addison disease -- r_associated #0: 57 / 0.221 -> en:absence of pubertal development
    n1=en:addison disease | n2=en:absence of pubertal development | rel=r_associated | relid=0 | w=57
  764. en:addison disease -- r_associated #0: 57 / 0.221 -> en:acquired immunodeficiency syndrome
    n1=en:addison disease | n2=en:acquired immunodeficiency syndrome | rel=r_associated | relid=0 | w=57
  765. en:addison disease -- r_associated #0: 57 / 0.221 -> en:acromegaloid features
    n1=en:addison disease | n2=en:acromegaloid features | rel=r_associated | relid=0 | w=57
  766. en:addison disease -- r_associated #0: 57 / 0.221 -> en:acth-independent hypercortisolemia
    n1=en:addison disease | n2=en:acth-independent hypercortisolemia | rel=r_associated | relid=0 | w=57
  767. en:addison disease -- r_associated #0: 57 / 0.221 -> en:adrenocortical insufficiency neonatal
    n1=en:addison disease | n2=en:adrenocortical insufficiency neonatal | rel=r_associated | relid=0 | w=57
  768. en:addison disease -- r_associated #0: 57 / 0.221 -> en:adrenocorticotropic hormone deficiency
    n1=en:addison disease | n2=en:adrenocorticotropic hormone deficiency | rel=r_associated | relid=0 | w=57
  769. en:addison disease -- r_associated #0: 57 / 0.221 -> en:allgrove syndrome
    n1=en:addison disease | n2=en:allgrove syndrome | rel=r_associated | relid=0 | w=57
  770. en:addison disease -- r_associated #0: 57 / 0.221 -> en:androgen levels normal
    n1=en:addison disease | n2=en:androgen levels normal | rel=r_associated | relid=0 | w=57
  771. en:addison disease -- r_associated #0: 57 / 0.221 -> en:antibody-producing cell
    n1=en:addison disease | n2=en:antibody-producing cell | rel=r_associated | relid=0 | w=57
  772. en:addison disease -- r_associated #0: 57 / 0.221 -> en:autoimmune enteropathy
    n1=en:addison disease | n2=en:autoimmune enteropathy | rel=r_associated | relid=0 | w=57
  773. en:addison disease -- r_associated #0: 57 / 0.221 -> en:blood glucose measurement
    n1=en:addison disease | n2=en:blood glucose measurement | rel=r_associated | relid=0 | w=57
  774. en:addison disease -- r_associated #0: 57 / 0.221 -> en:chronic lymphocytic leukemia
    n1=en:addison disease | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=57
  775. en:addison disease -- r_associated #0: 57 / 0.221 -> en:ctla4 haploinsufficiency
    n1=en:addison disease | n2=en:ctla4 haploinsufficiency | rel=r_associated | relid=0 | w=57
  776. en:addison disease -- r_associated #0: 57 / 0.221 -> en:delayed conversion of oral cortisone acetate to plasma cortisol
    n1=en:addison disease | n2=en:delayed conversion of oral cortisone acetate to plasma cortisol | rel=r_associated | relid=0 | w=57
  777. en:addison disease -- r_associated #0: 57 / 0.221 -> en:delayed onset of puberty
    n1=en:addison disease | n2=en:delayed onset of puberty | rel=r_associated | relid=0 | w=57
  778. en:addison disease -- r_associated #0: 57 / 0.221 -> en:delayed secondary sexual characteristics in males
    n1=en:addison disease | n2=en:delayed secondary sexual characteristics in males | rel=r_associated | relid=0 | w=57
  779. en:addison disease -- r_associated #0: 57 / 0.221 -> en:diabetes (may develop later in life)
    n1=en:addison disease | n2=en:diabetes (may develop later in life) | rel=r_associated | relid=0 | w=57
  780. en:addison disease -- r_associated #0: 57 / 0.221 -> en:diabetes mellitus (rare)
    n1=en:addison disease | n2=en:diabetes mellitus (rare) | rel=r_associated | relid=0 | w=57
  781. en:addison disease -- r_associated #0: 57 / 0.221 -> en:diabetes mellitus, insulin-dependent, late onset (uncommon)
    n1=en:addison disease | n2=en:diabetes mellitus, insulin-dependent, late onset (uncommon) | rel=r_associated | relid=0 | w=57
  782. en:addison disease -- r_associated #0: 57 / 0.221 -> en:diabetes, early-onset (in some patients)
    n1=en:addison disease | n2=en:diabetes, early-onset (in some patients) | rel=r_associated | relid=0 | w=57
  783. en:addison disease -- r_associated #0: 57 / 0.221 -> en:diabetic heart disease
    n1=en:addison disease | n2=en:diabetic heart disease | rel=r_associated | relid=0 | w=57
  784. en:addison disease -- r_associated #0: 57 / 0.221 -> en:diabetic nerve problems
    n1=en:addison disease | n2=en:diabetic nerve problems | rel=r_associated | relid=0 | w=57
  785. en:addison disease -- r_associated #0: 57 / 0.221 -> en:elevated 18-hydroxycortisol
    n1=en:addison disease | n2=en:elevated 18-hydroxycortisol | rel=r_associated | relid=0 | w=57
  786. en:addison disease -- r_associated #0: 57 / 0.221 -> en:elevated follicle-stimulating hormone (fsh) level
    n1=en:addison disease | n2=en:elevated follicle-stimulating hormone (fsh) level | rel=r_associated | relid=0 | w=57
  787. en:addison disease -- r_associated #0: 57 / 0.221 -> en:elevated prepubertal levels of testosterone
    n1=en:addison disease | n2=en:elevated prepubertal levels of testosterone | rel=r_associated | relid=0 | w=57
  788. en:addison disease -- r_associated #0: 57 / 0.221 -> en:elevated thyroid stimulating hormone (tsh)
    n1=en:addison disease | n2=en:elevated thyroid stimulating hormone (tsh) | rel=r_associated | relid=0 | w=57
  789. en:addison disease -- r_associated #0: 57 / 0.221 -> en:enzyme abnormality (nos)
    n1=en:addison disease | n2=en:enzyme abnormality (nos) | rel=r_associated | relid=0 | w=57
  790. en:addison disease -- r_associated #0: 57 / 0.221 -> en:fatigue
    n1=en:addison disease | n2=en:fatigue | rel=r_associated | relid=0 | w=57
  791. en:addison disease -- r_associated #0: 57 / 0.221 -> en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients)
    n1=en:addison disease | n2=en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients) | rel=r_associated | relid=0 | w=57
  792. en:addison disease -- r_associated #0: 57 / 0.221 -> en:growth hormone deficiency (2 patients)
    n1=en:addison disease | n2=en:growth hormone deficiency (2 patients) | rel=r_associated | relid=0 | w=57
  793. en:addison disease -- r_associated #0: 57 / 0.221 -> en:high aldosterone/renin ratio
    n1=en:addison disease | n2=en:high aldosterone/renin ratio | rel=r_associated | relid=0 | w=57
  794. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hypergonadotropic hypogonadism (males)
    n1=en:addison disease | n2=en:hypergonadotropic hypogonadism (males) | rel=r_associated | relid=0 | w=57
  795. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hyperinsulinemic hypoglycemia (in some patients)
    n1=en:addison disease | n2=en:hyperinsulinemic hypoglycemia (in some patients) | rel=r_associated | relid=0 | w=57
  796. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hyperreninemic hypoaldosteronism
    n1=en:addison disease | n2=en:hyperreninemic hypoaldosteronism | rel=r_associated | relid=0 | w=57
  797. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hypogonadotropic hypergonadism
    n1=en:addison disease | n2=en:hypogonadotropic hypergonadism | rel=r_associated | relid=0 | w=57
  798. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hypoinsulinaemia (disorder)
    n1=en:addison disease | n2=en:hypoinsulinaemia (disorder) | rel=r_associated | relid=0 | w=57
  799. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hypometabolism
    n1=en:addison disease | n2=en:hypometabolism | rel=r_associated | relid=0 | w=57
  800. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hypoplastic thyroid gland
    n1=en:addison disease | n2=en:hypoplastic thyroid gland | rel=r_associated | relid=0 | w=57
  801. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hyporeninenmic hypoaldosteronism
    n1=en:addison disease | n2=en:hyporeninenmic hypoaldosteronism | rel=r_associated | relid=0 | w=57
  802. en:addison disease -- r_associated #0: 57 / 0.221 -> en:hypothyroidism
    n1=en:addison disease | n2=en:hypothyroidism | rel=r_associated | relid=0 | w=57
  803. en:addison disease -- r_associated #0: 57 / 0.221 -> en:increased incidence of fibrocalculus pancreatic diabetes (fcpd)
    n1=en:addison disease | n2=en:increased incidence of fibrocalculus pancreatic diabetes (fcpd) | rel=r_associated | relid=0 | w=57
  804. en:addison disease -- r_associated #0: 57 / 0.221 -> en:infertility
    n1=en:addison disease | n2=en:infertility | rel=r_associated | relid=0 | w=57
  805. en:addison disease -- r_associated #0: 57 / 0.221 -> en:insulin-dependent diabetes mellitus (onset in infancy)
    n1=en:addison disease | n2=en:insulin-dependent diabetes mellitus (onset in infancy) | rel=r_associated | relid=0 | w=57
  806. en:addison disease -- r_associated #0: 57 / 0.221 -> en:ipsilateral adrenal gland hypoplasia
    n1=en:addison disease | n2=en:ipsilateral adrenal gland hypoplasia | rel=r_associated | relid=0 | w=57
  807. en:addison disease -- r_associated #0: 57 / 0.221 -> en:ipsilateral thyroid gland hypoplasia
    n1=en:addison disease | n2=en:ipsilateral thyroid gland hypoplasia | rel=r_associated | relid=0 | w=57
  808. en:addison disease -- r_associated #0: 57 / 0.221 -> en:lh level normal
    n1=en:addison disease | n2=en:lh level normal | rel=r_associated | relid=0 | w=57
  809. en:addison disease -- r_associated #0: 57 / 0.221 -> en:linear iga bullous dermatosis
    n1=en:addison disease | n2=en:linear iga bullous dermatosis | rel=r_associated | relid=0 | w=57
  810. en:addison disease -- r_associated #0: 57 / 0.221 -> en:low acth
    n1=en:addison disease | n2=en:low acth | rel=r_associated | relid=0 | w=57
  811. en:addison disease -- r_associated #0: 57 / 0.221 -> en:low luteinizing hormone levels
    n1=en:addison disease | n2=en:low luteinizing hormone levels | rel=r_associated | relid=0 | w=57
  812. en:addison disease -- r_associated #0: 57 / 0.221 -> en:low serum estradiol
    n1=en:addison disease | n2=en:low serum estradiol | rel=r_associated | relid=0 | w=57
  813. en:addison disease -- r_associated #0: 57 / 0.221 -> en:low to normal serum lh low to normal serum fsh
    n1=en:addison disease | n2=en:low to normal serum lh low to normal serum fsh | rel=r_associated | relid=0 | w=57
  814. en:addison disease -- r_associated #0: 57 / 0.221 -> en:lymphoid system structure
    n1=en:addison disease | n2=en:lymphoid system structure | rel=r_associated | relid=0 | w=57
  815. en:addison disease -- r_associated #0: 57 / 0.221 -> en:magnesium carbonate 260 mg oral capsule
    n1=en:addison disease | n2=en:magnesium carbonate 260 mg oral capsule | rel=r_associated | relid=0 | w=57
  816. en:addison disease -- r_associated #0: 57 / 0.221 -> en:magnesium sulfate
    n1=en:addison disease | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=57
  817. en:addison disease -- r_associated #0: 57 / 0.221 -> en:magnesium sulfate 5%(4gm/100ml) intravenous
    n1=en:addison disease | n2=en:magnesium sulfate 5%(4gm/100ml) intravenous | rel=r_associated | relid=0 | w=57
  818. en:addison disease -- r_associated #0: 57 / 0.221 -> en:neonatal hypocalcemia, rare
    n1=en:addison disease | n2=en:neonatal hypocalcemia, rare | rel=r_associated | relid=0 | w=57
  819. en:addison disease -- r_associated #0: 57 / 0.221 -> en:neonatal hypoglycemia
    n1=en:addison disease | n2=en:neonatal hypoglycemia | rel=r_associated | relid=0 | w=57
  820. en:addison disease -- r_associated #0: 57 / 0.221 -> en:neonatal insulin-dependent diabetes mellitus
    n1=en:addison disease | n2=en:neonatal insulin-dependent diabetes mellitus | rel=r_associated | relid=0 | w=57
  821. en:addison disease -- r_associated #0: 57 / 0.221 -> en:no growth response to exogenous growth hormone (gh, 139250)
    n1=en:addison disease | n2=en:no growth response to exogenous growth hormone (gh, 139250) | rel=r_associated | relid=0 | w=57
  822. en:addison disease -- r_associated #0: 57 / 0.221 -> en:no increase in testosterone after hcg or acth stimulation
    n1=en:addison disease | n2=en:no increase in testosterone after hcg or acth stimulation | rel=r_associated | relid=0 | w=57
  823. en:addison disease -- r_associated #0: 57 / 0.221 -> en:normal growth hormone response to provocative testing
    n1=en:addison disease | n2=en:normal growth hormone response to provocative testing | rel=r_associated | relid=0 | w=57
  824. en:addison disease -- r_associated #0: 57 / 0.221 -> en:ovarian hyperandrogenemia
    n1=en:addison disease | n2=en:ovarian hyperandrogenemia | rel=r_associated | relid=0 | w=57
  825. en:addison disease -- r_associated #0: 57 / 0.221 -> en:pigmented micronodular adrenocortical disease
    n1=en:addison disease | n2=en:pigmented micronodular adrenocortical disease | rel=r_associated | relid=0 | w=57
  826. en:addison disease -- r_associated #0: 57 / 0.221 -> en:plasma aldosterone increased
    n1=en:addison disease | n2=en:plasma aldosterone increased | rel=r_associated | relid=0 | w=57
  827. en:addison disease -- r_associated #0: 57 / 0.221 -> en:potassium bicarbonate 6.5 meq oral tablet
    n1=en:addison disease | n2=en:potassium bicarbonate 6.5 meq oral tablet | rel=r_associated | relid=0 | w=57
  828. en:addison disease -- r_associated #0: 57 / 0.221 -> en:potassium chloride 20 meq extended release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 20 meq extended release oral tablet | rel=r_associated | relid=0 | w=57
  829. en:addison disease -- r_associated #0: 57 / 0.221 -> en:precocious puberty
    n1=en:addison disease | n2=en:precocious puberty | rel=r_associated | relid=0 | w=57
  830. en:addison disease -- r_associated #0: 57 / 0.221 -> en:primary hyperthyroidism
    n1=en:addison disease | n2=en:primary hyperthyroidism | rel=r_associated | relid=0 | w=57
  831. en:addison disease -- r_associated #0: 57 / 0.221 -> en:thyroxin binding globulin decreased
    n1=en:addison disease | n2=en:thyroxin binding globulin decreased | rel=r_associated | relid=0 | w=57
  832. en:addison disease -- r_associated #0: 57 / 0.221 -> en:urinary 17-oxosteroids normal
    n1=en:addison disease | n2=en:urinary 17-oxosteroids normal | rel=r_associated | relid=0 | w=57
  833. en:addison disease -- r_associated #0: 56 / 0.217 -> en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable
    n1=en:addison disease | n2=en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable | rel=r_associated | relid=0 | w=56
  834. en:addison disease -- r_associated #0: 56 / 0.217 -> en:animal bite
    n1=en:addison disease | n2=en:animal bite | rel=r_associated | relid=0 | w=56
  835. en:addison disease -- r_associated #0: 56 / 0.217 -> en:autoimmune antibody positivity
    n1=en:addison disease | n2=en:autoimmune antibody positivity | rel=r_associated | relid=0 | w=56
  836. en:addison disease -- r_associated #0: 56 / 0.217 -> en:baseline pregnanediol and pregnanetriol normal
    n1=en:addison disease | n2=en:baseline pregnanediol and pregnanetriol normal | rel=r_associated | relid=0 | w=56
  837. en:addison disease -- r_associated #0: 56 / 0.217 -> en:blau syndrome
    n1=en:addison disease | n2=en:blau syndrome | rel=r_associated | relid=0 | w=56
  838. en:addison disease -- r_associated #0: 56 / 0.217 -> en:citric acid,hydrous
    n1=en:addison disease | n2=en:citric acid,hydrous | rel=r_associated | relid=0 | w=56
  839. en:addison disease -- r_associated #0: 56 / 0.217 -> en:congenital hyperthyroidism
    n1=en:addison disease | n2=en:congenital hyperthyroidism | rel=r_associated | relid=0 | w=56
  840. en:addison disease -- r_associated #0: 56 / 0.217 -> en:diabetes (in affected males)
    n1=en:addison disease | n2=en:diabetes (in affected males) | rel=r_associated | relid=0 | w=56
  841. en:addison disease -- r_associated #0: 56 / 0.217 -> en:diabetes mellitus, infantile
    n1=en:addison disease | n2=en:diabetes mellitus, infantile | rel=r_associated | relid=0 | w=56
  842. en:addison disease -- r_associated #0: 56 / 0.217 -> en:ectopic hyperthyroidism
    n1=en:addison disease | n2=en:ectopic hyperthyroidism | rel=r_associated | relid=0 | w=56
  843. en:addison disease -- r_associated #0: 56 / 0.217 -> en:elevated serum adiponectin
    n1=en:addison disease | n2=en:elevated serum adiponectin | rel=r_associated | relid=0 | w=56
  844. en:addison disease -- r_associated #0: 56 / 0.217 -> en:endocrine glands with iron deposition
    n1=en:addison disease | n2=en:endocrine glands with iron deposition | rel=r_associated | relid=0 | w=56
  845. en:addison disease -- r_associated #0: 56 / 0.217 -> en:enlarged adrenal gland
    n1=en:addison disease | n2=en:enlarged adrenal gland | rel=r_associated | relid=0 | w=56
  846. en:addison disease -- r_associated #0: 56 / 0.217 -> en:euthyroid multinodular goiter
    n1=en:addison disease | n2=en:euthyroid multinodular goiter | rel=r_associated | relid=0 | w=56
  847. en:addison disease -- r_associated #0: 56 / 0.217 -> en:evans syndrome
    n1=en:addison disease | n2=en:evans syndrome | rel=r_associated | relid=0 | w=56
  848. en:addison disease -- r_associated #0: 56 / 0.217 -> en:follicle stimulating hormone, increased
    n1=en:addison disease | n2=en:follicle stimulating hormone, increased | rel=r_associated | relid=0 | w=56
  849. en:addison disease -- r_associated #0: 56 / 0.217 -> en:food allergy
    n1=en:addison disease | n2=en:food allergy | rel=r_associated | relid=0 | w=56
  850. en:addison disease -- r_associated #0: 56 / 0.217 -> en:glucose intolerance
    n1=en:addison disease | n2=en:glucose intolerance | rel=r_associated | relid=0 | w=56
  851. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hyperglycemia, insulin-responsive, episodic
    n1=en:addison disease | n2=en:hyperglycemia, insulin-responsive, episodic | rel=r_associated | relid=0 | w=56
  852. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hypoaldosteronism, transient, isolated
    n1=en:addison disease | n2=en:hypoaldosteronism, transient, isolated | rel=r_associated | relid=0 | w=56
  853. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hypogonadotropic hypogonadism (in some females)
    n1=en:addison disease | n2=en:hypogonadotropic hypogonadism (in some females) | rel=r_associated | relid=0 | w=56
  854. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hypomagnesemia
    n1=en:addison disease | n2=en:hypomagnesemia | rel=r_associated | relid=0 | w=56
  855. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hypophosphatemic vitamin d-resistant rickets (in some)
    n1=en:addison disease | n2=en:hypophosphatemic vitamin d-resistant rickets (in some) | rel=r_associated | relid=0 | w=56
  856. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hypopituitarism
    n1=en:addison disease | n2=en:hypopituitarism | rel=r_associated | relid=0 | w=56
  857. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hypothyroidism in subset of patients
    n1=en:addison disease | n2=en:hypothyroidism in subset of patients | rel=r_associated | relid=0 | w=56
  858. en:addison disease -- r_associated #0: 56 / 0.217 -> en:hypothyroidism, nongoitrous
    n1=en:addison disease | n2=en:hypothyroidism, nongoitrous | rel=r_associated | relid=0 | w=56
  859. en:addison disease -- r_associated #0: 56 / 0.217 -> en:iga nephropathy
    n1=en:addison disease | n2=en:iga nephropathy | rel=r_associated | relid=0 | w=56
  860. en:addison disease -- r_associated #0: 56 / 0.217 -> en:insulin-resistant diabetes mellitus (onset around puberty)
    n1=en:addison disease | n2=en:insulin-resistant diabetes mellitus (onset around puberty) | rel=r_associated | relid=0 | w=56
  861. en:addison disease -- r_associated #0: 56 / 0.217 -> en:living with hiv/aids
    n1=en:addison disease | n2=en:living with hiv/aids | rel=r_associated | relid=0 | w=56
  862. en:addison disease -- r_associated #0: 56 / 0.217 -> en:low or absent growth hormone
    n1=en:addison disease | n2=en:low or absent growth hormone | rel=r_associated | relid=0 | w=56
  863. en:addison disease -- r_associated #0: 56 / 0.217 -> en:magnesium so4 2meq/ml inj
    n1=en:addison disease | n2=en:magnesium so4 2meq/ml inj | rel=r_associated | relid=0 | w=56
  864. en:addison disease -- r_associated #0: 56 / 0.217 -> en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates
    n1=en:addison disease | n2=en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates | rel=r_associated | relid=0 | w=56
  865. en:addison disease -- r_associated #0: 56 / 0.217 -> en:no hormone resistance
    n1=en:addison disease | n2=en:no hormone resistance | rel=r_associated | relid=0 | w=56
  866. en:addison disease -- r_associated #0: 56 / 0.217 -> en:normal response to exogenously administered insulin
    n1=en:addison disease | n2=en:normal response to exogenously administered insulin | rel=r_associated | relid=0 | w=56
  867. en:addison disease -- r_associated #0: 56 / 0.217 -> en:pancreatic disorder
    n1=en:addison disease | n2=en:pancreatic disorder | rel=r_associated | relid=0 | w=56
  868. en:addison disease -- r_associated #0: 56 / 0.217 -> en:pancreatic exocrine deficiency
    n1=en:addison disease | n2=en:pancreatic exocrine deficiency | rel=r_associated | relid=0 | w=56
  869. en:addison disease -- r_associated #0: 56 / 0.217 -> en:panhypopituitarism
    n1=en:addison disease | n2=en:panhypopituitarism | rel=r_associated | relid=0 | w=56
  870. en:addison disease -- r_associated #0: 56 / 0.217 -> en:partial growth hormone deficiency
    n1=en:addison disease | n2=en:partial growth hormone deficiency | rel=r_associated | relid=0 | w=56
  871. en:addison disease -- r_associated #0: 56 / 0.217 -> en:pituitary gland disorder
    n1=en:addison disease | n2=en:pituitary gland disorder | rel=r_associated | relid=0 | w=56
  872. en:addison disease -- r_associated #0: 56 / 0.217 -> en:potassium chloride 8 meq extended release oral capsule
    n1=en:addison disease | n2=en:potassium chloride 8 meq extended release oral capsule | rel=r_associated | relid=0 | w=56
  873. en:addison disease -- r_associated #0: 56 / 0.217 -> en:potassium gluconate 2.2 meq oral tablet
    n1=en:addison disease | n2=en:potassium gluconate 2.2 meq oral tablet | rel=r_associated | relid=0 | w=56
  874. en:addison disease -- r_associated #0: 56 / 0.217 -> en:premature ovarian failure (less common)
    n1=en:addison disease | n2=en:premature ovarian failure (less common) | rel=r_associated | relid=0 | w=56
  875. en:addison disease -- r_associated #0: 56 / 0.217 -> en:primary hypothyroidism
    n1=en:addison disease | n2=en:primary hypothyroidism | rel=r_associated | relid=0 | w=56
  876. en:addison disease -- r_associated #0: 56 / 0.217 -> en:prolactin level normal
    n1=en:addison disease | n2=en:prolactin level normal | rel=r_associated | relid=0 | w=56
  877. en:addison disease -- r_associated #0: 56 / 0.217 -> en:pseudohypoparathyroidism
    n1=en:addison disease | n2=en:pseudohypoparathyroidism | rel=r_associated | relid=0 | w=56
  878. en:addison disease -- r_associated #0: 56 / 0.217 -> en:reactive hypoglycemia
    n1=en:addison disease | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=56
  879. en:addison disease -- r_associated #0: 56 / 0.217 -> en:refeeding syndrome
    n1=en:addison disease | n2=en:refeeding syndrome | rel=r_associated | relid=0 | w=56
  880. en:addison disease -- r_associated #0: 56 / 0.217 -> en:renal salt wasting
    n1=en:addison disease | n2=en:renal salt wasting | rel=r_associated | relid=0 | w=56
  881. en:addison disease -- r_associated #0: 56 / 0.217 -> en:small to absent parathyroid glands
    n1=en:addison disease | n2=en:small to absent parathyroid glands | rel=r_associated | relid=0 | w=56
  882. en:addison disease -- r_associated #0: 56 / 0.217 -> en:stein-leventhal syndrome
    n1=en:addison disease | n2=en:stein-leventhal syndrome | rel=r_associated | relid=0 | w=56
  883. en:addison disease -- r_associated #0: 56 / 0.217 -> en:structure of right inferior parathyroid gland
    n1=en:addison disease | n2=en:structure of right inferior parathyroid gland | rel=r_associated | relid=0 | w=56
  884. en:addison disease -- r_associated #0: 56 / 0.217 -> en:tertiary hypothyroidism
    n1=en:addison disease | n2=en:tertiary hypothyroidism | rel=r_associated | relid=0 | w=56
  885. en:addison disease -- r_associated #0: 56 / 0.217 -> en:transient hypothyroidism (in some patients)
    n1=en:addison disease | n2=en:transient hypothyroidism (in some patients) | rel=r_associated | relid=0 | w=56
  886. en:addison disease -- r_associated #0: 56 / 0.217 -> en:vasointestinal peptide tumor
    n1=en:addison disease | n2=en:vasointestinal peptide tumor | rel=r_associated | relid=0 | w=56
  887. en:addison disease -- r_associated #0: 55 / 0.213 -> en:'cytomegalic' cells (large, pale) in adrenal glands
    n1=en:addison disease | n2=en:'cytomegalic' cells (large, pale) in adrenal glands | rel=r_associated | relid=0 | w=55
  888. en:addison disease -- r_associated #0: 55 / 0.213 -> en:adrenal androgen deficiency
    n1=en:addison disease | n2=en:adrenal androgen deficiency | rel=r_associated | relid=0 | w=55
  889. en:addison disease -- r_associated #0: 55 / 0.213 -> en:anaphylaxis (non medication)
    n1=en:addison disease | n2=en:anaphylaxis (non medication) | rel=r_associated | relid=0 | w=55
  890. en:addison disease -- r_associated #0: 55 / 0.213 -> en:autoimmune inflammation of skeletal muscle
    n1=en:addison disease | n2=en:autoimmune inflammation of skeletal muscle | rel=r_associated | relid=0 | w=55
  891. en:addison disease -- r_associated #0: 55 / 0.213 -> en:autoimmune neonatal thrombocytopenia
    n1=en:addison disease | n2=en:autoimmune neonatal thrombocytopenia | rel=r_associated | relid=0 | w=55
  892. en:addison disease -- r_associated #0: 55 / 0.213 -> en:bone marrow
    n1=en:addison disease | n2=en:bone marrow | rel=r_associated | relid=0 | w=55
  893. en:addison disease -- r_associated #0: 55 / 0.213 -> en:bone marrow transplantation
    n1=en:addison disease | n2=en:bone marrow transplantation | rel=r_associated | relid=0 | w=55
  894. en:addison disease -- r_associated #0: 55 / 0.213 -> en:compensated hypothyroidism
    n1=en:addison disease | n2=en:compensated hypothyroidism | rel=r_associated | relid=0 | w=55
  895. en:addison disease -- r_associated #0: 55 / 0.213 -> en:congenital adrenal gland hypoplasia
    n1=en:addison disease | n2=en:congenital adrenal gland hypoplasia | rel=r_associated | relid=0 | w=55
  896. en:addison disease -- r_associated #0: 55 / 0.213 -> en:dendritic cell system structure
    n1=en:addison disease | n2=en:dendritic cell system structure | rel=r_associated | relid=0 | w=55
  897. en:addison disease -- r_associated #0: 55 / 0.213 -> en:diabetes mellitus, susceptibility to
    n1=en:addison disease | n2=en:diabetes mellitus, susceptibility to | rel=r_associated | relid=0 | w=55
  898. en:addison disease -- r_associated #0: 55 / 0.213 -> en:diffuse neuroendocrine structure
    n1=en:addison disease | n2=en:diffuse neuroendocrine structure | rel=r_associated | relid=0 | w=55
  899. en:addison disease -- r_associated #0: 55 / 0.213 -> en:dysfunction syndromes, hypothalamic
    n1=en:addison disease | n2=en:dysfunction syndromes, hypothalamic | rel=r_associated | relid=0 | w=55
  900. en:addison disease -- r_associated #0: 55 / 0.213 -> en:elevated follicle-stimulating hormone level
    n1=en:addison disease | n2=en:elevated follicle-stimulating hormone level | rel=r_associated | relid=0 | w=55
  901. en:addison disease -- r_associated #0: 55 / 0.213 -> en:elevated luteinizing hormone (lh) level
    n1=en:addison disease | n2=en:elevated luteinizing hormone (lh) level | rel=r_associated | relid=0 | w=55
  902. en:addison disease -- r_associated #0: 55 / 0.213 -> en:elevated urinary gonadotropins
    n1=en:addison disease | n2=en:elevated urinary gonadotropins | rel=r_associated | relid=0 | w=55
  903. en:addison disease -- r_associated #0: 55 / 0.213 -> en:functional anorchia
    n1=en:addison disease | n2=en:functional anorchia | rel=r_associated | relid=0 | w=55
  904. en:addison disease -- r_associated #0: 55 / 0.213 -> en:hypoplastic pituitary gland
    n1=en:addison disease | n2=en:hypoplastic pituitary gland | rel=r_associated | relid=0 | w=55
  905. en:addison disease -- r_associated #0: 55 / 0.213 -> en:hypothalamic hypogonadism
    n1=en:addison disease | n2=en:hypothalamic hypogonadism | rel=r_associated | relid=0 | w=55
  906. en:addison disease -- r_associated #0: 55 / 0.213 -> en:impaired glucose tolerance (in male patient)
    n1=en:addison disease | n2=en:impaired glucose tolerance (in male patient) | rel=r_associated | relid=0 | w=55
  907. en:addison disease -- r_associated #0: 55 / 0.213 -> en:impaired processing of proopiomelanocortin (pomc, 176830)
    n1=en:addison disease | n2=en:impaired processing of proopiomelanocortin (pomc, 176830) | rel=r_associated | relid=0 | w=55
  908. en:addison disease -- r_associated #0: 55 / 0.213 -> en:low or absent thyroid-stimulating hormone
    n1=en:addison disease | n2=en:low or absent thyroid-stimulating hormone | rel=r_associated | relid=0 | w=55
  909. en:addison disease -- r_associated #0: 55 / 0.213 -> en:low serum testosterone in males
    n1=en:addison disease | n2=en:low serum testosterone in males | rel=r_associated | relid=0 | w=55
  910. en:addison disease -- r_associated #0: 55 / 0.213 -> en:magnesium carbonate blocks
    n1=en:addison disease | n2=en:magnesium carbonate blocks | rel=r_associated | relid=0 | w=55
  911. en:addison disease -- r_associated #0: 55 / 0.213 -> en:magnesium oxide 400 mg oral tablet
    n1=en:addison disease | n2=en:magnesium oxide 400 mg oral tablet | rel=r_associated | relid=0 | w=55
  912. en:addison disease -- r_associated #0: 55 / 0.213 -> en:marked increase in pregnanetriolone after hcg or acth stimulation
    n1=en:addison disease | n2=en:marked increase in pregnanetriolone after hcg or acth stimulation | rel=r_associated | relid=0 | w=55
  913. en:addison disease -- r_associated #0: 55 / 0.213 -> en:myxedema coma
    n1=en:addison disease | n2=en:myxedema coma | rel=r_associated | relid=0 | w=55
  914. en:addison disease -- r_associated #0: 55 / 0.213 -> en:no breast development or menstruation at puberty
    n1=en:addison disease | n2=en:no breast development or menstruation at puberty | rel=r_associated | relid=0 | w=55
  915. en:addison disease -- r_associated #0: 55 / 0.213 -> en:oestradiol decreased
    n1=en:addison disease | n2=en:oestradiol decreased | rel=r_associated | relid=0 | w=55
  916. en:addison disease -- r_associated #0: 55 / 0.213 -> en:pituitary dwarfism
    n1=en:addison disease | n2=en:pituitary dwarfism | rel=r_associated | relid=0 | w=55
  917. en:addison disease -- r_associated #0: 55 / 0.213 -> en:postprocedural adrenocortical(-medullary) hypofunction
    n1=en:addison disease | n2=en:postprocedural adrenocortical(-medullary) hypofunction | rel=r_associated | relid=0 | w=55
  918. en:addison disease -- r_associated #0: 55 / 0.213 -> en:potassium bicarbonate 10 meq effervescent oral tablet
    n1=en:addison disease | n2=en:potassium bicarbonate 10 meq effervescent oral tablet | rel=r_associated | relid=0 | w=55
  919. en:addison disease -- r_associated #0: 55 / 0.213 -> en:potassium chloride 13 meq delayed release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 13 meq delayed release oral tablet | rel=r_associated | relid=0 | w=55
  920. en:addison disease -- r_associated #0: 55 / 0.213 -> en:potassium chloride 2.4 meq delayed release oral tablet
    n1=en:addison disease | n2=en:potassium chloride 2.4 meq delayed release oral tablet | rel=r_associated | relid=0 | w=55
  921. en:addison disease -- r_associated #0: 55 / 0.213 -> en:sarcoidosis
    n1=en:addison disease | n2=en:sarcoidosis | rel=r_associated | relid=0 | w=55
  922. en:addison disease -- r_associated #0: 55 / 0.213 -> en:serum testosterone decreased
    n1=en:addison disease | n2=en:serum testosterone decreased | rel=r_associated | relid=0 | w=55
  923. en:addison disease -- r_associated #0: 55 / 0.213 -> en:thyroid disease (less common)
    n1=en:addison disease | n2=en:thyroid disease (less common) | rel=r_associated | relid=0 | w=55
  924. en:addison disease -- r_associated #0: 55 / 0.213 -> en:thyrotoxic cardiomyopathy
    n1=en:addison disease | n2=en:thyrotoxic cardiomyopathy | rel=r_associated | relid=0 | w=55
  925. en:addison disease -- r_associated #0: 54 / 0.209 -> Addison (maladie d')
    n1=en:addison disease | n2=Addison (maladie d') | rel=r_associated | relid=0 | w=54
  926. en:addison disease -- r_associated #0: 54 / 0.209 -> en:absent dehydroepiandrosterone-sulphate, even after acth stimulation
    n1=en:addison disease | n2=en:absent dehydroepiandrosterone-sulphate, even after acth stimulation | rel=r_associated | relid=0 | w=54
  927. en:addison disease -- r_associated #0: 54 / 0.209 -> en:crystal nephropathy
    n1=en:addison disease | n2=en:crystal nephropathy | rel=r_associated | relid=0 | w=54
  928. en:addison disease -- r_associated #0: 54 / 0.209 -> en:decreased fertility in males
    n1=en:addison disease | n2=en:decreased fertility in males | rel=r_associated | relid=0 | w=54
  929. en:addison disease -- r_associated #0: 54 / 0.209 -> en:delay in secondary sexual characteristics
    n1=en:addison disease | n2=en:delay in secondary sexual characteristics | rel=r_associated | relid=0 | w=54
  930. en:addison disease -- r_associated #0: 54 / 0.209 -> en:diabetes mellitus (1 patient)
    n1=en:addison disease | n2=en:diabetes mellitus (1 patient) | rel=r_associated | relid=0 | w=54
  931. en:addison disease -- r_associated #0: 54 / 0.209 -> en:ectopic thyroid gland (finding)
    n1=en:addison disease | n2=en:ectopic thyroid gland (finding) | rel=r_associated | relid=0 | w=54
  932. en:addison disease -- r_associated #0: 54 / 0.209 -> en:endocrine dysgenesis
    n1=en:addison disease | n2=en:endocrine dysgenesis | rel=r_associated | relid=0 | w=54
  933. en:addison disease -- r_associated #0: 54 / 0.209 -> en:familial adrenal hypoplasia with absent pituitary lh
    n1=en:addison disease | n2=en:familial adrenal hypoplasia with absent pituitary lh | rel=r_associated | relid=0 | w=54
  934. en:addison disease -- r_associated #0: 54 / 0.209 -> en:familial adrenocortical hypoplasia
    n1=en:addison disease | n2=en:familial adrenocortical hypoplasia | rel=r_associated | relid=0 | w=54
  935. en:addison disease -- r_associated #0: 54 / 0.209 -> en:gestational diabetes
    n1=en:addison disease | n2=en:gestational diabetes | rel=r_associated | relid=0 | w=54
  936. en:addison disease -- r_associated #0: 54 / 0.209 -> en:gonadotrophin increased
    n1=en:addison disease | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=54
  937. en:addison disease -- r_associated #0: 54 / 0.209 -> en:hormone replacement therapy
    n1=en:addison disease | n2=en:hormone replacement therapy | rel=r_associated | relid=0 | w=54
  938. en:addison disease -- r_associated #0: 54 / 0.209 -> en:hyperaldosteronemia (rare)
    n1=en:addison disease | n2=en:hyperaldosteronemia (rare) | rel=r_associated | relid=0 | w=54
  939. en:addison disease -- r_associated #0: 54 / 0.209 -> en:low gonadotropins (secondary hypogonadism)
    n1=en:addison disease | n2=en:low gonadotropins (secondary hypogonadism) | rel=r_associated | relid=0 | w=54
  940. en:addison disease -- r_associated #0: 54 / 0.209 -> en:low or normal serum gonadotropins
    n1=en:addison disease | n2=en:low or normal serum gonadotropins | rel=r_associated | relid=0 | w=54
  941. en:addison disease -- r_associated #0: 54 / 0.209 -> en:low sex hormone-binding globulin levels
    n1=en:addison disease | n2=en:low sex hormone-binding globulin levels | rel=r_associated | relid=0 | w=54
  942. en:addison disease -- r_associated #0: 54 / 0.209 -> en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio
    n1=en:addison disease | n2=en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio | rel=r_associated | relid=0 | w=54
  943. en:addison disease -- r_associated #0: 54 / 0.209 -> en:macroamylasemia
    n1=en:addison disease | n2=en:macroamylasemia | rel=r_associated | relid=0 | w=54
  944. en:addison disease -- r_associated #0: 54 / 0.209 -> en:normal testosterone levels in adulthood
    n1=en:addison disease | n2=en:normal testosterone levels in adulthood | rel=r_associated | relid=0 | w=54
  945. en:addison disease -- r_associated #0: 54 / 0.209 -> en:overlap syndrome
    n1=en:addison disease | n2=en:overlap syndrome | rel=r_associated | relid=0 | w=54
  946. en:addison disease -- r_associated #0: 54 / 0.209 -> en:pancreatic insulinoma
    n1=en:addison disease | n2=en:pancreatic insulinoma | rel=r_associated | relid=0 | w=54
  947. en:addison disease -- r_associated #0: 54 / 0.209 -> en:pituitary agenesis
    n1=en:addison disease | n2=en:pituitary agenesis | rel=r_associated | relid=0 | w=54
  948. en:addison disease -- r_associated #0: 54 / 0.209 -> en:postprocedural hypothyroidism
    n1=en:addison disease | n2=en:postprocedural hypothyroidism | rel=r_associated | relid=0 | w=54
  949. en:addison disease -- r_associated #0: 54 / 0.209 -> en:potassium chloride 2.4 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 2.4 meq/ml injectable solution | rel=r_associated | relid=0 | w=54
  950. en:addison disease -- r_associated #0: 54 / 0.209 -> en:sex-hormone binding globulin markedly elevated
    n1=en:addison disease | n2=en:sex-hormone binding globulin markedly elevated | rel=r_associated | relid=0 | w=54
  951. en:addison disease -- r_associated #0: 54 / 0.209 -> en:thyroid iodine accumulation defect
    n1=en:addison disease | n2=en:thyroid iodine accumulation defect | rel=r_associated | relid=0 | w=54
  952. en:addison disease -- r_associated #0: 54 / 0.209 -> en:waterhouse-friderichsen syndrome, meningococcal
    n1=en:addison disease | n2=en:waterhouse-friderichsen syndrome, meningococcal | rel=r_associated | relid=0 | w=54
  953. en:addison disease -- r_associated #0: 53 / 0.205 -> en:Addison's syndrome
    n1=en:addison disease | n2=en:Addison's syndrome | rel=r_associated | relid=0 | w=53
  954. en:addison disease -- r_associated #0: 53 / 0.205 -> en:hypothyroidism (rare)
    n1=en:addison disease | n2=en:hypothyroidism (rare) | rel=r_associated | relid=0 | w=53
  955. en:addison disease -- r_associated #0: 53 / 0.205 -> en:irregular menstruation
    n1=en:addison disease | n2=en:irregular menstruation | rel=r_associated | relid=0 | w=53
  956. en:addison disease -- r_associated #0: 53 / 0.205 -> en:low c-peptide levels
    n1=en:addison disease | n2=en:low c-peptide levels | rel=r_associated | relid=0 | w=53
  957. en:addison disease -- r_associated #0: 53 / 0.205 -> en:magnesium sulfate 10%(0.4mmol/ml) injection
    n1=en:addison disease | n2=en:magnesium sulfate 10%(0.4mmol/ml) injection | rel=r_associated | relid=0 | w=53
  958. en:addison disease -- r_associated #0: 53 / 0.205 -> en:metabolic disorders nec
    n1=en:addison disease | n2=en:metabolic disorders nec | rel=r_associated | relid=0 | w=53
  959. en:addison disease -- r_associated #0: 53 / 0.205 -> en:temporal arteritis
    n1=en:addison disease | n2=en:temporal arteritis | rel=r_associated | relid=0 | w=53
  960. en:addison disease -- r_associated #0: 53 / 0.205 -> insuffisance surrénalienne chronique primaire
    n1=en:addison disease | n2=insuffisance surrénalienne chronique primaire | rel=r_associated | relid=0 | w=53
  961. en:addison disease -- r_associated #0: 52 / 0.202 -> en:anti-neutrophil cytoplasmic antibody-associated vasculitis
    n1=en:addison disease | n2=en:anti-neutrophil cytoplasmic antibody-associated vasculitis | rel=r_associated | relid=0 | w=52
  962. en:addison disease -- r_associated #0: 52 / 0.202 -> en:hiv/aids and pregnancy
    n1=en:addison disease | n2=en:hiv/aids and pregnancy | rel=r_associated | relid=0 | w=52
  963. en:addison disease -- r_associated #0: 52 / 0.202 -> en:low-to-normal serum growth hormone
    n1=en:addison disease | n2=en:low-to-normal serum growth hormone | rel=r_associated | relid=0 | w=52
  964. en:addison disease -- r_associated #0: 52 / 0.202 -> en:magnesium oxide 420 mg oral tablet
    n1=en:addison disease | n2=en:magnesium oxide 420 mg oral tablet | rel=r_associated | relid=0 | w=52
  965. en:addison disease -- r_associated #0: 52 / 0.202 -> en:magnesium sulfate 20 mg/ml injection
    n1=en:addison disease | n2=en:magnesium sulfate 20 mg/ml injection | rel=r_associated | relid=0 | w=52
  966. en:addison disease -- r_associated #0: 52 / 0.202 -> en:medulloadrenal hyperfunction
    n1=en:addison disease | n2=en:medulloadrenal hyperfunction | rel=r_associated | relid=0 | w=52
  967. en:addison disease -- r_associated #0: 52 / 0.202 -> en:partial deficiency of cytoplasmic dht-binding
    n1=en:addison disease | n2=en:partial deficiency of cytoplasmic dht-binding | rel=r_associated | relid=0 | w=52
  968. en:addison disease -- r_associated #0: 52 / 0.202 -> en:potassium bitartrate pwdr
    n1=en:addison disease | n2=en:potassium bitartrate pwdr | rel=r_associated | relid=0 | w=52
  969. en:addison disease -- r_associated #0: 52 / 0.202 -> en:potassium chloride 0.1 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 0.1 meq/ml injectable solution | rel=r_associated | relid=0 | w=52
  970. en:addison disease -- r_associated #0: 52 / 0.202 -> en:potassium gluconate 2.6 meq oral tablet
    n1=en:addison disease | n2=en:potassium gluconate 2.6 meq oral tablet | rel=r_associated | relid=0 | w=52
  971. en:addison disease -- r_associated #0: 52 / 0.202 -> en:secondary hyperparathyroidism
    n1=en:addison disease | n2=en:secondary hyperparathyroidism | rel=r_associated | relid=0 | w=52
  972. en:addison disease -- r_associated #0: 52 / 0.202 -> en:thymus gland
    n1=en:addison disease | n2=en:thymus gland | rel=r_associated | relid=0 | w=52
  973. en:addison disease -- r_associated #0: 52 / 0.202 -> en:waterhouse-friderichsen syndrome
    n1=en:addison disease | n2=en:waterhouse-friderichsen syndrome | rel=r_associated | relid=0 | w=52
  974. en:addison disease -- r_associated #0: 51 / 0.198 -> en:autoimmune pancytopenia
    n1=en:addison disease | n2=en:autoimmune pancytopenia | rel=r_associated | relid=0 | w=51
  975. en:addison disease -- r_associated #0: 51 / 0.198 -> en:central hypothyroidism, borderline
    n1=en:addison disease | n2=en:central hypothyroidism, borderline | rel=r_associated | relid=0 | w=51
  976. en:addison disease -- r_associated #0: 51 / 0.198 -> en:cryptosporidiosis
    n1=en:addison disease | n2=en:cryptosporidiosis | rel=r_associated | relid=0 | w=51
  977. en:addison disease -- r_associated #0: 51 / 0.198 -> en:diabetes mellitus (less common)
    n1=en:addison disease | n2=en:diabetes mellitus (less common) | rel=r_associated | relid=0 | w=51
  978. en:addison disease -- r_associated #0: 51 / 0.198 -> en:diabetic eye disease
    n1=en:addison disease | n2=en:diabetic eye disease | rel=r_associated | relid=0 | w=51
  979. en:addison disease -- r_associated #0: 51 / 0.198 -> en:dwarfism
    n1=en:addison disease | n2=en:dwarfism | rel=r_associated | relid=0 | w=51
  980. en:addison disease -- r_associated #0: 51 / 0.198 -> en:hypernatremia
    n1=en:addison disease | n2=en:hypernatremia | rel=r_associated | relid=0 | w=51
  981. en:addison disease -- r_associated #0: 51 / 0.198 -> en:increased circulating gonadotropin level
    n1=en:addison disease | n2=en:increased circulating gonadotropin level | rel=r_associated | relid=0 | w=51
  982. en:addison disease -- r_associated #0: 51 / 0.198 -> en:juvenile rheumatoid arthritis
    n1=en:addison disease | n2=en:juvenile rheumatoid arthritis | rel=r_associated | relid=0 | w=51
  983. en:addison disease -- r_associated #0: 51 / 0.198 -> en:low to undetectable gonadotropin levels
    n1=en:addison disease | n2=en:low to undetectable gonadotropin levels | rel=r_associated | relid=0 | w=51
  984. en:addison disease -- r_associated #0: 51 / 0.198 -> en:magnesium sulfate 0.8 mg/mg topical ointment
    n1=en:addison disease | n2=en:magnesium sulfate 0.8 mg/mg topical ointment | rel=r_associated | relid=0 | w=51
  985. en:addison disease -- r_associated #0: 51 / 0.198 -> en:oestradiol increased
    n1=en:addison disease | n2=en:oestradiol increased | rel=r_associated | relid=0 | w=51
  986. en:addison disease -- r_associated #0: 51 / 0.198 -> en:partial or complete serum gonadotropin deficiency
    n1=en:addison disease | n2=en:partial or complete serum gonadotropin deficiency | rel=r_associated | relid=0 | w=51
  987. en:addison disease -- r_associated #0: 51 / 0.198 -> en:potassium chloride 0.4 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 0.4 meq/ml injectable solution | rel=r_associated | relid=0 | w=51
  988. en:addison disease -- r_associated #0: 51 / 0.198 -> en:potassium,chelated
    n1=en:addison disease | n2=en:potassium,chelated | rel=r_associated | relid=0 | w=51
  989. en:addison disease -- r_associated #0: 51 / 0.198 -> en:precocious puberty (less common)
    n1=en:addison disease | n2=en:precocious puberty (less common) | rel=r_associated | relid=0 | w=51
  990. en:addison disease -- r_associated #0: 51 / 0.198 -> en:skin autoimmune disorders nec
    n1=en:addison disease | n2=en:skin autoimmune disorders nec | rel=r_associated | relid=0 | w=51
  991. en:addison disease -- r_associated #0: 51 / 0.198 -> en:total thyroxine to total triiodothyronine ratio markedly low
    n1=en:addison disease | n2=en:total thyroxine to total triiodothyronine ratio markedly low | rel=r_associated | relid=0 | w=51
  992. en:addison disease -- r_associated #0: 51 / 0.198 -> en:uveomeningoencephalitic syndrome
    n1=en:addison disease | n2=en:uveomeningoencephalitic syndrome | rel=r_associated | relid=0 | w=51
  993. en:addison disease -- r_associated #0: 50 / 0.194 -> en:anterior pituitary hypoplasia
    n1=en:addison disease | n2=en:anterior pituitary hypoplasia | rel=r_associated | relid=0 | w=50
  994. en:addison disease -- r_associated #0: 50 / 0.194 -> en:growth hormone deficiency (1 patient)
    n1=en:addison disease | n2=en:growth hormone deficiency (1 patient) | rel=r_associated | relid=0 | w=50
  995. en:addison disease -- r_associated #0: 50 / 0.194 -> en:high plasma cortisol
    n1=en:addison disease | n2=en:high plasma cortisol | rel=r_associated | relid=0 | w=50
  996. en:addison disease -- r_associated #0: 50 / 0.194 -> en:lymphedema
    n1=en:addison disease | n2=en:lymphedema | rel=r_associated | relid=0 | w=50
  997. en:addison disease -- r_associated #0: 50 / 0.194 -> en:pancreatic islet transplantation
    n1=en:addison disease | n2=en:pancreatic islet transplantation | rel=r_associated | relid=0 | w=50
  998. en:addison disease -- r_associated #0: 50 / 0.194 -> en:pneumocystis infections
    n1=en:addison disease | n2=en:pneumocystis infections | rel=r_associated | relid=0 | w=50
  999. en:addison disease -- r_associated #0: 50 / 0.194 -> en:potassium chloride
    n1=en:addison disease | n2=en:potassium chloride | rel=r_associated | relid=0 | w=50
  1000. en:addison disease -- r_associated #0: 50 / 0.194 -> en:potassium chloride 0.3 meq/ml injectable solution
    n1=en:addison disease | n2=en:potassium chloride 0.3 meq/ml injectable solution | rel=r_associated | relid=0 | w=50
  1001. en:addison disease -- r_associated #0: 50 / 0.194 -> insuffisance
    n1=en:addison disease | n2=insuffisance | rel=r_associated | relid=0 | w=50
  1002. en:addison disease -- r_associated #0: 49 / 0.19 -> en:altered melatonin secretion
    n1=en:addison disease | n2=en:altered melatonin secretion | rel=r_associated | relid=0 | w=49
  1003. en:addison disease -- r_associated #0: 49 / 0.19 -> en:ankylosing spondylitis
    n1=en:addison disease | n2=en:ankylosing spondylitis | rel=r_associated | relid=0 | w=49
  1004. en:addison disease -- r_associated #0: 49 / 0.19 -> en:entire juxtaglomerular apparatus
    n1=en:addison disease | n2=en:entire juxtaglomerular apparatus | rel=r_associated | relid=0 | w=49
  1005. en:addison disease -- r_associated #0: 49 / 0.19 -> en:magnesium sulfate 100 mg oral capsule
    n1=en:addison disease | n2=en:magnesium sulfate 100 mg oral capsule | rel=r_associated | relid=0 | w=49
  1006. en:addison disease -- r_associated #0: 47 / 0.182 -> en:absence of immune complexes and lymphocytes in thyroid tissue
    n1=en:addison disease | n2=en:absence of immune complexes and lymphocytes in thyroid tissue | rel=r_associated | relid=0 | w=47
  1007. en:addison disease -- r_associated #0: 47 / 0.182 -> en:decreased serum progesterone
    n1=en:addison disease | n2=en:decreased serum progesterone | rel=r_associated | relid=0 | w=47
  1008. en:addison disease -- r_associated #0: 47 / 0.182 -> en:diabetic ketoacidosis
    n1=en:addison disease | n2=en:diabetic ketoacidosis | rel=r_associated | relid=0 | w=47
  1009. en:addison disease -- r_associated #0: 47 / 0.182 -> en:hypogonadotropic hypogonadism (rare)
    n1=en:addison disease | n2=en:hypogonadotropic hypogonadism (rare) | rel=r_associated | relid=0 | w=47
  1010. en:addison disease -- r_associated #0: 47 / 0.182 -> en:nutritional and metabolic cardiomyopathy
    n1=en:addison disease | n2=en:nutritional and metabolic cardiomyopathy | rel=r_associated | relid=0 | w=47
  1011. en:addison disease -- r_associated #0: 46 / 0.178 -> en:exophthalmos
    n1=en:addison disease | n2=en:exophthalmos | rel=r_associated | relid=0 | w=46
  1012. en:addison disease -- r_associated #0: 46 / 0.178 -> en:failure of secondary sexual development
    n1=en:addison disease | n2=en:failure of secondary sexual development | rel=r_associated | relid=0 | w=46
  1013. en:addison disease -- r_associated #0: 46 / 0.178 -> en:patients with hypothyroidism have hypoplastic thyroid gland
    n1=en:addison disease | n2=en:patients with hypothyroidism have hypoplastic thyroid gland | rel=r_associated | relid=0 | w=46
  1014. en:addison disease -- r_associated #0: 45 / 0.174 -> en:maturity-onset diabetes of the young
    n1=en:addison disease | n2=en:maturity-onset diabetes of the young | rel=r_associated | relid=0 | w=45
  1015. en:addison disease -- r_associated #0: 45 / 0.174 -> en:potassium bicarbonate 0.208 meq/ml oral solution
    n1=en:addison disease | n2=en:potassium bicarbonate 0.208 meq/ml oral solution | rel=r_associated | relid=0 | w=45
  1016. en:addison disease -- r_associated #0: 44 / 0.171 -> en:steroid compound
    n1=en:addison disease | n2=en:steroid compound | rel=r_associated | relid=0 | w=44
  1017. en:addison disease -- r_associated #0: 40 / 0.155 -> chronique
    n1=en:addison disease | n2=chronique | rel=r_associated | relid=0 | w=40
  1018. en:addison disease -- r_associated #0: 40 / 0.155 -> insuffisance rénale
    n1=en:addison disease | n2=insuffisance rénale | rel=r_associated | relid=0 | w=40
  1019. en:addison disease -- r_associated #0: 40 / 0.155 -> primaire
    n1=en:addison disease | n2=primaire | rel=r_associated | relid=0 | w=40
  1020. en:addison disease -- r_associated #0: 40 / 0.155 -> surrénalienne
    n1=en:addison disease | n2=surrénalienne | rel=r_associated | relid=0 | w=40
  1021. en:addison disease -- r_associated #0: 39 / 0.151 -> en:thyrotoxic periodic paralysis
    n1=en:addison disease | n2=en:thyrotoxic periodic paralysis | rel=r_associated | relid=0 | w=39
  1022. en:addison disease -- r_associated #0: 34 / 0.132 -> en:hypoglycemic agents
    n1=en:addison disease | n2=en:hypoglycemic agents | rel=r_associated | relid=0 | w=34
  1023. en:addison disease -- r_associated #0: 30 / 0.116 -> médecine vétérinaire
    n1=en:addison disease | n2=médecine vétérinaire | rel=r_associated | relid=0 | w=30
  1024. en:addison disease -- r_associated #0: 30 / 0.116 -> Médecine vétérinaire
    n1=en:addison disease | n2=Médecine vétérinaire | rel=r_associated | relid=0 | w=30
  1025. en:addison disease -- r_associated #0: 30 / 0.116 -> processus
    n1=en:addison disease | n2=processus | rel=r_associated | relid=0 | w=30
  1026. en:addison disease -- r_associated #0: 28 / 0.109 -> pathologie
    n1=en:addison disease | n2=pathologie | rel=r_associated | relid=0 | w=28
  1027. en:addison disease -- r_associated #0: 25 / 0.097 -> en:medicine
    n1=en:addison disease | n2=en:medicine | rel=r_associated | relid=0 | w=25
  1028. en:addison disease -- r_associated #0: 21 / 0.081 -> en:primitive adrenocortical failure
    n1=en:addison disease | n2=en:primitive adrenocortical failure | rel=r_associated | relid=0 | w=21
  1029. en:addison disease -- r_associated #0: 21 / 0.081 -> maladie endocrinienne
    n1=en:addison disease | n2=maladie endocrinienne | rel=r_associated | relid=0 | w=21
  1030. en:addison disease -- r_associated #0: 20 / 0.078 -> dermatose bulleuse auto-immune
    n1=en:addison disease | n2=dermatose bulleuse auto-immune | rel=r_associated | relid=0 | w=20
  1031. en:addison disease -- r_associated #0: 20 / 0.078 -> en:autoimmune bullous dermatosis
    n1=en:addison disease | n2=en:autoimmune bullous dermatosis | rel=r_associated | relid=0 | w=20
  1032. en:addison disease -- r_associated #0: 20 / 0.078 -> en:autoimmune thyroiditis (rare)
    n1=en:addison disease | n2=en:autoimmune thyroiditis (rare) | rel=r_associated | relid=0 | w=20
  1033. en:addison disease -- r_associated #0: 20 / 0.078 -> en:delayed puberty (in most patients)
    n1=en:addison disease | n2=en:delayed puberty (in most patients) | rel=r_associated | relid=0 | w=20
  1034. en:addison disease -- r_associated #0: 20 / 0.078 -> en:ectopic thyroid gland
    n1=en:addison disease | n2=en:ectopic thyroid gland | rel=r_associated | relid=0 | w=20
  1035. en:addison disease -- r_associated #0: 20 / 0.078 -> en:elevated baseline 17-hydroxypregnenolone levels
    n1=en:addison disease | n2=en:elevated baseline 17-hydroxypregnenolone levels | rel=r_associated | relid=0 | w=20
  1036. en:addison disease -- r_associated #0: 20 / 0.078 -> en:elevated fasting plasma glucose
    n1=en:addison disease | n2=en:elevated fasting plasma glucose | rel=r_associated | relid=0 | w=20
  1037. en:addison disease -- r_associated #0: 20 / 0.078 -> en:elevated gonadotropin levels
    n1=en:addison disease | n2=en:elevated gonadotropin levels | rel=r_associated | relid=0 | w=20
  1038. en:addison disease -- r_associated #0: 20 / 0.078 -> en:epilepsy occipital calcifications
    n1=en:addison disease | n2=en:epilepsy occipital calcifications | rel=r_associated | relid=0 | w=20
  1039. en:addison disease -- r_associated #0: 20 / 0.078 -> en:low basal testosterone
    n1=en:addison disease | n2=en:low basal testosterone | rel=r_associated | relid=0 | w=20
  1040. en:addison disease -- r_associated #0: 20 / 0.078 -> en:low serum igf2 levels
    n1=en:addison disease | n2=en:low serum igf2 levels | rel=r_associated | relid=0 | w=20
  1041. en:addison disease -- r_associated #0: 20 / 0.078 -> en:low to normal estradiol levels
    n1=en:addison disease | n2=en:low to normal estradiol levels | rel=r_associated | relid=0 | w=20
  1042. en:addison disease -- r_associated #0: 20 / 0.078 -> en:normal basal plasma cortisol
    n1=en:addison disease | n2=en:normal basal plasma cortisol | rel=r_associated | relid=0 | w=20
  1043. en:addison disease -- r_associated #0: 20 / 0.078 -> en:normal serum igfbp3 levels
    n1=en:addison disease | n2=en:normal serum igfbp3 levels | rel=r_associated | relid=0 | w=20
  1044. en:addison disease -- r_associated #0: 20 / 0.078 -> en:ras-associated autoimmune leukoproliferative disorder
    n1=en:addison disease | n2=en:ras-associated autoimmune leukoproliferative disorder | rel=r_associated | relid=0 | w=20
  1045. en:addison disease -- r_associated #0: 20 / 0.078 -> en:thyroid oncocytic metaplasia
    n1=en:addison disease | n2=en:thyroid oncocytic metaplasia | rel=r_associated | relid=0 | w=20
  1046. en:addison disease -- r_associated #0: 15 / 0.058 -> en:hypoadrenalism
    n1=en:addison disease | n2=en:hypoadrenalism | rel=r_associated | relid=0 | w=15
  1047. en:addison disease -- r_associated #0: 15 / 0.058 -> en:hypoadrenocorticism
    n1=en:addison disease | n2=en:hypoadrenocorticism | rel=r_associated | relid=0 | w=15
  1048. en:addison disease -- r_associated #0: 5 / 0.019 -> en:veterinary medicine
    n1=en:addison disease | n2=en:veterinary medicine | rel=r_associated | relid=0 | w=5
  1049. en:addison disease -- r_associated #0: 5 / 0.019 -> hypoadrénocorticisme
    n1=en:addison disease | n2=hypoadrénocorticisme | rel=r_associated | relid=0 | w=5
  1050. en:addison disease -- r_associated #0: 5 / 0.019 -> Médecine
    n1=en:addison disease | n2=Médecine | rel=r_associated | relid=0 | w=5
  1051. en:addison disease -- r_associated #0: 1 / 0.004 -> en:endocrinal disease
    n1=en:addison disease | n2=en:endocrinal disease | rel=r_associated | relid=0 | w=1
  1052. en:addison disease -- r_associated #0: 1 / 0.004 -> insuffisance surrénalienne lente
    n1=en:addison disease | n2=insuffisance surrénalienne lente | rel=r_associated | relid=0 | w=1
  1053. en:addison disease -- r_associated #0: 1 / 0.004 -> maladie endocrinienne rare
    n1=en:addison disease | n2=maladie endocrinienne rare | rel=r_associated | relid=0 | w=1
≈ 1195 relations entrantes

  1. maladie d'Addison --- r_associated #0: 298 --> en:addison disease
    n1=maladie d'Addison | n2=en:addison disease | rel=r_associated | relid=0 | w=298
  2. en:Addison's disease --- r_associated #0: 295 --> en:addison disease
    n1=en:Addison's disease | n2=en:addison disease | rel=r_associated | relid=0 | w=295
  3. médecine --- r_associated #0: 177 --> en:addison disease
    n1=médecine | n2=en:addison disease | rel=r_associated | relid=0 | w=177
  4. en:addison's disease --- r_associated #0: 97 --> en:addison disease
    n1=en:addison's disease | n2=en:addison disease | rel=r_associated | relid=0 | w=97
  5. insuffisance surrénalienne chronique primaire --- r_associated #0: 90 --> en:addison disease
    n1=insuffisance surrénalienne chronique primaire | n2=en:addison disease | rel=r_associated | relid=0 | w=90
  6. maladie d'addison --- r_associated #0: 49 --> en:addison disease
    n1=maladie d'addison | n2=en:addison disease | rel=r_associated | relid=0 | w=49
  7. en:low to normal estradiol levels --- r_associated #0: 42 --> en:addison disease
    n1=en:low to normal estradiol levels | n2=en:addison disease | rel=r_associated | relid=0 | w=42
  8. en:normal serum igfbp3 levels --- r_associated #0: 38 --> en:addison disease
    n1=en:normal serum igfbp3 levels | n2=en:addison disease | rel=r_associated | relid=0 | w=38
  9. en:autoimmune thyroiditis (rare) --- r_associated #0: 37 --> en:addison disease
    n1=en:autoimmune thyroiditis (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=37
  10. en:epilepsy occipital calcifications --- r_associated #0: 35 --> en:addison disease
    n1=en:epilepsy occipital calcifications | n2=en:addison disease | rel=r_associated | relid=0 | w=35
  11. en:low basal testosterone --- r_associated #0: 35 --> en:addison disease
    n1=en:low basal testosterone | n2=en:addison disease | rel=r_associated | relid=0 | w=35
  12. insuffisance corticosurrénalienne primaire --- r_associated #0: 35 --> en:addison disease
    n1=insuffisance corticosurrénalienne primaire | n2=en:addison disease | rel=r_associated | relid=0 | w=35
  13. insuffisance surrénale primitive --- r_associated #0: 35 --> en:addison disease
    n1=insuffisance surrénale primitive | n2=en:addison disease | rel=r_associated | relid=0 | w=35
  14. en:elevated baseline 17-hydroxypregnenolone levels --- r_associated #0: 34 --> en:addison disease
    n1=en:elevated baseline 17-hydroxypregnenolone levels | n2=en:addison disease | rel=r_associated | relid=0 | w=34
  15. en:primitive adrenocortical failure --- r_associated #0: 34 --> en:addison disease
    n1=en:primitive adrenocortical failure | n2=en:addison disease | rel=r_associated | relid=0 | w=34
  16. insuffisance corticosurrénalienne primitive --- r_associated #0: 34 --> en:addison disease
    n1=insuffisance corticosurrénalienne primitive | n2=en:addison disease | rel=r_associated | relid=0 | w=34
  17. en:abcd1, ser606leu --- r_associated #0: 32 --> en:addison disease
    n1=en:abcd1, ser606leu | n2=en:addison disease | rel=r_associated | relid=0 | w=32
  18. en:delayed puberty (in most patients) --- r_associated #0: 32 --> en:addison disease
    n1=en:delayed puberty (in most patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=32
  19. en:low serum igf2 levels --- r_associated #0: 32 --> en:addison disease
    n1=en:low serum igf2 levels | n2=en:addison disease | rel=r_associated | relid=0 | w=32
  20. dermatose bulleuse auto-immune --- r_associated #0: 31 --> en:addison disease
    n1=dermatose bulleuse auto-immune | n2=en:addison disease | rel=r_associated | relid=0 | w=31
  21. en:autoimmune bullous dermatosis --- r_associated #0: 31 --> en:addison disease
    n1=en:autoimmune bullous dermatosis | n2=en:addison disease | rel=r_associated | relid=0 | w=31
  22. en:ectopic thyroid gland --- r_associated #0: 31 --> en:addison disease
    n1=en:ectopic thyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=31
  23. en:Addison disease --- r_associated #0: 30 --> en:addison disease
    n1=en:Addison disease | n2=en:addison disease | rel=r_associated | relid=0 | w=30
  24. en:elevated gonadotropin levels --- r_associated #0: 30 --> en:addison disease
    n1=en:elevated gonadotropin levels | n2=en:addison disease | rel=r_associated | relid=0 | w=30
  25. insuffisance corticosurrénalienne chronique --- r_associated #0: 30 --> en:addison disease
    n1=insuffisance corticosurrénalienne chronique | n2=en:addison disease | rel=r_associated | relid=0 | w=30
  26. insuffisance surrénalienne primaire --- r_associated #0: 30 --> en:addison disease
    n1=insuffisance surrénalienne primaire | n2=en:addison disease | rel=r_associated | relid=0 | w=30
  27. maladie bronzée --- r_associated #0: 30 --> en:addison disease
    n1=maladie bronzée | n2=en:addison disease | rel=r_associated | relid=0 | w=30
  28. en:abcd1, 1-bp del, 2204g --- r_associated #0: 29 --> en:addison disease
    n1=en:abcd1, 1-bp del, 2204g | n2=en:addison disease | rel=r_associated | relid=0 | w=29
  29. en:normal basal plasma cortisol --- r_associated #0: 29 --> en:addison disease
    n1=en:normal basal plasma cortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=29
  30. en:ras-associated autoimmune leukoproliferative disorder --- r_associated #0: 29 --> en:addison disease
    n1=en:ras-associated autoimmune leukoproliferative disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=29
  31. Addison --- r_associated #0: 27 --> en:addison disease
    n1=Addison | n2=en:addison disease | rel=r_associated | relid=0 | w=27
  32. insuffisance surrénale lente --- r_associated #0: 27 --> en:addison disease
    n1=insuffisance surrénale lente | n2=en:addison disease | rel=r_associated | relid=0 | w=27
  33. en:elevated fasting plasma glucose --- r_associated #0: 26 --> en:addison disease
    n1=en:elevated fasting plasma glucose | n2=en:addison disease | rel=r_associated | relid=0 | w=26
  34. en:thyroid oncocytic metaplasia --- r_associated #0: 26 --> en:addison disease
    n1=en:thyroid oncocytic metaplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=26
  35. insuffisance surrénalienne primitive --- r_associated #0: 26 --> en:addison disease
    n1=insuffisance surrénalienne primitive | n2=en:addison disease | rel=r_associated | relid=0 | w=26
  36. maladie due à un virus --- r_associated #0: 25 --> en:addison disease
    n1=maladie due à un virus | n2=en:addison disease | rel=r_associated | relid=0 | w=25
  37. maladie à cytomégalovirus --- r_associated #0: 25 --> en:addison disease
    n1=maladie à cytomégalovirus | n2=en:addison disease | rel=r_associated | relid=0 | w=25
  38. insuffisance surrénale --- r_associated #0: 21 --> en:addison disease
    n1=insuffisance surrénale | n2=en:addison disease | rel=r_associated | relid=0 | w=21
  39. surrénalite auto-immune --- r_associated #0: 21 --> en:addison disease
    n1=surrénalite auto-immune | n2=en:addison disease | rel=r_associated | relid=0 | w=21
  40. ACTH --- r_associated #0: 20 --> en:addison disease
    n1=ACTH | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  41. DAX1 --- r_associated #0: 20 --> en:addison disease
    n1=DAX1 | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  42. DHA --- r_associated #0: 20 --> en:addison disease
    n1=DHA | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  43. Médecine vétérinaire --- r_associated #0: 20 --> en:addison disease
    n1=Médecine vétérinaire | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  44. Rénine --- r_associated #0: 20 --> en:addison disease
    n1=Rénine | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  45. achalasie et insuffisance surrénalienne --- r_associated #0: 20 --> en:addison disease
    n1=achalasie et insuffisance surrénalienne | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  46. activité rénine plasmatique --- r_associated #0: 20 --> en:addison disease
    n1=activité rénine plasmatique | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  47. adrénoleucodystrophie --- r_associated #0: 20 --> en:addison disease
    n1=adrénoleucodystrophie | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  48. aldostérone --- r_associated #0: 20 --> en:addison disease
    n1=aldostérone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  49. amylose --- r_associated #0: 20 --> en:addison disease
    n1=amylose | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  50. anticorps anti21-hydroxylase --- r_associated #0: 20 --> en:addison disease
    n1=anticorps anti21-hydroxylase | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  51. atrophie corticosurrénalienne auto-immune --- r_associated #0: 20 --> en:addison disease
    n1=atrophie corticosurrénalienne auto-immune | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  52. chat --- r_associated #0: 20 --> en:addison disease
    n1=chat | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  53. chien --- r_associated #0: 20 --> en:addison disease
    n1=chien | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  54. chronique --- r_associated #0: 20 --> en:addison disease
    n1=chronique | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  55. cortisol --- r_associated #0: 20 --> en:addison disease
    n1=cortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  56. destruction des cellules des glandes surrénales --- r_associated #0: 20 --> en:addison disease
    n1=destruction des cellules des glandes surrénales | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  57. en:'cytomegalic' cells (large, pale) in adrenal glands --- r_associated #0: 20 --> en:addison disease
    n1=en:'cytomegalic' cells (large, pale) in adrenal glands | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  58. en:50 ml magnesium sulfate 40 mg/ml injection --- r_associated #0: 20 --> en:addison disease
    n1=en:50 ml magnesium sulfate 40 mg/ml injection | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  59. en:50 ml magnesium sulfate 80 mg/ml injection --- r_associated #0: 20 --> en:addison disease
    n1=en:50 ml magnesium sulfate 80 mg/ml injection | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  60. en:Addison's syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:Addison's syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  61. en:abnormal glucose tolerance --- r_associated #0: 20 --> en:addison disease
    n1=en:abnormal glucose tolerance | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  62. en:abnormal glucose tolerance test --- r_associated #0: 20 --> en:addison disease
    n1=en:abnormal glucose tolerance test | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  63. en:abnormal growth hormone (139250) response to stimulus --- r_associated #0: 20 --> en:addison disease
    n1=en:abnormal growth hormone (139250) response to stimulus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  64. en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable --- r_associated #0: 20 --> en:addison disease
    n1=en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  65. en:absence of immune complexes and lymphocytes in thyroid tissue --- r_associated #0: 20 --> en:addison disease
    n1=en:absence of immune complexes and lymphocytes in thyroid tissue | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  66. en:absence of pubertal development --- r_associated #0: 20 --> en:addison disease
    n1=en:absence of pubertal development | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  67. en:absent dehydroepiandrosterone-sulphate, even after acth stimulation --- r_associated #0: 20 --> en:addison disease
    n1=en:absent dehydroepiandrosterone-sulphate, even after acth stimulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  68. en:absent or delayed puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:absent or delayed puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  69. en:absent or low response to gonadotropin-releasing hormone stimulation --- r_associated #0: 20 --> en:addison disease
    n1=en:absent or low response to gonadotropin-releasing hormone stimulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  70. en:absent or minimal increase in pregnanetriol after hcg stimulation --- r_associated #0: 20 --> en:addison disease
    n1=en:absent or minimal increase in pregnanetriol after hcg stimulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  71. en:accessory parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:accessory parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  72. en:accessory thyroid tissue --- r_associated #0: 20 --> en:addison disease
    n1=en:accessory thyroid tissue | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  73. en:acquired immunodeficiency syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:acquired immunodeficiency syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  74. en:acquired porphyria --- r_associated #0: 20 --> en:addison disease
    n1=en:acquired porphyria | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  75. en:acral overgrowth --- r_associated #0: 20 --> en:addison disease
    n1=en:acral overgrowth | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  76. en:acromegaloid features --- r_associated #0: 20 --> en:addison disease
    n1=en:acromegaloid features | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  77. en:acromegaly --- r_associated #0: 20 --> en:addison disease
    n1=en:acromegaly | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  78. en:acth-independent hypercortisolemia --- r_associated #0: 20 --> en:addison disease
    n1=en:acth-independent hypercortisolemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  79. en:acute lymphoblastic leukemia --- r_associated #0: 20 --> en:addison disease
    n1=en:acute lymphoblastic leukemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  80. en:addison melanoderma (disorder) --- r_associated #0: 20 --> en:addison disease
    n1=en:addison melanoderma (disorder) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  81. en:addison's disease due to autoimmunity --- r_associated #0: 20 --> en:addison disease
    n1=en:addison's disease due to autoimmunity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  82. en:adrenal --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  83. en:adrenal adenomas, bilateral --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal adenomas, bilateral | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  84. en:adrenal androgen deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal androgen deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  85. en:adrenal atrophy --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal atrophy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  86. en:adrenal cortex adenoma --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal cortex adenoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  87. en:adrenal cortical hypofunction --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal cortical hypofunction | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  88. en:adrenal crisis --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal crisis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  89. en:adrenal crisis in neonatal period --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal crisis in neonatal period | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  90. en:adrenal failure (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal failure (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  91. en:adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  92. en:adrenal gland disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal gland disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  93. en:adrenal gland dysgenesis --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal gland dysgenesis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  94. en:adrenal gland pheochromocytoma --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal gland pheochromocytoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  95. en:adrenal glands may be normal, atrophic, or slightly enlarged --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal glands may be normal, atrophic, or slightly enlarged | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  96. en:adrenal hemangiomas --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal hemangiomas | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  97. en:adrenal hyperplasia, bilateral --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal hyperplasia, bilateral | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  98. en:adrenal hypoplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal hypoplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  99. en:adrenal insufficiency due to adrenal metastasis --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal insufficiency due to adrenal metastasis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  100. en:adrenal insufficiency neonatal --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal insufficiency neonatal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  101. en:adrenal insufficiency, congenital (300200) in 'complex' form --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal insufficiency, congenital (300200) in 'complex' form | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  102. en:adrenal medullary insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenal medullary insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  103. en:adrenocortical cytomegaly --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocortical cytomegaly | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  104. en:adrenocortical hypofunction, chronic primary congenital --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocortical hypofunction, chronic primary congenital | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  105. en:adrenocortical insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocortical insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  106. en:adrenocortical insufficiency (uncommon) --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocortical insufficiency (uncommon) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  107. en:adrenocortical insufficiency neonatal --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocortical insufficiency neonatal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  108. en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  109. en:adrenocorticotropic hormone deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocorticotropic hormone deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  110. en:adrenocorticotropin deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenocorticotropin deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  111. en:adrenogenital syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenogenital syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  112. en:adrenoleukodystrophy --- r_associated #0: 20 --> en:addison disease
    n1=en:adrenoleukodystrophy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  113. en:age at natural menopause qtl --- r_associated #0: 20 --> en:addison disease
    n1=en:age at natural menopause qtl | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  114. en:alcohol-induced pseudo-cushing's syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:alcohol-induced pseudo-cushing's syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  115. en:aldosterone level increased above normal --- r_associated #0: 20 --> en:addison disease
    n1=en:aldosterone level increased above normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  116. en:aldosterone synthase deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:aldosterone synthase deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  117. en:allergic arthritis --- r_associated #0: 20 --> en:addison disease
    n1=en:allergic arthritis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  118. en:allgrove syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:allgrove syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  119. en:altered melatonin secretion --- r_associated #0: 20 --> en:addison disease
    n1=en:altered melatonin secretion | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  120. en:amenorrhea --- r_associated #0: 20 --> en:addison disease
    n1=en:amenorrhea | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  121. en:anaphylaxis (non medication) --- r_associated #0: 20 --> en:addison disease
    n1=en:anaphylaxis (non medication) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  122. en:anatomic structures --- r_associated #0: 20 --> en:addison disease
    n1=en:anatomic structures | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  123. en:androgen excess --- r_associated #0: 20 --> en:addison disease
    n1=en:androgen excess | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  124. en:androgen levels normal --- r_associated #0: 20 --> en:addison disease
    n1=en:androgen levels normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  125. en:anhydrous citric acid --- r_associated #0: 20 --> en:addison disease
    n1=en:anhydrous citric acid | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  126. en:animal bite --- r_associated #0: 20 --> en:addison disease
    n1=en:animal bite | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  127. en:ankylosing spondylitis --- r_associated #0: 20 --> en:addison disease
    n1=en:ankylosing spondylitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  128. en:anterior pituitary enlargement --- r_associated #0: 20 --> en:addison disease
    n1=en:anterior pituitary enlargement | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  129. en:anterior pituitary hypoplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:anterior pituitary hypoplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  130. en:anti-glomerular basement membrane disease --- r_associated #0: 20 --> en:addison disease
    n1=en:anti-glomerular basement membrane disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  131. en:anti-neutrophil cytoplasmic antibody-associated vasculitis --- r_associated #0: 20 --> en:addison disease
    n1=en:anti-neutrophil cytoplasmic antibody-associated vasculitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  132. en:antibody-producing cell --- r_associated #0: 20 --> en:addison disease
    n1=en:antibody-producing cell | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  133. en:antigen presenting cell --- r_associated #0: 20 --> en:addison disease
    n1=en:antigen presenting cell | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  134. en:antiphospholipid syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:antiphospholipid syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  135. en:antisynthetase syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:antisynthetase syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  136. en:aplastic anemia --- r_associated #0: 20 --> en:addison disease
    n1=en:aplastic anemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  137. en:argentaffin cell --- r_associated #0: 20 --> en:addison disease
    n1=en:argentaffin cell | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  138. en:aspects of mortality statistics --- r_associated #0: 20 --> en:addison disease
    n1=en:aspects of mortality statistics | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  139. en:aspects of radionuclide imaging --- r_associated #0: 20 --> en:addison disease
    n1=en:aspects of radionuclide imaging | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  140. en:asthma --- r_associated #0: 20 --> en:addison disease
    n1=en:asthma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  141. en:autoimmune adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  142. en:autoimmune antibody positivity --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune antibody positivity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  143. en:autoimmune cholangitis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune cholangitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  144. en:autoimmune disease --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  145. en:autoimmune disease, nec in mdr --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune disease, nec in mdr | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  146. en:autoimmune disease:find:pt:^family member:nom:phenx --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune disease:find:pt:^family member:nom:phenx | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  147. en:autoimmune disorder of inner ear --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune disorder of inner ear | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  148. en:autoimmune disorders nec --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune disorders nec | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  149. en:autoimmune encephalitis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune encephalitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  150. en:autoimmune endocrine disease --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune endocrine disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  151. en:autoimmune enteropathy --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune enteropathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  152. en:autoimmune hematologic disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune hematologic disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  153. en:autoimmune hemolytic anemia --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune hemolytic anemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  154. en:autoimmune hepatitis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune hepatitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  155. en:autoimmune hypoparathyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune hypoparathyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  156. en:autoimmune hypophysitis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune hypophysitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  157. en:autoimmune inflammation of skeletal muscle --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune inflammation of skeletal muscle | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  158. en:autoimmune leukopenia --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune leukopenia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  159. en:autoimmune liver disease --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune liver disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  160. en:autoimmune lymphoproliferative syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune lymphoproliferative syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  161. en:autoimmune necrotizing myopathy --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune necrotizing myopathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  162. en:autoimmune neonatal thrombocytopenia --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune neonatal thrombocytopenia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  163. en:autoimmune nervous system disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune nervous system disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  164. en:autoimmune neutropenia --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune neutropenia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  165. en:autoimmune pancreatitis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune pancreatitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  166. en:autoimmune pancytopenia --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune pancytopenia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  167. en:autoimmune parathyroiditis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune parathyroiditis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  168. en:autoimmune polyendocrine syndrome type 3 --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune polyendocrine syndrome type 3 | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  169. en:autoimmune polyendocrinopathy syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune polyendocrinopathy syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  170. en:autoimmune primary adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune primary adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  171. en:autoimmune primary ovarian failure --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune primary ovarian failure | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  172. en:autoimmune skin disease --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune skin disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  173. en:autoimmune syndrome type ii, polyglandular --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune syndrome type ii, polyglandular | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  174. en:autoimmune thyroiditis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune thyroiditis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  175. en:autoimmune vasculitis --- r_associated #0: 20 --> en:addison disease
    n1=en:autoimmune vasculitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  176. en:baseline pregnanediol and pregnanetriol normal --- r_associated #0: 20 --> en:addison disease
    n1=en:baseline pregnanediol and pregnanetriol normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  177. en:benign lymphoepithelial lesion of the salivary gland --- r_associated #0: 20 --> en:addison disease
    n1=en:benign lymphoepithelial lesion of the salivary gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  178. en:blau syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:blau syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  179. en:blood glucose measurement --- r_associated #0: 20 --> en:addison disease
    n1=en:blood glucose measurement | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  180. en:bone marrow --- r_associated #0: 20 --> en:addison disease
    n1=en:bone marrow | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  181. en:bone marrow disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:bone marrow disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  182. en:bone marrow transplantation --- r_associated #0: 20 --> en:addison disease
    n1=en:bone marrow transplantation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  183. en:brain diseases, metabolic --- r_associated #0: 20 --> en:addison disease
    n1=en:brain diseases, metabolic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  184. en:bullous pemphigoid --- r_associated #0: 20 --> en:addison disease
    n1=en:bullous pemphigoid | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  185. en:c-cell hyperplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:c-cell hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  186. en:calcitonin decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:calcitonin decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  187. en:carotenemia --- r_associated #0: 20 --> en:addison disease
    n1=en:carotenemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  188. en:catabolic state --- r_associated #0: 20 --> en:addison disease
    n1=en:catabolic state | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  189. en:central hyperthyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:central hyperthyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  190. en:central hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:central hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  191. en:central hypothyroidism, borderline --- r_associated #0: 20 --> en:addison disease
    n1=en:central hypothyroidism, borderline | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  192. en:cervical neuroendocrine carcinoma --- r_associated #0: 20 --> en:addison disease
    n1=en:cervical neuroendocrine carcinoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  193. en:chemically induced --- r_associated #0: 20 --> en:addison disease
    n1=en:chemically induced | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  194. en:childhood asthma --- r_associated #0: 20 --> en:addison disease
    n1=en:childhood asthma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  195. en:childhood immunization --- r_associated #0: 20 --> en:addison disease
    n1=en:childhood immunization | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  196. en:childhood leukemia --- r_associated #0: 20 --> en:addison disease
    n1=en:childhood leukemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  197. en:chromaffin system --- r_associated #0: 20 --> en:addison disease
    n1=en:chromaffin system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  198. en:chronic lymphocytic leukemia --- r_associated #0: 20 --> en:addison disease
    n1=en:chronic lymphocytic leukemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  199. en:citrate toxicity --- r_associated #0: 20 --> en:addison disease
    n1=en:citrate toxicity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  200. en:citric acid --- r_associated #0: 20 --> en:addison disease
    n1=en:citric acid | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  201. en:citric acid granules --- r_associated #0: 20 --> en:addison disease
    n1=en:citric acid granules | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  202. en:citric acid monohydrate --- r_associated #0: 20 --> en:addison disease
    n1=en:citric acid monohydrate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  203. en:citric acid,hydrous --- r_associated #0: 20 --> en:addison disease
    n1=en:citric acid,hydrous | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  204. en:citrus naringinine --- r_associated #0: 20 --> en:addison disease
    n1=en:citrus naringinine | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  205. en:compensated hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:compensated hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  206. en:complement --- r_associated #0: 20 --> en:addison disease
    n1=en:complement | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  207. en:complication aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:complication aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  208. en:congenital absence of adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital absence of adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  209. en:congenital absence of parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital absence of parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  210. en:congenital absence of thymus --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital absence of thymus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  211. en:congenital adrenal gland hypoplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital adrenal gland hypoplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  212. en:congenital adrenal hyperplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital adrenal hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  213. en:congenital hyperthyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital hyperthyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  214. en:congenital hypoparathyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital hypoparathyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  215. en:congenital hypoplasia of thymus --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital hypoplasia of thymus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  216. en:congenital hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  217. en:congenital mesh qualifier --- r_associated #0: 20 --> en:addison disease
    n1=en:congenital mesh qualifier | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  218. en:corticosteroid deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:corticosteroid deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  219. en:cortisol deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:cortisol deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  220. en:cortisol insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:cortisol insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  221. en:cryptosporidiosis --- r_associated #0: 20 --> en:addison disease
    n1=en:cryptosporidiosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  222. en:crystal arthropathy --- r_associated #0: 20 --> en:addison disease
    n1=en:crystal arthropathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  223. en:crystal nephropathy --- r_associated #0: 20 --> en:addison disease
    n1=en:crystal nephropathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  224. en:ctla4 haploinsufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:ctla4 haploinsufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  225. en:cushing disease --- r_associated #0: 20 --> en:addison disease
    n1=en:cushing disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  226. en:cushing disease due to increased acth secretion (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:cushing disease due to increased acth secretion (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  227. en:cushing syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:cushing syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  228. en:cushingoid --- r_associated #0: 20 --> en:addison disease
    n1=en:cushingoid | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  229. en:cushingoid appearance (2 patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:cushingoid appearance (2 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  230. en:decreased circulating renin level --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased circulating renin level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  231. en:decreased fertility --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased fertility | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  232. en:decreased fertility in females --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased fertility in females | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  233. en:decreased fertility in males --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased fertility in males | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  234. en:decreased growth hormone (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased growth hormone (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  235. en:decreased growth hormone secretion (1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased growth hormone secretion (1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  236. en:decreased secondary sexual characteristics (in a subset of patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased secondary sexual characteristics (in a subset of patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  237. en:decreased serum progesterone --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased serum progesterone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  238. en:decreased testosterone (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased testosterone (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  239. en:decreased testosterone in males --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased testosterone in males | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  240. en:decreased testosterone level --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased testosterone level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  241. en:decreased thyroxine level --- r_associated #0: 20 --> en:addison disease
    n1=en:decreased thyroxine level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  242. en:defective dht formation --- r_associated #0: 20 --> en:addison disease
    n1=en:defective dht formation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  243. en:deficient growth hormone response to insulin, arginine, or levodopa --- r_associated #0: 20 --> en:addison disease
    n1=en:deficient growth hormone response to insulin, arginine, or levodopa | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  244. en:delay in secondary sexual characteristics --- r_associated #0: 20 --> en:addison disease
    n1=en:delay in secondary sexual characteristics | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  245. en:delayed conversion of oral cortisone acetate to plasma cortisol --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed conversion of oral cortisone acetate to plasma cortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  246. en:delayed onset of puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed onset of puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  247. en:delayed or incomplete puberty (1 family) --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed or incomplete puberty (1 family) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  248. en:delayed pubertal development (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed pubertal development (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  249. en:delayed puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  250. en:delayed puberty (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed puberty (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  251. en:delayed secondary sexual characteristics in males --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed secondary sexual characteristics in males | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  252. en:delayed testosterone increase at puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:delayed testosterone increase at puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  253. en:dendritic cell system structure --- r_associated #0: 20 --> en:addison disease
    n1=en:dendritic cell system structure | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  254. en:dermatitis herpetiformis --- r_associated #0: 20 --> en:addison disease
    n1=en:dermatitis herpetiformis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  255. en:dermatomyositis --- r_associated #0: 20 --> en:addison disease
    n1=en:dermatomyositis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  256. en:diabetes (in affected males) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes (in affected males) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  257. en:diabetes (may develop later in life) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes (may develop later in life) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  258. en:diabetes complication --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes complication | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  259. en:diabetes in children and teens --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes in children and teens | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  260. en:diabetes insipidus --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes insipidus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  261. en:diabetes insipidus (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes insipidus (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  262. en:diabetes mellitus --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  263. en:diabetes mellitus (1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus (1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  264. en:diabetes mellitus (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  265. en:diabetes mellitus (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  266. en:diabetes mellitus (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  267. en:diabetes mellitus, infantile --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus, infantile | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  268. en:diabetes mellitus, insulin-dependent (1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus, insulin-dependent (1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  269. en:diabetes mellitus, insulin-dependent, late onset (uncommon) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus, insulin-dependent, late onset (uncommon) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  270. en:diabetes mellitus, susceptibility to --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus, susceptibility to | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  271. en:diabetes mellitus, type 1 (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus, type 1 (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  272. en:diabetes mellitus, type 2 (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes mellitus, type 2 (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  273. en:diabetes, early-onset (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetes, early-onset (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  274. en:diabetic diet --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic diet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  275. en:diabetic eye disease --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic eye disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  276. en:diabetic foot --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic foot | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  277. en:diabetic heart disease --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic heart disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  278. en:diabetic ketoacidosis --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic ketoacidosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  279. en:diabetic mastopathy --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic mastopathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  280. en:diabetic nephropathy --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic nephropathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  281. en:diabetic nerve problems --- r_associated #0: 20 --> en:addison disease
    n1=en:diabetic nerve problems | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  282. en:diagnosis aspect --- r_associated #0: 20 --> en:addison disease
    n1=en:diagnosis aspect | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  283. en:diffuse endocrine system --- r_associated #0: 20 --> en:addison disease
    n1=en:diffuse endocrine system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  284. en:diffuse neuroendocrine structure --- r_associated #0: 20 --> en:addison disease
    n1=en:diffuse neuroendocrine structure | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  285. en:disorder of pineal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:disorder of pineal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  286. en:disorders of bilirubin excretion --- r_associated #0: 20 --> en:addison disease
    n1=en:disorders of bilirubin excretion | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  287. en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx --- r_associated #0: 20 --> en:addison disease
    n1=en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  288. en:drug-induced adrenocortical insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:drug-induced adrenocortical insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  289. en:dwarfism --- r_associated #0: 20 --> en:addison disease
    n1=en:dwarfism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  290. en:dysfunction of hypothalamo-pituitary-gonadal axis --- r_associated #0: 20 --> en:addison disease
    n1=en:dysfunction of hypothalamo-pituitary-gonadal axis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  291. en:dysfunction syndromes, hypothalamic --- r_associated #0: 20 --> en:addison disease
    n1=en:dysfunction syndromes, hypothalamic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  292. en:early-onset puberty (in 2 of 3 patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:early-onset puberty (in 2 of 3 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  293. en:early-onset puberty (menarche about 2 years early) --- r_associated #0: 20 --> en:addison disease
    n1=en:early-onset puberty (menarche about 2 years early) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  294. en:early-onset type ii diabetes (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:early-onset type ii diabetes (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  295. en:ectopic endocrine structure --- r_associated #0: 20 --> en:addison disease
    n1=en:ectopic endocrine structure | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  296. en:ectopic hyperthyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:ectopic hyperthyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  297. en:ectopic or absent posterior pituitary --- r_associated #0: 20 --> en:addison disease
    n1=en:ectopic or absent posterior pituitary | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  298. en:ectopic posterior pituitary --- r_associated #0: 20 --> en:addison disease
    n1=en:ectopic posterior pituitary | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  299. en:ectopic thyroid gland (finding) --- r_associated #0: 20 --> en:addison disease
    n1=en:ectopic thyroid gland (finding) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  300. en:elevated 18-hydroxycortisol --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated 18-hydroxycortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  301. en:elevated 18-oxocortisol --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated 18-oxocortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  302. en:elevated aldosterone --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated aldosterone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  303. en:elevated androgen metabolite excretion level --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated androgen metabolite excretion level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  304. en:elevated fasting glucose --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated fasting glucose | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  305. en:elevated follicle stimulating hormone (fsh) --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated follicle stimulating hormone (fsh) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  306. en:elevated follicle-stimulating hormone (fsh) level --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated follicle-stimulating hormone (fsh) level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  307. en:elevated follicle-stimulating hormone level --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated follicle-stimulating hormone level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  308. en:elevated growth hormone (gh) levels --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated growth hormone (gh) levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  309. en:elevated igf1 levels --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated igf1 levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  310. en:elevated insulin --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated insulin | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  311. en:elevated luteinizing hormone (lh) level --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated luteinizing hormone (lh) level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  312. en:elevated prepubertal levels of estradiol --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated prepubertal levels of estradiol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  313. en:elevated prepubertal levels of testosterone --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated prepubertal levels of testosterone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  314. en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect) --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  315. en:elevated serum adiponectin --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated serum adiponectin | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  316. en:elevated serum estradiol (in male and female patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated serum estradiol (in male and female patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  317. en:elevated serum estrone (in male and female patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated serum estrone (in male and female patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  318. en:elevated serum follicle-stimulating hormone (in male and female patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated serum follicle-stimulating hormone (in male and female patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  319. en:elevated serum luteinizing hormone (in male and female patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated serum luteinizing hormone (in male and female patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  320. en:elevated thyroid stimulating hormone (tsh) --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated thyroid stimulating hormone (tsh) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  321. en:elevated urinary gonadotropins --- r_associated #0: 20 --> en:addison disease
    n1=en:elevated urinary gonadotropins | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  322. en:embryologic --- r_associated #0: 20 --> en:addison disease
    n1=en:embryologic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  323. en:endocrine abnormalities, variable, (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine abnormalities, variable, (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  324. en:endocrine dysgenesis --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine dysgenesis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  325. en:endocrine features --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine features | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  326. en:endocrine gland --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  327. en:endocrine glands with iron deposition --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine glands with iron deposition | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  328. en:endocrine pancreas disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine pancreas disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  329. en:endocrine pancreatic adenoma --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine pancreatic adenoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  330. en:endocrine system --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  331. en:endocrine system disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine system disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  332. en:endocrine system disorders, general, polyglandular and nec --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine system disorders, general, polyglandular and nec | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  333. en:endocrine system subdivision --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine system subdivision | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  334. en:endocrine tissue --- r_associated #0: 20 --> en:addison disease
    n1=en:endocrine tissue | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  335. en:enhanced insulin sensitivity --- r_associated #0: 20 --> en:addison disease
    n1=en:enhanced insulin sensitivity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  336. en:enlarged adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:enlarged adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  337. en:enlarged thyroid gland (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:enlarged thyroid gland (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  338. en:enteroendocrine cell --- r_associated #0: 20 --> en:addison disease
    n1=en:enteroendocrine cell | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  339. en:entire endocrine system --- r_associated #0: 20 --> en:addison disease
    n1=en:entire endocrine system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  340. en:entire immune system --- r_associated #0: 20 --> en:addison disease
    n1=en:entire immune system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  341. en:entire juxtaglomerular apparatus --- r_associated #0: 20 --> en:addison disease
    n1=en:entire juxtaglomerular apparatus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  342. en:enzyme abnormality (nos) --- r_associated #0: 20 --> en:addison disease
    n1=en:enzyme abnormality (nos) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  343. en:enzyme induction --- r_associated #0: 20 --> en:addison disease
    n1=en:enzyme induction | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  344. en:enzyme inhibition disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:enzyme inhibition disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  345. en:enzymology --- r_associated #0: 20 --> en:addison disease
    n1=en:enzymology | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  346. en:eosinophilic disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:eosinophilic disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  347. en:epidemiologic --- r_associated #0: 20 --> en:addison disease
    n1=en:epidemiologic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  348. en:episodic asymptomatic severe hypoglycemia in childhood --- r_associated #0: 20 --> en:addison disease
    n1=en:episodic asymptomatic severe hypoglycemia in childhood | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  349. en:estradiol undetectable --- r_associated #0: 20 --> en:addison disease
    n1=en:estradiol undetectable | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  350. en:ethnologic --- r_associated #0: 20 --> en:addison disease
    n1=en:ethnologic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  351. en:etiology aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:etiology aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  352. en:eunuchoid appearance of males --- r_associated #0: 20 --> en:addison disease
    n1=en:eunuchoid appearance of males | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  353. en:euthyroid (compensated hypothyroidism) --- r_associated #0: 20 --> en:addison disease
    n1=en:euthyroid (compensated hypothyroidism) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  354. en:euthyroid (finding) --- r_associated #0: 20 --> en:addison disease
    n1=en:euthyroid (finding) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  355. en:euthyroid multinodular goiter --- r_associated #0: 20 --> en:addison disease
    n1=en:euthyroid multinodular goiter | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  356. en:euthyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:euthyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  357. en:evans syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:evans syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  358. en:exophthalmos --- r_associated #0: 20 --> en:addison disease
    n1=en:exophthalmos | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  359. en:experimental allergic encephalomyelitis --- r_associated #0: 20 --> en:addison disease
    n1=en:experimental allergic encephalomyelitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  360. en:exposure as collected domain --- r_associated #0: 20 --> en:addison disease
    n1=en:exposure as collected domain | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  361. en:failure of secondary sexual development --- r_associated #0: 20 --> en:addison disease
    n1=en:failure of secondary sexual development | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  362. en:familial adrenal hypoplasia with absent pituitary lh --- r_associated #0: 20 --> en:addison disease
    n1=en:familial adrenal hypoplasia with absent pituitary lh | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  363. en:familial adrenocortical hypoplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:familial adrenocortical hypoplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  364. en:familial hypoaldosteronism --- r_associated #0: 20 --> en:addison disease
    n1=en:familial hypoaldosteronism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  365. en:family history of addison disease --- r_associated #0: 20 --> en:addison disease
    n1=en:family history of addison disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  366. en:fatigue --- r_associated #0: 20 --> en:addison disease
    n1=en:fatigue | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  367. en:female infertility --- r_associated #0: 20 --> en:addison disease
    n1=en:female infertility | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  368. en:few and small islets of langerhans --- r_associated #0: 20 --> en:addison disease
    n1=en:few and small islets of langerhans | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  369. en:fisher syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:fisher syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  370. en:follicle stimulating hormone, increased --- r_associated #0: 20 --> en:addison disease
    n1=en:follicle stimulating hormone, increased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  371. en:food allergy --- r_associated #0: 20 --> en:addison disease
    n1=en:food allergy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  372. en:free thyroxine to free triiodothyronine ratio markedly low --- r_associated #0: 20 --> en:addison disease
    n1=en:free thyroxine to free triiodothyronine ratio markedly low | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  373. en:functional anorchia --- r_associated #0: 20 --> en:addison disease
    n1=en:functional anorchia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  374. en:gastrin-producing neuroendocrine tumor --- r_associated #0: 20 --> en:addison disease
    n1=en:gastrin-producing neuroendocrine tumor | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  375. en:genetic aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:genetic aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  376. en:gestational diabetes --- r_associated #0: 20 --> en:addison disease
    n1=en:gestational diabetes | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  377. en:glomerulonephritis --- r_associated #0: 20 --> en:addison disease
    n1=en:glomerulonephritis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  378. en:glucagonoma syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:glucagonoma syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  379. en:glucocorticoid deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:glucocorticoid deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  380. en:glucocorticoid insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:glucocorticoid insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  381. en:glucose intolerance --- r_associated #0: 20 --> en:addison disease
    n1=en:glucose intolerance | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  382. en:goiter --- r_associated #0: 20 --> en:addison disease
    n1=en:goiter | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  383. en:goiter may occur --- r_associated #0: 20 --> en:addison disease
    n1=en:goiter may occur | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  384. en:gonad --- r_associated #0: 20 --> en:addison disease
    n1=en:gonad | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  385. en:gonadotrophin increased --- r_associated #0: 20 --> en:addison disease
    n1=en:gonadotrophin increased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  386. en:gonadotrophin levels low --- r_associated #0: 20 --> en:addison disease
    n1=en:gonadotrophin levels low | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  387. en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  388. en:graves disease --- r_associated #0: 20 --> en:addison disease
    n1=en:graves disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  389. en:growth disorders --- r_associated #0: 20 --> en:addison disease
    n1=en:growth disorders | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  390. en:growth hormone deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:growth hormone deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  391. en:growth hormone deficiency (1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:growth hormone deficiency (1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  392. en:growth hormone deficiency (2 patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:growth hormone deficiency (2 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  393. en:growth hormone deficiency (hcs) --- r_associated #0: 20 --> en:addison disease
    n1=en:growth hormone deficiency (hcs) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  394. en:growth hormone deficiency (in 1/4 patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:growth hormone deficiency (in 1/4 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  395. en:growth hormone deficiency (reported in 1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:growth hormone deficiency (reported in 1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  396. en:growth hormone deficiency in some individuals --- r_associated #0: 20 --> en:addison disease
    n1=en:growth hormone deficiency in some individuals | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  397. en:hashimoto thyroiditis --- r_associated #0: 20 --> en:addison disease
    n1=en:hashimoto thyroiditis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  398. en:hashitoxicosis --- r_associated #0: 20 --> en:addison disease
    n1=en:hashitoxicosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  399. en:hepatic autoimmune disorders --- r_associated #0: 20 --> en:addison disease
    n1=en:hepatic autoimmune disorders | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  400. en:hereditary adrenal unresponsiveness to corticotropin --- r_associated #0: 20 --> en:addison disease
    n1=en:hereditary adrenal unresponsiveness to corticotropin | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  401. en:high absolute level of cortisone metabolites --- r_associated #0: 20 --> en:addison disease
    n1=en:high absolute level of cortisone metabolites | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  402. en:high aldosterone/renin ratio --- r_associated #0: 20 --> en:addison disease
    n1=en:high aldosterone/renin ratio | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  403. en:high follicle-stimulating hormone levels --- r_associated #0: 20 --> en:addison disease
    n1=en:high follicle-stimulating hormone levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  404. en:high fsh secondary to androgen insensitivity --- r_associated #0: 20 --> en:addison disease
    n1=en:high fsh secondary to androgen insensitivity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  405. en:high level of cortisone metabolites --- r_associated #0: 20 --> en:addison disease
    n1=en:high level of cortisone metabolites | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  406. en:high luteinizing hormone levels --- r_associated #0: 20 --> en:addison disease
    n1=en:high luteinizing hormone levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  407. en:high plasma cortisol --- r_associated #0: 20 --> en:addison disease
    n1=en:high plasma cortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  408. en:high serum leptin levels (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:high serum leptin levels (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  409. en:high to high-normal cortisol secretion rate --- r_associated #0: 20 --> en:addison disease
    n1=en:high to high-normal cortisol secretion rate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  410. en:historical aspects qualifier --- r_associated #0: 20 --> en:addison disease
    n1=en:historical aspects qualifier | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  411. en:hiv/aids --- r_associated #0: 20 --> en:addison disease
    n1=en:hiv/aids | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  412. en:hiv/aids and infections --- r_associated #0: 20 --> en:addison disease
    n1=en:hiv/aids and infections | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  413. en:hiv/aids and pregnancy --- r_associated #0: 20 --> en:addison disease
    n1=en:hiv/aids and pregnancy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  414. en:hiv/aids in women --- r_associated #0: 20 --> en:addison disease
    n1=en:hiv/aids in women | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  415. en:hiv/aids medicines --- r_associated #0: 20 --> en:addison disease
    n1=en:hiv/aids medicines | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  416. en:hodgkin lymphoma --- r_associated #0: 20 --> en:addison disease
    n1=en:hodgkin lymphoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  417. en:hormone --- r_associated #0: 20 --> en:addison disease
    n1=en:hormone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  418. en:hormone replacement therapy --- r_associated #0: 20 --> en:addison disease
    n1=en:hormone replacement therapy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  419. en:hyperactive renin-angiotensin system --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperactive renin-angiotensin system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  420. en:hyperaldosteronemia (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperaldosteronemia (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  421. en:hyperaldosteronism --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperaldosteronism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  422. en:hyperamylasemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperamylasemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  423. en:hyperbilirubinemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperbilirubinemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  424. en:hypercalcemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypercalcemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  425. en:hypercatabolism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypercatabolism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  426. en:hypercortisolemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypercortisolemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  427. en:hypercortisolism, mild (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypercortisolism, mild (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  428. en:hypercreatinaemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypercreatinaemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  429. en:hypercreatininaemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypercreatininaemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  430. en:hyperglycemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperglycemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  431. en:hyperglycemia (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperglycemia (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  432. en:hyperglycemia, insulin-responsive, episodic --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperglycemia, insulin-responsive, episodic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  433. en:hypergonadotrophic hypogonadism (in females in adolescence) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypergonadotrophic hypogonadism (in females in adolescence) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  434. en:hypergonadotropic hypogonadism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypergonadotropic hypogonadism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  435. en:hypergonadotropic hypogonadism (hcs) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypergonadotropic hypogonadism (hcs) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  436. en:hypergonadotropic hypogonadism (in a subset of patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypergonadotropic hypogonadism (in a subset of patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  437. en:hypergonadotropic hypogonadism (males) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypergonadotropic hypogonadism (males) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  438. en:hypergonadotropic hypogonadism (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypergonadotropic hypogonadism (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  439. en:hypergonadotropic hypogonadism (reported in 1 female) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypergonadotropic hypogonadism (reported in 1 female) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  440. en:hyperinsulinemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperinsulinemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  441. en:hyperinsulinemia (in male patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperinsulinemia (in male patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  442. en:hyperinsulinemia (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperinsulinemia (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  443. en:hyperinsulinemic hypoglycemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperinsulinemic hypoglycemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  444. en:hyperinsulinemic hypoglycemia (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperinsulinemic hypoglycemia (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  445. en:hyperlipasaemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperlipasaemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  446. en:hypermetabolism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypermetabolism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  447. en:hypernatremia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypernatremia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  448. en:hyperoxalaemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperoxalaemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  449. en:hyperparathyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperparathyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  450. en:hyperphosphatasaemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperphosphatasaemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  451. en:hyperproinsulinemia (asymptomatic in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperproinsulinemia (asymptomatic in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  452. en:hyperprolactinemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperprolactinemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  453. en:hyperreninemia (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperreninemia (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  454. en:hyperreninemic hypoaldosteronism --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperreninemic hypoaldosteronism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  455. en:hypersensitivity --- r_associated #0: 20 --> en:addison disease
    n1=en:hypersensitivity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  456. en:hypertension --- r_associated #0: 20 --> en:addison disease
    n1=en:hypertension | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  457. en:hyperthyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:hyperthyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  458. en:hypoadrenalism (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoadrenalism (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  459. en:hypoadrenocorticism, familial --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoadrenocorticism, familial | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  460. en:hypoaldosteronemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoaldosteronemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  461. en:hypoaldosteronism, hyporeninemic --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoaldosteronism, hyporeninemic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  462. en:hypoaldosteronism, transient, isolated --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoaldosteronism, transient, isolated | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  463. en:hypocalcemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypocalcemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  464. en:hypocalcemia, mild or severe --- r_associated #0: 20 --> en:addison disease
    n1=en:hypocalcemia, mild or severe | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  465. en:hypocortisolemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypocortisolemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  466. en:hypoglycemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoglycemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  467. en:hypoglycemia, fasting --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoglycemia, fasting | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  468. en:hypoglycemic agents --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoglycemic agents | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  469. en:hypogonadaism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadaism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  470. en:hypogonadism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  471. en:hypogonadism (1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadism (1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  472. en:hypogonadism (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadism (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  473. en:hypogonadism (reported in 1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadism (reported in 1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  474. en:hypogonadotropic hypergonadism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadotropic hypergonadism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  475. en:hypogonadotropic hypogonadism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadotropic hypogonadism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  476. en:hypogonadotropic hypogonadism (in some females) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadotropic hypogonadism (in some females) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  477. en:hypogonadotropic hypogonadism (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadotropic hypogonadism (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  478. en:hypogonadotropic hypogonadism (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogonadotropic hypogonadism (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  479. en:hypogondotropic hypogonadism (1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypogondotropic hypogonadism (1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  480. en:hypoinsulinaemia (disorder) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoinsulinaemia (disorder) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  481. en:hypokalemia (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypokalemia (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  482. en:hypomagnesemia --- r_associated #0: 20 --> en:addison disease
    n1=en:hypomagnesemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  483. en:hypometabolism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypometabolism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  484. en:hypoparathyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoparathyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  485. en:hypophosphatemic vitamin d-resistant rickets (in some) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypophosphatemic vitamin d-resistant rickets (in some) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  486. en:hypophyseal agenesis --- r_associated #0: 20 --> en:addison disease
    n1=en:hypophyseal agenesis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  487. en:hypopituitarism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypopituitarism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  488. en:hypopituitarism (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypopituitarism (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  489. en:hypoplasia of the thyroid gland in some patients --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoplasia of the thyroid gland in some patients | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  490. en:hypoplastic pituitary gland --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoplastic pituitary gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  491. en:hypoplastic thyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:hypoplastic thyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  492. en:hyporeninenmic hypoaldosteronism --- r_associated #0: 20 --> en:addison disease
    n1=en:hyporeninenmic hypoaldosteronism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  493. en:hypothalamic and/or pituitary defect --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothalamic and/or pituitary defect | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  494. en:hypothalamic hypogonadism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothalamic hypogonadism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  495. en:hypothalamic insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothalamic insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  496. en:hypothyroidic goitre --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidic goitre | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  497. en:hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  498. en:hypothyroidism (20% of adults) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (20% of adults) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  499. en:hypothyroidism (30% patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (30% patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  500. en:hypothyroidism (if untreated) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (if untreated) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  501. en:hypothyroidism (in 1 of 3 siblings) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (in 1 of 3 siblings) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  502. en:hypothyroidism (in 2/4 patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  503. en:hypothyroidism (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  504. en:hypothyroidism (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  505. en:hypothyroidism (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  506. en:hypothyroidism in subset of patients --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism in subset of patients | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  507. en:hypothyroidism, autoantibody-positive (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism, autoantibody-positive (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  508. en:hypothyroidism, autoimmune --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism, autoimmune | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  509. en:hypothyroidism, congenital (1 patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism, congenital (1 patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  510. en:hypothyroidism, nongoitrous --- r_associated #0: 20 --> en:addison disease
    n1=en:hypothyroidism, nongoitrous | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  511. en:iatrogenic adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:iatrogenic adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  512. en:idiopathic atrophic hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:idiopathic atrophic hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  513. en:idiopathic thrombocytopenic purpura --- r_associated #0: 20 --> en:addison disease
    n1=en:idiopathic thrombocytopenic purpura | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  514. en:iga nephropathy --- r_associated #0: 20 --> en:addison disease
    n1=en:iga nephropathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  515. en:immune system --- r_associated #0: 20 --> en:addison disease
    n1=en:immune system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  516. en:immune system disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:immune system disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  517. en:immunization --- r_associated #0: 20 --> en:addison disease
    n1=en:immunization | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  518. en:immunological synapses --- r_associated #0: 20 --> en:addison disease
    n1=en:immunological synapses | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  519. en:immunology aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:immunology aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  520. en:impaired glucose tolerance (in male patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:impaired glucose tolerance (in male patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  521. en:impaired glucose tolerance (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:impaired glucose tolerance (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  522. en:impaired processing of proopiomelanocortin (pomc, 176830) --- r_associated #0: 20 --> en:addison disease
    n1=en:impaired processing of proopiomelanocortin (pomc, 176830) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  523. en:impaired temperature regulation --- r_associated #0: 20 --> en:addison disease
    n1=en:impaired temperature regulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  524. en:in blood --- r_associated #0: 20 --> en:addison disease
    n1=en:in blood | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  525. en:in cerebrospinal fluid --- r_associated #0: 20 --> en:addison disease
    n1=en:in cerebrospinal fluid | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  526. en:in urine --- r_associated #0: 20 --> en:addison disease
    n1=en:in urine | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  527. en:increase in pregnanediol and pregnanetriol after acth stimulation --- r_associated #0: 20 --> en:addison disease
    n1=en:increase in pregnanediol and pregnanetriol after acth stimulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  528. en:increased baseline gonadotropins --- r_associated #0: 20 --> en:addison disease
    n1=en:increased baseline gonadotropins | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  529. en:increased circulating gonadotropin level --- r_associated #0: 20 --> en:addison disease
    n1=en:increased circulating gonadotropin level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  530. en:increased circulating renin level --- r_associated #0: 20 --> en:addison disease
    n1=en:increased circulating renin level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  531. en:increased cortisol excretion rate --- r_associated #0: 20 --> en:addison disease
    n1=en:increased cortisol excretion rate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  532. en:increased gonadotropin levels (in female patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:increased gonadotropin levels (in female patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  533. en:increased incidence of fibrocalculus pancreatic diabetes (fcpd) --- r_associated #0: 20 --> en:addison disease
    n1=en:increased incidence of fibrocalculus pancreatic diabetes (fcpd) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  534. en:increased prolactin level --- r_associated #0: 20 --> en:addison disease
    n1=en:increased prolactin level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  535. en:increased serum gonadotropins --- r_associated #0: 20 --> en:addison disease
    n1=en:increased serum gonadotropins | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  536. en:increased serum pth, mild --- r_associated #0: 20 --> en:addison disease
    n1=en:increased serum pth, mild | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  537. en:increased serum tsh (2 patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:increased serum tsh (2 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  538. en:increased sweating at early age --- r_associated #0: 20 --> en:addison disease
    n1=en:increased sweating at early age | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  539. en:increased testosterone --- r_associated #0: 20 --> en:addison disease
    n1=en:increased testosterone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  540. en:increased thyroxine level --- r_associated #0: 20 --> en:addison disease
    n1=en:increased thyroxine level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  541. en:infectious disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:infectious disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  542. en:infectious mononucleosis --- r_associated #0: 20 --> en:addison disease
    n1=en:infectious mononucleosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  543. en:infertility --- r_associated #0: 20 --> en:addison disease
    n1=en:infertility | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  544. en:insensitivity to growth hormone therapy --- r_associated #0: 20 --> en:addison disease
    n1=en:insensitivity to growth hormone therapy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  545. en:insulin autoimmune syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin autoimmune syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  546. en:insulin deficiency (may develop later in life) --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin deficiency (may develop later in life) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  547. en:insulin insensitivity --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin insensitivity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  548. en:insulin resistance --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin resistance | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  549. en:insulin resistance (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin resistance (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  550. en:insulin resistance - type b --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin resistance - type b | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  551. en:insulin-dependent but ketosis-resistant diabetes --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin-dependent but ketosis-resistant diabetes | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  552. en:insulin-dependent diabetes mellitus (onset in infancy) --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin-dependent diabetes mellitus (onset in infancy) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  553. en:insulin-like growth factor slightly low --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin-like growth factor slightly low | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  554. en:insulin-resistant diabetes mellitus --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin-resistant diabetes mellitus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  555. en:insulin-resistant diabetes mellitus (onset around puberty) --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin-resistant diabetes mellitus (onset around puberty) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  556. en:insulin-resistant diabetes mellitus at puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin-resistant diabetes mellitus at puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  557. en:insulin-resistant diabetes mellitus in adulthood --- r_associated #0: 20 --> en:addison disease
    n1=en:insulin-resistant diabetes mellitus in adulthood | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  558. en:intermittent severe hypoglycemia --- r_associated #0: 20 --> en:addison disease
    n1=en:intermittent severe hypoglycemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  559. en:intermittent thrombocytopenia --- r_associated #0: 20 --> en:addison disease
    n1=en:intermittent thrombocytopenia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  560. en:ipsilateral adrenal gland hypoplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:ipsilateral adrenal gland hypoplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  561. en:ipsilateral thyroid gland hypoplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:ipsilateral thyroid gland hypoplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  562. en:irregular menstruation --- r_associated #0: 20 --> en:addison disease
    n1=en:irregular menstruation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  563. en:juvenile arthritis --- r_associated #0: 20 --> en:addison disease
    n1=en:juvenile arthritis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  564. en:juvenile rheumatoid arthritis --- r_associated #0: 20 --> en:addison disease
    n1=en:juvenile rheumatoid arthritis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  565. en:kawasaki disease --- r_associated #0: 20 --> en:addison disease
    n1=en:kawasaki disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  566. en:kearns-sayre syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:kearns-sayre syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  567. en:klinefelter syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:klinefelter syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  568. en:lack of growth hormone (gh) response to stimulation --- r_associated #0: 20 --> en:addison disease
    n1=en:lack of growth hormone (gh) response to stimulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  569. en:lack of lh pulsatility --- r_associated #0: 20 --> en:addison disease
    n1=en:lack of lh pulsatility | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  570. en:lack of secondary sex characteristics --- r_associated #0: 20 --> en:addison disease
    n1=en:lack of secondary sex characteristics | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  571. en:lack of secondary sexual characteristics (in 1 family) --- r_associated #0: 20 --> en:addison disease
    n1=en:lack of secondary sexual characteristics (in 1 family) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  572. en:lambert eaton myasthenic syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:lambert eaton myasthenic syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  573. en:late menarche --- r_associated #0: 20 --> en:addison disease
    n1=en:late menarche | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  574. en:latent autoimmune diabetes in adults --- r_associated #0: 20 --> en:addison disease
    n1=en:latent autoimmune diabetes in adults | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  575. en:latex allergy --- r_associated #0: 20 --> en:addison disease
    n1=en:latex allergy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  576. en:left adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:left adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  577. en:leukocyte --- r_associated #0: 20 --> en:addison disease
    n1=en:leukocyte | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  578. en:lh level normal --- r_associated #0: 20 --> en:addison disease
    n1=en:lh level normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  579. en:linear iga bullous dermatosis --- r_associated #0: 20 --> en:addison disease
    n1=en:linear iga bullous dermatosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  580. en:lingual thyroid --- r_associated #0: 20 --> en:addison disease
    n1=en:lingual thyroid | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  581. en:living with hiv/aids --- r_associated #0: 20 --> en:addison disease
    n1=en:living with hiv/aids | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  582. en:localized scleroderma --- r_associated #0: 20 --> en:addison disease
    n1=en:localized scleroderma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  583. en:low acth --- r_associated #0: 20 --> en:addison disease
    n1=en:low acth | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  584. en:low adh (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:low adh (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  585. en:low adrenocorticotropic hormone (acth) --- r_associated #0: 20 --> en:addison disease
    n1=en:low adrenocorticotropic hormone (acth) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  586. en:low anti-mullerian hormone (amh) level --- r_associated #0: 20 --> en:addison disease
    n1=en:low anti-mullerian hormone (amh) level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  587. en:low c-peptide levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low c-peptide levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  588. en:low cortols-to-cortolone ratio --- r_associated #0: 20 --> en:addison disease
    n1=en:low cortols-to-cortolone ratio | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  589. en:low estradiol in females --- r_associated #0: 20 --> en:addison disease
    n1=en:low estradiol in females | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  590. en:low estradiol levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low estradiol levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  591. en:low estradiol levels in females --- r_associated #0: 20 --> en:addison disease
    n1=en:low estradiol levels in females | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  592. en:low estrogen and progesterone --- r_associated #0: 20 --> en:addison disease
    n1=en:low estrogen and progesterone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  593. en:low follicle-stimulating hormone (fsh) --- r_associated #0: 20 --> en:addison disease
    n1=en:low follicle-stimulating hormone (fsh) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  594. en:low follicle-stimulating hormone levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low follicle-stimulating hormone levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  595. en:low free-t4 levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low free-t4 levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  596. en:low gonadotropins (secondary hypogonadism) --- r_associated #0: 20 --> en:addison disease
    n1=en:low gonadotropins (secondary hypogonadism) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  597. en:low igf1 and igfbp3 --- r_associated #0: 20 --> en:addison disease
    n1=en:low igf1 and igfbp3 | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  598. en:low inhibin b level --- r_associated #0: 20 --> en:addison disease
    n1=en:low inhibin b level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  599. en:low insulin-like growth factor-1 (igf1) concentration --- r_associated #0: 20 --> en:addison disease
    n1=en:low insulin-like growth factor-1 (igf1) concentration | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  600. en:low insulin-like growth factor-i (igf1 147440) levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low insulin-like growth factor-i (igf1 147440) levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  601. en:low luteinizing hormone (lh) --- r_associated #0: 20 --> en:addison disease
    n1=en:low luteinizing hormone (lh) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  602. en:low luteinizing hormone levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low luteinizing hormone levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  603. en:low or absent growth hormone --- r_associated #0: 20 --> en:addison disease
    n1=en:low or absent growth hormone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  604. en:low or absent growth hormone (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:low or absent growth hormone (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  605. en:low or absent prolactin --- r_associated #0: 20 --> en:addison disease
    n1=en:low or absent prolactin | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  606. en:low or absent thyroid-stimulating hormone --- r_associated #0: 20 --> en:addison disease
    n1=en:low or absent thyroid-stimulating hormone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  607. en:low or normal serum gonadotropins --- r_associated #0: 20 --> en:addison disease
    n1=en:low or normal serum gonadotropins | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  608. en:low prolactin (prl) levels (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:low prolactin (prl) levels (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  609. en:low serum estradiol --- r_associated #0: 20 --> en:addison disease
    n1=en:low serum estradiol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  610. en:low serum estradiol levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low serum estradiol levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  611. en:low serum gonadotropins --- r_associated #0: 20 --> en:addison disease
    n1=en:low serum gonadotropins | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  612. en:low serum leptin levels (in most patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:low serum leptin levels (in most patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  613. en:low serum testosterone in males --- r_associated #0: 20 --> en:addison disease
    n1=en:low serum testosterone in males | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  614. en:low sex hormone-binding globulin levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low sex hormone-binding globulin levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  615. en:low testosterone in males --- r_associated #0: 20 --> en:addison disease
    n1=en:low testosterone in males | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  616. en:low testosterone levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low testosterone levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  617. en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio --- r_associated #0: 20 --> en:addison disease
    n1=en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  618. en:low to normal absolute level of cortisol metabolites --- r_associated #0: 20 --> en:addison disease
    n1=en:low to normal absolute level of cortisol metabolites | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  619. en:low to normal level of cortisol metabolites --- r_associated #0: 20 --> en:addison disease
    n1=en:low to normal level of cortisol metabolites | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  620. en:low to normal serum gonadotropins --- r_associated #0: 20 --> en:addison disease
    n1=en:low to normal serum gonadotropins | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  621. en:low to normal serum lh low to normal serum fsh --- r_associated #0: 20 --> en:addison disease
    n1=en:low to normal serum lh low to normal serum fsh | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  622. en:low to undetectable gonadotropin levels --- r_associated #0: 20 --> en:addison disease
    n1=en:low to undetectable gonadotropin levels | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  623. en:low to undetectable insulin levels in the presence of hyperglycemia --- r_associated #0: 20 --> en:addison disease
    n1=en:low to undetectable insulin levels in the presence of hyperglycemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  624. en:low urinary cortols-to-cortolone ratio --- r_associated #0: 20 --> en:addison disease
    n1=en:low urinary cortols-to-cortolone ratio | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  625. en:low urinary estrogens --- r_associated #0: 20 --> en:addison disease
    n1=en:low urinary estrogens | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  626. en:low-to-normal serum growth hormone --- r_associated #0: 20 --> en:addison disease
    n1=en:low-to-normal serum growth hormone | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  627. en:lupus erythematosus --- r_associated #0: 20 --> en:addison disease
    n1=en:lupus erythematosus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  628. en:lupus erythematosus and associated conditions --- r_associated #0: 20 --> en:addison disease
    n1=en:lupus erythematosus and associated conditions | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  629. en:luteinizing hormone levels elevated --- r_associated #0: 20 --> en:addison disease
    n1=en:luteinizing hormone levels elevated | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  630. en:lymphatic diseases --- r_associated #0: 20 --> en:addison disease
    n1=en:lymphatic diseases | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  631. en:lymphatic system --- r_associated #0: 20 --> en:addison disease
    n1=en:lymphatic system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  632. en:lymphedema --- r_associated #0: 20 --> en:addison disease
    n1=en:lymphedema | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  633. en:lymphocytic hypopituitarism --- r_associated #0: 20 --> en:addison disease
    n1=en:lymphocytic hypopituitarism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  634. en:lymphoid system structure --- r_associated #0: 20 --> en:addison disease
    n1=en:lymphoid system structure | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  635. en:lymphoma --- r_associated #0: 20 --> en:addison disease
    n1=en:lymphoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  636. en:macroamylasemia --- r_associated #0: 20 --> en:addison disease
    n1=en:macroamylasemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  637. en:macronodular adrenal hyperplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:macronodular adrenal hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  638. en:magnesium 192mg tab --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium 192mg tab | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  639. en:magnesium carbonate --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium carbonate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  640. en:magnesium carbonate 260 mg oral capsule --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium carbonate 260 mg oral capsule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  641. en:magnesium carbonate blocks --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium carbonate blocks | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  642. en:magnesium oxide --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  643. en:magnesium oxide 140 mg oral capsule --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide 140 mg oral capsule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  644. en:magnesium oxide 200 mg oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide 200 mg oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  645. en:magnesium oxide 250 mg oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide 250 mg oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  646. en:magnesium oxide 400 mg oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide 400 mg oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  647. en:magnesium oxide 420 mg oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide 420 mg oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  648. en:magnesium oxide 500 mg oral capsule --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide 500 mg oral capsule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  649. en:magnesium oxide 500 mg oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium oxide 500 mg oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  650. en:magnesium so4 2meq/ml inj --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium so4 2meq/ml inj | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  651. en:magnesium sulfate --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  652. en:magnesium sulfate 0.8 mg/mg topical ointment --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 0.8 mg/mg topical ointment | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  653. en:magnesium sulfate 10 mg/ml injection --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 10 mg/ml injection | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  654. en:magnesium sulfate 10%(0.4mmol/ml) injection --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 10%(0.4mmol/ml) injection | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  655. en:magnesium sulfate 100 mg oral capsule --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 100 mg oral capsule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  656. en:magnesium sulfate 1000 mg oral granules --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 1000 mg oral granules | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  657. en:magnesium sulfate 10gm/1000ml intravenous --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 10gm/1000ml intravenous | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  658. en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  659. en:magnesium sulfate 20 mg/ml injection --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 20 mg/ml injection | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  660. en:magnesium sulfate 40meq/5gm pwdr --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 40meq/5gm pwdr | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  661. en:magnesium sulfate 5%(4gm/100ml) intravenous --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 5%(4gm/100ml) intravenous | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  662. en:magnesium sulfate 500 mg/ml injection --- r_associated #0: 20 --> en:addison disease
    n1=en:magnesium sulfate 500 mg/ml injection | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  663. en:malignant adrenal gland neoplasm --- r_associated #0: 20 --> en:addison disease
    n1=en:malignant adrenal gland neoplasm | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  664. en:malignant ovarian neoplasm --- r_associated #0: 20 --> en:addison disease
    n1=en:malignant ovarian neoplasm | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  665. en:malignant pancreatic neoplasm --- r_associated #0: 20 --> en:addison disease
    n1=en:malignant pancreatic neoplasm | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  666. en:malignant testicular neoplasm --- r_associated #0: 20 --> en:addison disease
    n1=en:malignant testicular neoplasm | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  667. en:malignant thymus neoplasm --- r_associated #0: 20 --> en:addison disease
    n1=en:malignant thymus neoplasm | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  668. en:marine lenhart syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:marine lenhart syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  669. en:marked increase in pregnanetriolone after hcg or acth stimulation --- r_associated #0: 20 --> en:addison disease
    n1=en:marked increase in pregnanetriolone after hcg or acth stimulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  670. en:masculinization at puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:masculinization at puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  671. en:mast cell --- r_associated #0: 20 --> en:addison disease
    n1=en:mast cell | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  672. en:maturity-onset diabetes of the young --- r_associated #0: 20 --> en:addison disease
    n1=en:maturity-onset diabetes of the young | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  673. en:maturity-onset diabetes of the young (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:maturity-onset diabetes of the young (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  674. en:medulloadrenal hyperfunction --- r_associated #0: 20 --> en:addison disease
    n1=en:medulloadrenal hyperfunction | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  675. en:membranous glomerulonephritis --- r_associated #0: 20 --> en:addison disease
    n1=en:membranous glomerulonephritis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  676. en:menstruation --- r_associated #0: 20 --> en:addison disease
    n1=en:menstruation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  677. en:metabolic aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:metabolic aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  678. en:metabolic disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:metabolic disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  679. en:metabolic disorders nec --- r_associated #0: 20 --> en:addison disease
    n1=en:metabolic disorders nec | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  680. en:metabolic syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:metabolic syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  681. en:microbiological --- r_associated #0: 20 --> en:addison disease
    n1=en:microbiological | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  682. en:mikulicz disease --- r_associated #0: 20 --> en:addison disease
    n1=en:mikulicz disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  683. en:mineralocorticoid deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:mineralocorticoid deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  684. en:mineralocorticoid insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:mineralocorticoid insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  685. en:mineralocorticoid insufficiency (in 15%) --- r_associated #0: 20 --> en:addison disease
    n1=en:mineralocorticoid insufficiency (in 15%) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  686. en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates --- r_associated #0: 20 --> en:addison disease
    n1=en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  687. en:mixed connective tissue disease --- r_associated #0: 20 --> en:addison disease
    n1=en:mixed connective tissue disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  688. en:modestly low estradiol --- r_associated #0: 20 --> en:addison disease
    n1=en:modestly low estradiol | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  689. en:mononuclear phagocyte system --- r_associated #0: 20 --> en:addison disease
    n1=en:mononuclear phagocyte system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  690. en:multinodular goiter --- r_associated #0: 20 --> en:addison disease
    n1=en:multinodular goiter | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  691. en:multiple hormone resistance --- r_associated #0: 20 --> en:addison disease
    n1=en:multiple hormone resistance | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  692. en:multiple sclerosis --- r_associated #0: 20 --> en:addison disease
    n1=en:multiple sclerosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  693. en:muscular autoimmune disorders --- r_associated #0: 20 --> en:addison disease
    n1=en:muscular autoimmune disorders | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  694. en:myasthenia gravis --- r_associated #0: 20 --> en:addison disease
    n1=en:myasthenia gravis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  695. en:myelodysplastic syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:myelodysplastic syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  696. en:myxedema coma --- r_associated #0: 20 --> en:addison disease
    n1=en:myxedema coma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  697. en:necrosis adrenal cortex --- r_associated #0: 20 --> en:addison disease
    n1=en:necrosis adrenal cortex | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  698. en:neonatal diabetes mellitus --- r_associated #0: 20 --> en:addison disease
    n1=en:neonatal diabetes mellitus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  699. en:neonatal hyperbilirubinemia --- r_associated #0: 20 --> en:addison disease
    n1=en:neonatal hyperbilirubinemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  700. en:neonatal hypocalcemia, rare --- r_associated #0: 20 --> en:addison disease
    n1=en:neonatal hypocalcemia, rare | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  701. en:neonatal hypoglycemia --- r_associated #0: 20 --> en:addison disease
    n1=en:neonatal hypoglycemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  702. en:neonatal hypoparathyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:neonatal hypoparathyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  703. en:neonatal insulin-dependent diabetes mellitus --- r_associated #0: 20 --> en:addison disease
    n1=en:neonatal insulin-dependent diabetes mellitus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  704. en:neuroendocrine system --- r_associated #0: 20 --> en:addison disease
    n1=en:neuroendocrine system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  705. en:neurogenic diabetes insipidus --- r_associated #0: 20 --> en:addison disease
    n1=en:neurogenic diabetes insipidus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  706. en:neuroimmune system --- r_associated #0: 20 --> en:addison disease
    n1=en:neuroimmune system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  707. en:no adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:no adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  708. en:no breast development or menstruation at puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:no breast development or menstruation at puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  709. en:no goiter --- r_associated #0: 20 --> en:addison disease
    n1=en:no goiter | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  710. en:no growth response to exogenous growth hormone (gh, 139250) --- r_associated #0: 20 --> en:addison disease
    n1=en:no growth response to exogenous growth hormone (gh, 139250) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  711. en:no hormone resistance --- r_associated #0: 20 --> en:addison disease
    n1=en:no hormone resistance | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  712. en:no increase in testosterone after hcg or acth stimulation --- r_associated #0: 20 --> en:addison disease
    n1=en:no increase in testosterone after hcg or acth stimulation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  713. en:no insulin-dependent diabetes mellitus --- r_associated #0: 20 --> en:addison disease
    n1=en:no insulin-dependent diabetes mellitus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  714. en:nonautoimmune insulin-dependent diabetes in second decade of life --- r_associated #0: 20 --> en:addison disease
    n1=en:nonautoimmune insulin-dependent diabetes in second decade of life | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  715. en:normal adrenal function --- r_associated #0: 20 --> en:addison disease
    n1=en:normal adrenal function | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  716. en:normal anterior pituitary function --- r_associated #0: 20 --> en:addison disease
    n1=en:normal anterior pituitary function | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  717. en:normal female secondary sexual characteristics --- r_associated #0: 20 --> en:addison disease
    n1=en:normal female secondary sexual characteristics | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  718. en:normal follicle-stimulating hormone (fsh) --- r_associated #0: 20 --> en:addison disease
    n1=en:normal follicle-stimulating hormone (fsh) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  719. en:normal growth hormone response to provocative testing --- r_associated #0: 20 --> en:addison disease
    n1=en:normal growth hormone response to provocative testing | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  720. en:normal growth hormone studies --- r_associated #0: 20 --> en:addison disease
    n1=en:normal growth hormone studies | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  721. en:normal luteinizing hormone (lh) --- r_associated #0: 20 --> en:addison disease
    n1=en:normal luteinizing hormone (lh) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  722. en:normal or mildly elevated serum phosphate --- r_associated #0: 20 --> en:addison disease
    n1=en:normal or mildly elevated serum phosphate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  723. en:normal pituitary function --- r_associated #0: 20 --> en:addison disease
    n1=en:normal pituitary function | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  724. en:normal response to exogenously administered insulin --- r_associated #0: 20 --> en:addison disease
    n1=en:normal response to exogenously administered insulin | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  725. en:normal sized thyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:normal sized thyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  726. en:normal testosterone level --- r_associated #0: 20 --> en:addison disease
    n1=en:normal testosterone level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  727. en:normal testosterone levels in adulthood --- r_associated #0: 20 --> en:addison disease
    n1=en:normal testosterone levels in adulthood | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  728. en:normal thyroid-stimulating hormone level --- r_associated #0: 20 --> en:addison disease
    n1=en:normal thyroid-stimulating hormone level | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  729. en:nursing therapy --- r_associated #0: 20 --> en:addison disease
    n1=en:nursing therapy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  730. en:nutritional and metabolic cardiomyopathy --- r_associated #0: 20 --> en:addison disease
    n1=en:nutritional and metabolic cardiomyopathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  731. en:nutritional management --- r_associated #0: 20 --> en:addison disease
    n1=en:nutritional management | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  732. en:oestradiol decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:oestradiol decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  733. en:oestradiol increased --- r_associated #0: 20 --> en:addison disease
    n1=en:oestradiol increased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  734. en:oligomenorrhea --- r_associated #0: 20 --> en:addison disease
    n1=en:oligomenorrhea | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  735. en:ophthalmia, sympathetic --- r_associated #0: 20 --> en:addison disease
    n1=en:ophthalmia, sympathetic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  736. en:other adrenal hypofunction --- r_associated #0: 20 --> en:addison disease
    n1=en:other adrenal hypofunction | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  737. en:other adrenocortical overactivity --- r_associated #0: 20 --> en:addison disease
    n1=en:other adrenocortical overactivity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  738. en:other and unspecified adrenocortical insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:other and unspecified adrenocortical insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  739. en:other disorders of adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:other disorders of adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  740. en:other specified disorders of adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:other specified disorders of adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  741. en:ovarian cyst --- r_associated #0: 20 --> en:addison disease
    n1=en:ovarian cyst | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  742. en:ovarian failure, premature --- r_associated #0: 20 --> en:addison disease
    n1=en:ovarian failure, premature | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  743. en:ovarian hyperandrogenemia --- r_associated #0: 20 --> en:addison disease
    n1=en:ovarian hyperandrogenemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  744. en:ovary --- r_associated #0: 20 --> en:addison disease
    n1=en:ovary | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  745. en:overlap syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:overlap syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  746. en:oxalosis --- r_associated #0: 20 --> en:addison disease
    n1=en:oxalosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  747. en:pancreas --- r_associated #0: 20 --> en:addison disease
    n1=en:pancreas | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  748. en:pancreas transplantation --- r_associated #0: 20 --> en:addison disease
    n1=en:pancreas transplantation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  749. en:pancreatic disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:pancreatic disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  750. en:pancreatic exocrine deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:pancreatic exocrine deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  751. en:pancreatic insulinoma --- r_associated #0: 20 --> en:addison disease
    n1=en:pancreatic insulinoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  752. en:pancreatic islet transplantation --- r_associated #0: 20 --> en:addison disease
    n1=en:pancreatic islet transplantation | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  753. en:pancreatitis --- r_associated #0: 20 --> en:addison disease
    n1=en:pancreatitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  754. en:panhypopituitarism --- r_associated #0: 20 --> en:addison disease
    n1=en:panhypopituitarism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  755. en:paraganglion --- r_associated #0: 20 --> en:addison disease
    n1=en:paraganglion | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  756. en:parasitology --- r_associated #0: 20 --> en:addison disease
    n1=en:parasitology | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  757. en:parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  758. en:parathyroid gland adenoma --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid gland adenoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  759. en:parathyroid gland disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid gland disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  760. en:parathyroid hormone concentration low or low-normal --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid hormone concentration low or low-normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  761. en:parathyroid hormone decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid hormone decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  762. en:parathyroid hormone levels low to low-normal --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid hormone levels low to low-normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  763. en:parathyroid hyperplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  764. en:parathyroid hyperplasia, benign --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid hyperplasia, benign | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  765. en:parathyroid hypoplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:parathyroid hypoplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  766. en:partial deficiency of cytoplasmic dht-binding --- r_associated #0: 20 --> en:addison disease
    n1=en:partial deficiency of cytoplasmic dht-binding | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  767. en:partial growth hormone deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:partial growth hormone deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  768. en:partial or complete serum gonadotropin deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:partial or complete serum gonadotropin deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  769. en:pathological aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:pathological aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  770. en:patients have normal pituitary function --- r_associated #0: 20 --> en:addison disease
    n1=en:patients have normal pituitary function | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  771. en:patients with hypothyroidism have hypoplastic thyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:patients with hypothyroidism have hypoplastic thyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  772. en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections --- r_associated #0: 20 --> en:addison disease
    n1=en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  773. en:pemphigus --- r_associated #0: 20 --> en:addison disease
    n1=en:pemphigus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  774. en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  775. en:phagocytic cell --- r_associated #0: 20 --> en:addison disease
    n1=en:phagocytic cell | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  776. en:pharmacotherapeutic --- r_associated #0: 20 --> en:addison disease
    n1=en:pharmacotherapeutic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  777. en:physiopathological --- r_associated #0: 20 --> en:addison disease
    n1=en:physiopathological | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  778. en:pigmented micronodular adrenal dysplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:pigmented micronodular adrenal dysplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  779. en:pigmented micronodular adrenocortical disease --- r_associated #0: 20 --> en:addison disease
    n1=en:pigmented micronodular adrenocortical disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  780. en:pituitary agenesis --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary agenesis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  781. en:pituitary amphophil hyperplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary amphophil hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  782. en:pituitary anomalies --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary anomalies | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  783. en:pituitary defects --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary defects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  784. en:pituitary dwarfism --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary dwarfism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  785. en:pituitary gland --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  786. en:pituitary gland adenoma --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary gland adenoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  787. en:pituitary gland disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary gland disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  788. en:pituitary gland neoplasm --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary gland neoplasm | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  789. en:pituitary gonadal axis --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary gonadal axis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  790. en:pituitary hormone deficiencies (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary hormone deficiencies (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  791. en:pituitary hormone deficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary hormone deficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  792. en:pituitary hypoplasia (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary hypoplasia (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  793. en:pituitary hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  794. en:pituitary thyroid axis --- r_associated #0: 20 --> en:addison disease
    n1=en:pituitary thyroid axis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  795. en:placenta --- r_associated #0: 20 --> en:addison disease
    n1=en:placenta | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  796. en:plasma aldosterone increased --- r_associated #0: 20 --> en:addison disease
    n1=en:plasma aldosterone increased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  797. en:plasma cell myeloma --- r_associated #0: 20 --> en:addison disease
    n1=en:plasma cell myeloma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  798. en:plasma dihydrotestosterone (dht) is decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:plasma dihydrotestosterone (dht) is decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  799. en:plasma testosterone is normal or increased --- r_associated #0: 20 --> en:addison disease
    n1=en:plasma testosterone is normal or increased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  800. en:pneumocystis infections --- r_associated #0: 20 --> en:addison disease
    n1=en:pneumocystis infections | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  801. en:polyglandular type i autoimmune syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:polyglandular type i autoimmune syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  802. en:poor secondary sexual development (1 family) --- r_associated #0: 20 --> en:addison disease
    n1=en:poor secondary sexual development (1 family) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  803. en:post-adrenalectomy adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:post-adrenalectomy adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  804. en:postprocedural adrenocortical(-medullary) hypofunction --- r_associated #0: 20 --> en:addison disease
    n1=en:postprocedural adrenocortical(-medullary) hypofunction | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  805. en:postprocedural hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:postprocedural hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  806. en:potassium acetate --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium acetate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  807. en:potassium acetate 0.2 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium acetate 0.2 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  808. en:potassium acetate 2 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium acetate 2 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  809. en:potassium acetate 4 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium acetate 4 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  810. en:potassium bicarbonate --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  811. en:potassium bicarbonate 0.208 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate 0.208 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  812. en:potassium bicarbonate 10 meq effervescent oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate 10 meq effervescent oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  813. en:potassium bicarbonate 20 meq effervescent oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate 20 meq effervescent oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  814. en:potassium bicarbonate 25 meq effervescent oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate 25 meq effervescent oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  815. en:potassium bicarbonate 6.5 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate 6.5 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  816. en:potassium bicarbonate 99 mg oral capsule --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate 99 mg oral capsule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  817. en:potassium bicarbonate pwdr --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bicarbonate pwdr | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  818. en:potassium bitartrate --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bitartrate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  819. en:potassium bitartrate pwdr --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium bitartrate pwdr | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  820. en:potassium chloride --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  821. en:potassium chloride 0.1 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 0.1 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  822. en:potassium chloride 0.125 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 0.125 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  823. en:potassium chloride 0.167 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 0.167 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  824. en:potassium chloride 0.2 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 0.2 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  825. en:potassium chloride 0.3 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 0.3 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  826. en:potassium chloride 0.4 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 0.4 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  827. en:potassium chloride 0.67 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 0.67 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  828. en:potassium chloride 1.33 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 1.33 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  829. en:potassium chloride 1.5 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 1.5 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  830. en:potassium chloride 10 meq extended release oral capsule --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 10 meq extended release oral capsule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  831. en:potassium chloride 10 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 10 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  832. en:potassium chloride 10 meq extended release oral tablet [k-dur] --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 10 meq extended release oral tablet [k-dur] | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  833. en:potassium chloride 10 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 10 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  834. en:potassium chloride 13 meq delayed release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 13 meq delayed release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  835. en:potassium chloride 15 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 15 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  836. en:potassium chloride 2 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 2 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  837. en:potassium chloride 2.4 meq delayed release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 2.4 meq delayed release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  838. en:potassium chloride 2.4 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 2.4 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  839. en:potassium chloride 2.67 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 2.67 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  840. en:potassium chloride 20 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 20 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  841. en:potassium chloride 20 meq extended release oral tablet [k-dur] --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 20 meq extended release oral tablet [k-dur] | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  842. en:potassium chloride 25meq tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 25meq tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  843. en:potassium chloride 3 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 3 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  844. en:potassium chloride 3.2 meq/ml injectable solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 3.2 meq/ml injectable solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  845. en:potassium chloride 4 meq delayed release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 4 meq delayed release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  846. en:potassium chloride 4 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 4 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  847. en:potassium chloride 6.7 meq delayed release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 6.7 meq delayed release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  848. en:potassium chloride 6.7 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 6.7 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  849. en:potassium chloride 7.5% syrup --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 7.5% syrup | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  850. en:potassium chloride 8 meq delayed release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 8 meq delayed release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  851. en:potassium chloride 8 meq extended release oral capsule --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 8 meq extended release oral capsule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  852. en:potassium chloride 8 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 8 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  853. en:potassium chloride 8 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride 8 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  854. en:potassium chloride strong 15% injection solution 10ml ampule --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium chloride strong 15% injection solution 10ml ampule | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  855. en:potassium citrate --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium citrate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  856. en:potassium citrate 10 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium citrate 10 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  857. en:potassium citrate 15 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium citrate 15 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  858. en:potassium citrate 260 mg oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium citrate 260 mg oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  859. en:potassium citrate 5 meq extended release oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium citrate 5 meq extended release oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  860. en:potassium gluconate --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  861. en:potassium gluconate 1.33 meq/ml oral solution --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 1.33 meq/ml oral solution | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  862. en:potassium gluconate 2 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 2 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  863. en:potassium gluconate 2.2 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 2.2 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  864. en:potassium gluconate 2.35 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 2.35 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  865. en:potassium gluconate 2.5 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 2.5 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  866. en:potassium gluconate 2.6 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 2.6 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  867. en:potassium gluconate 5 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 5 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  868. en:potassium gluconate 6.66 meq oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium gluconate 6.66 meq oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  869. en:potassium,chelated --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium,chelated | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  870. en:potassium,chelated 99 mg oral tablet --- r_associated #0: 20 --> en:addison disease
    n1=en:potassium,chelated 99 mg oral tablet | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  871. en:precocious puberty --- r_associated #0: 20 --> en:addison disease
    n1=en:precocious puberty | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  872. en:precocious puberty (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:precocious puberty (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  873. en:precocious puberty in males --- r_associated #0: 20 --> en:addison disease
    n1=en:precocious puberty in males | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  874. en:precocious puberty with sertoli cell tumor --- r_associated #0: 20 --> en:addison disease
    n1=en:precocious puberty with sertoli cell tumor | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  875. en:prediabetes --- r_associated #0: 20 --> en:addison disease
    n1=en:prediabetes | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  876. en:pregnanetriolone (ptl) present in urine --- r_associated #0: 20 --> en:addison disease
    n1=en:pregnanetriolone (ptl) present in urine | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  877. en:premature adrenarche --- r_associated #0: 20 --> en:addison disease
    n1=en:premature adrenarche | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  878. en:premature menopause --- r_associated #0: 20 --> en:addison disease
    n1=en:premature menopause | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  879. en:premature menopause (in a subset of patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:premature menopause (in a subset of patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  880. en:premature ovarian failure (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:premature ovarian failure (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  881. en:premature ovarian failure in female carriers --- r_associated #0: 20 --> en:addison disease
    n1=en:premature ovarian failure in female carriers | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  882. en:premature pubarche (in 1 female patient) --- r_associated #0: 20 --> en:addison disease
    n1=en:premature pubarche (in 1 female patient) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  883. en:premature pubertal basal levels of luteinizing hormone (lh) --- r_associated #0: 20 --> en:addison disease
    n1=en:premature pubertal basal levels of luteinizing hormone (lh) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  884. en:premature pubertal stimulated levels of lh --- r_associated #0: 20 --> en:addison disease
    n1=en:premature pubertal stimulated levels of lh | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  885. en:premature thelarche --- r_associated #0: 20 --> en:addison disease
    n1=en:premature thelarche | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  886. en:prevention & control --- r_associated #0: 20 --> en:addison disease
    n1=en:prevention & control | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  887. en:primary adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:primary adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  888. en:primary amenorrhea --- r_associated #0: 20 --> en:addison disease
    n1=en:primary amenorrhea | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  889. en:primary amenorrhea (in a subset of patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:primary amenorrhea (in a subset of patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  890. en:primary hyperthyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:primary hyperthyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  891. en:primary hypogonadism (in 2 male patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:primary hypogonadism (in 2 male patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  892. en:primary hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:primary hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  893. en:primary hypothyroidism (reported in 2 patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:primary hypothyroidism (reported in 2 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  894. en:primary testicular failure --- r_associated #0: 20 --> en:addison disease
    n1=en:primary testicular failure | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  895. en:progesterone undetectable --- r_associated #0: 20 --> en:addison disease
    n1=en:progesterone undetectable | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  896. en:prolactin level normal --- r_associated #0: 20 --> en:addison disease
    n1=en:prolactin level normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  897. en:prolactin, increased --- r_associated #0: 20 --> en:addison disease
    n1=en:prolactin, increased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  898. en:prolactin-producing pituitary gland adenoma --- r_associated #0: 20 --> en:addison disease
    n1=en:prolactin-producing pituitary gland adenoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  899. en:prominent body odor --- r_associated #0: 20 --> en:addison disease
    n1=en:prominent body odor | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  900. en:pseudohypoaldosteronism type 1 --- r_associated #0: 20 --> en:addison disease
    n1=en:pseudohypoaldosteronism type 1 | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  901. en:pseudohypoparathyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:pseudohypoparathyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  902. en:pseudophaeochromocytoma --- r_associated #0: 20 --> en:addison disease
    n1=en:pseudophaeochromocytoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  903. en:psychology qualifier --- r_associated #0: 20 --> en:addison disease
    n1=en:psychology qualifier | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  904. en:pulmonary alveolar proteinosis, acquired --- r_associated #0: 20 --> en:addison disease
    n1=en:pulmonary alveolar proteinosis, acquired | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  905. en:radiotherapeutic --- r_associated #0: 20 --> en:addison disease
    n1=en:radiotherapeutic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  906. en:reactive hypoglycemia --- r_associated #0: 20 --> en:addison disease
    n1=en:reactive hypoglycemia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  907. en:refeeding syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:refeeding syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  908. en:rehabilitation aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:rehabilitation aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  909. en:reiter syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:reiter syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  910. en:renal diseases (endocrine only) --- r_associated #0: 20 --> en:addison disease
    n1=en:renal diseases (endocrine only) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  911. en:renal resistance to pth --- r_associated #0: 20 --> en:addison disease
    n1=en:renal resistance to pth | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  912. en:renal salt wasting --- r_associated #0: 20 --> en:addison disease
    n1=en:renal salt wasting | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  913. en:reticuloendothelial system --- r_associated #0: 20 --> en:addison disease
    n1=en:reticuloendothelial system | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  914. en:rheumatoid arthritis --- r_associated #0: 20 --> en:addison disease
    n1=en:rheumatoid arthritis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  915. en:rheumatoid arthritis and associated conditions --- r_associated #0: 20 --> en:addison disease
    n1=en:rheumatoid arthritis and associated conditions | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  916. en:right adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:right adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  917. en:roentgenographic --- r_associated #0: 20 --> en:addison disease
    n1=en:roentgenographic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  918. en:sarcoidosis --- r_associated #0: 20 --> en:addison disease
    n1=en:sarcoidosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  919. en:scleroderma --- r_associated #0: 20 --> en:addison disease
    n1=en:scleroderma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  920. en:scleroderma and associated disorders --- r_associated #0: 20 --> en:addison disease
    n1=en:scleroderma and associated disorders | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  921. en:seasonal allergic rhinitis --- r_associated #0: 20 --> en:addison disease
    n1=en:seasonal allergic rhinitis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  922. en:secondary adrenal insufficiency --- r_associated #0: 20 --> en:addison disease
    n1=en:secondary adrenal insufficiency | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  923. en:secondary amenorrhea --- r_associated #0: 20 --> en:addison disease
    n1=en:secondary amenorrhea | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  924. en:secondary amenorrhea (in a subset of patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:secondary amenorrhea (in a subset of patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  925. en:secondary hyperparathyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:secondary hyperparathyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  926. en:secondary sexual characteristics lacking --- r_associated #0: 20 --> en:addison disease
    n1=en:secondary sexual characteristics lacking | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  927. en:sequential loss of anterior pituitary tropic hormones --- r_associated #0: 20 --> en:addison disease
    n1=en:sequential loss of anterior pituitary tropic hormones | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  928. en:serum aldosterone elevated --- r_associated #0: 20 --> en:addison disease
    n1=en:serum aldosterone elevated | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  929. en:serum estrogen decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:serum estrogen decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  930. en:serum phosphorus normal or mildly elevated --- r_associated #0: 20 --> en:addison disease
    n1=en:serum phosphorus normal or mildly elevated | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  931. en:serum prolactin decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:serum prolactin decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  932. en:serum testosterone decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:serum testosterone decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  933. en:sex-hormone binding globulin markedly elevated --- r_associated #0: 20 --> en:addison disease
    n1=en:sex-hormone binding globulin markedly elevated | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  934. en:sjogren syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:sjogren syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  935. en:skin autoimmune disorders nec --- r_associated #0: 20 --> en:addison disease
    n1=en:skin autoimmune disorders nec | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  936. en:small adrenal gland --- r_associated #0: 20 --> en:addison disease
    n1=en:small adrenal gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  937. en:small to absent parathyroid glands --- r_associated #0: 20 --> en:addison disease
    n1=en:small to absent parathyroid glands | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  938. en:solitary parathyroid adenomas (rarely multiple) --- r_associated #0: 20 --> en:addison disease
    n1=en:solitary parathyroid adenomas (rarely multiple) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  939. en:splenic disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:splenic disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  940. en:stein-leventhal syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:stein-leventhal syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  941. en:steroid compound --- r_associated #0: 20 --> en:addison disease
    n1=en:steroid compound | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  942. en:steroid withdrawal syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:steroid withdrawal syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  943. en:stimulation of the renin/angiotensin/aldosterone axis --- r_associated #0: 20 --> en:addison disease
    n1=en:stimulation of the renin/angiotensin/aldosterone axis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  944. en:structure of left inferior parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:structure of left inferior parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  945. en:structure of left superior parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:structure of left superior parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  946. en:structure of right inferior parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:structure of right inferior parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  947. en:structure of right superior parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:structure of right superior parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  948. en:subclinical hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:subclinical hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  949. en:subset of patients with ovarioleukodystrophy have primary amenorrhea --- r_associated #0: 20 --> en:addison disease
    n1=en:subset of patients with ovarioleukodystrophy have primary amenorrhea | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  950. en:superior parathyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:superior parathyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  951. en:surgical aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:surgical aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  952. en:susac syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:susac syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  953. en:syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  954. en:syndrome of inappropriate antidiuretic hormone secretion --- r_associated #0: 20 --> en:addison disease
    n1=en:syndrome of inappropriate antidiuretic hormone secretion | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  955. en:systemic lupus erythematosus --- r_associated #0: 20 --> en:addison disease
    n1=en:systemic lupus erythematosus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  956. en:systemic scleroderma --- r_associated #0: 20 --> en:addison disease
    n1=en:systemic scleroderma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  957. en:taxonomic --- r_associated #0: 20 --> en:addison disease
    n1=en:taxonomic | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  958. en:temporal arteritis --- r_associated #0: 20 --> en:addison disease
    n1=en:temporal arteritis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  959. en:tertiary hypothyroidism --- r_associated #0: 20 --> en:addison disease
    n1=en:tertiary hypothyroidism | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  960. en:testicular disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:testicular disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  961. en:testicular hypofunction due to defect in adrenocortical hormone synthesis --- r_associated #0: 20 --> en:addison disease
    n1=en:testicular hypofunction due to defect in adrenocortical hormone synthesis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  962. en:therapeutic aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:therapeutic aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  963. en:thin pituitary stalk --- r_associated #0: 20 --> en:addison disease
    n1=en:thin pituitary stalk | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  964. en:thymus disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:thymus disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  965. en:thymus gland --- r_associated #0: 20 --> en:addison disease
    n1=en:thymus gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  966. en:thyroid associated opthalmopathies --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid associated opthalmopathies | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  967. en:thyroid defect in oxidation and organification of iodide --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid defect in oxidation and organification of iodide | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  968. en:thyroid disease (less common) --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid disease (less common) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  969. en:thyroid dysplasia/aplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid dysplasia/aplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  970. en:thyroid failure (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid failure (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  971. en:thyroid follicular hyperplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid follicular hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  972. en:thyroid function normal --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid function normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  973. en:thyroid gland --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid gland | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  974. en:thyroid gland carcinoma --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid gland carcinoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  975. en:thyroid gland disorder --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid gland disorder | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  976. en:thyroid gland follicular adenoma --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid gland follicular adenoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  977. en:thyroid gland papillary carcinoma --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid gland papillary carcinoma | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  978. en:thyroid hyperplasia --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid hyperplasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  979. en:thyroid iodine accumulation defect --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid iodine accumulation defect | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  980. en:thyroid lymphangiectasia --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid lymphangiectasia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  981. en:thyroid stimulating hormone normal --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid stimulating hormone normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  982. en:thyroid storm --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid storm | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  983. en:thyroid volume 22-66ml (adults) --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroid volume 22-66ml (adults) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  984. en:thyroiditis --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroiditis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  985. en:thyrotoxic cardiomyopathy --- r_associated #0: 20 --> en:addison disease
    n1=en:thyrotoxic cardiomyopathy | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  986. en:thyrotoxic periodic paralysis --- r_associated #0: 20 --> en:addison disease
    n1=en:thyrotoxic periodic paralysis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  987. en:thyroxin binding globulin decreased --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroxin binding globulin decreased | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  988. en:thyroxin binding globulin normal --- r_associated #0: 20 --> en:addison disease
    n1=en:thyroxin binding globulin normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  989. en:tonsil and adenoid structure --- r_associated #0: 20 --> en:addison disease
    n1=en:tonsil and adenoid structure | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  990. en:total and free thyroxine low-normal or subnormal --- r_associated #0: 20 --> en:addison disease
    n1=en:total and free thyroxine low-normal or subnormal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  991. en:total and free triiodothyronine high-normal or elevated --- r_associated #0: 20 --> en:addison disease
    n1=en:total and free triiodothyronine high-normal or elevated | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  992. en:total thyroxine to total triiodothyronine ratio markedly low --- r_associated #0: 20 --> en:addison disease
    n1=en:total thyroxine to total triiodothyronine ratio markedly low | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  993. en:toxic goiter --- r_associated #0: 20 --> en:addison disease
    n1=en:toxic goiter | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  994. en:toxic nodular goiter --- r_associated #0: 20 --> en:addison disease
    n1=en:toxic nodular goiter | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  995. en:transient hypothyroidism (in some patients) --- r_associated #0: 20 --> en:addison disease
    n1=en:transient hypothyroidism (in some patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  996. en:trivalent influenza vaccine --- r_associated #0: 20 --> en:addison disease
    n1=en:trivalent influenza vaccine | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  997. en:truncal obesity (rare) --- r_associated #0: 20 --> en:addison disease
    n1=en:truncal obesity (rare) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  998. en:tuberculosis --- r_associated #0: 20 --> en:addison disease
    n1=en:tuberculosis | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  999. en:tuberculous addison's disease --- r_associated #0: 20 --> en:addison disease
    n1=en:tuberculous addison's disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1000. en:turner syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:turner syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1001. en:type 1 diabetes mellitus --- r_associated #0: 20 --> en:addison disease
    n1=en:type 1 diabetes mellitus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1002. en:type 1 diabetes mellitus developed in some patients --- r_associated #0: 20 --> en:addison disease
    n1=en:type 1 diabetes mellitus developed in some patients | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1003. en:type 2 diabetes (in some) --- r_associated #0: 20 --> en:addison disease
    n1=en:type 2 diabetes (in some) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1004. en:type 2 diabetes mellitus --- r_associated #0: 20 --> en:addison disease
    n1=en:type 2 diabetes mellitus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1005. en:type 2 diabetes mellitus (t2d) --- r_associated #0: 20 --> en:addison disease
    n1=en:type 2 diabetes mellitus (t2d) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1006. en:type iii hypersensitivity --- r_associated #0: 20 --> en:addison disease
    n1=en:type iii hypersensitivity | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1007. en:undervirilization --- r_associated #0: 20 --> en:addison disease
    n1=en:undervirilization | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1008. en:undifferentiated connective tissue disease --- r_associated #0: 20 --> en:addison disease
    n1=en:undifferentiated connective tissue disease | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1009. en:urinary 17-hydroxycorticoids normal --- r_associated #0: 20 --> en:addison disease
    n1=en:urinary 17-hydroxycorticoids normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1010. en:urinary 17-oxosteroids normal --- r_associated #0: 20 --> en:addison disease
    n1=en:urinary 17-oxosteroids normal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1011. en:urticaria --- r_associated #0: 20 --> en:addison disease
    n1=en:urticaria | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1012. en:use of ultrasonography --- r_associated #0: 20 --> en:addison disease
    n1=en:use of ultrasonography | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1013. en:uveomeningoencephalitic syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:uveomeningoencephalitic syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1014. en:vasointestinal peptide tumor --- r_associated #0: 20 --> en:addison disease
    n1=en:vasointestinal peptide tumor | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1015. en:veterinary aspects --- r_associated #0: 20 --> en:addison disease
    n1=en:veterinary aspects | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1016. en:viral infection --- r_associated #0: 20 --> en:addison disease
    n1=en:viral infection | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1017. en:viremia --- r_associated #0: 20 --> en:addison disease
    n1=en:viremia | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1018. en:viruses --- r_associated #0: 20 --> en:addison disease
    n1=en:viruses | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1019. en:waterhouse-friderichsen syndrome --- r_associated #0: 20 --> en:addison disease
    n1=en:waterhouse-friderichsen syndrome | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1020. en:waterhouse-friderichsen syndrome, meningococcal --- r_associated #0: 20 --> en:addison disease
    n1=en:waterhouse-friderichsen syndrome, meningococcal | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1021. glandes surrénales --- r_associated #0: 20 --> en:addison disease
    n1=glandes surrénales | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1022. hormones surrénaliennes --- r_associated #0: 20 --> en:addison disease
    n1=hormones surrénaliennes | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1023. insuffisance --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1024. insuffisance corticosurrénale primaire --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance corticosurrénale primaire | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1025. insuffisance corticosurrénalienne lente --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance corticosurrénalienne lente | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1026. insuffisance de la corticale surrénalienne --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance de la corticale surrénalienne | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1027. insuffisance de production des hormones surrénaliennes --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance de production des hormones surrénaliennes | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1028. insuffisance rénale --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance rénale | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1029. insuffisance surrénale aigüe --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance surrénale aigüe | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1030. insuffisance surrénalienne --- r_associated #0: 20 --> en:addison disease
    n1=insuffisance surrénalienne | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1031. maladie --- r_associated #0: 20 --> en:addison disease
    n1=maladie | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1032. maladie d --- r_associated #0: 20 --> en:addison disease
    n1=maladie d | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1033. maladie d'addison d'origine auto-immune --- r_associated #0: 20 --> en:addison disease
    n1=maladie d'addison d'origine auto-immune | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1034. maladie de Wolman --- r_associated #0: 20 --> en:addison disease
    n1=maladie de Wolman | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1035. maladie infectieuse virale --- r_associated #0: 20 --> en:addison disease
    n1=maladie infectieuse virale | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1036. maladie rare --- r_associated #0: 20 --> en:addison disease
    n1=maladie rare | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1037. maladie
    (médecine)
     --- r_associated #0: 20 --> en:addison disease
    n1=maladie
    (médecine)
    | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1038. maladies --- r_associated #0: 20 --> en:addison disease
    n1=maladies | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1039. médecine vétérinaire --- r_associated #0: 20 --> en:addison disease
    n1=médecine vétérinaire | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1040. pathologie --- r_associated #0: 20 --> en:addison disease
    n1=pathologie | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1041. polyendocrinopathies auto-immunes --- r_associated #0: 20 --> en:addison disease
    n1=polyendocrinopathies auto-immunes | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1042. primaire --- r_associated #0: 20 --> en:addison disease
    n1=primaire | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1043. processus --- r_associated #0: 20 --> en:addison disease
    n1=processus | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1044. processus pathologique --- r_associated #0: 20 --> en:addison disease
    n1=processus pathologique | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1045. rénine --- r_associated #0: 20 --> en:addison disease
    n1=rénine | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1046. surrénalienne --- r_associated #0: 20 --> en:addison disease
    n1=surrénalienne | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1047. syndrome de Allgrove --- r_associated #0: 20 --> en:addison disease
    n1=syndrome de Allgrove | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  1048. adréno-leucodystrophie --- r_associated #0: 15 --> en:addison disease
    n1=adréno-leucodystrophie | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1049. anémie médullaire --- r_associated #0: 15 --> en:addison disease
    n1=anémie médullaire | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1050. cancer de la testicule --- r_associated #0: 15 --> en:addison disease
    n1=cancer de la testicule | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1051. diabète de la maturité --- r_associated #0: 15 --> en:addison disease
    n1=diabète de la maturité | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1052. diabète de type ii --- r_associated #0: 15 --> en:addison disease
    n1=diabète de type ii | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1053. diabète sucré de type 2 --- r_associated #0: 15 --> en:addison disease
    n1=diabète sucré de type 2 | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1054. diabète sucré type ii --- r_associated #0: 15 --> en:addison disease
    n1=diabète sucré type ii | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1055. en:hydrocortisone --- r_associated #0: 15 --> en:addison disease
    n1=en:hydrocortisone | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1056. hydrocortisones --- r_associated #0: 15 --> en:addison disease
    n1=hydrocortisones | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1057. hyperbilirubinémie du nouveau-né --- r_associated #0: 15 --> en:addison disease
    n1=hyperbilirubinémie du nouveau-né | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1058. hyperbilirubinémie néonatale --- r_associated #0: 15 --> en:addison disease
    n1=hyperbilirubinémie néonatale | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1059. infertilité féminine --- r_associated #0: 15 --> en:addison disease
    n1=infertilité féminine | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1060. lupus érythémateux --- r_associated #0: 15 --> en:addison disease
    n1=lupus érythémateux | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1061. non précisée, anémie aplasique --- r_associated #0: 15 --> en:addison disease
    n1=non précisée, anémie aplasique | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1062. préparation d'hydrocortisone --- r_associated #0: 15 --> en:addison disease
    n1=préparation d'hydrocortisone | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1063. préparation de cortisol --- r_associated #0: 15 --> en:addison disease
    n1=préparation de cortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1064. préparation du composé f --- r_associated #0: 15 --> en:addison disease
    n1=préparation du composé f | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1065. sclérose systémique --- r_associated #0: 15 --> en:addison disease
    n1=sclérose systémique | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1066. sclérose systémique progressive --- r_associated #0: 15 --> en:addison disease
    n1=sclérose systémique progressive | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1067. syndrome adénocutanéomuqueux --- r_associated #0: 15 --> en:addison disease
    n1=syndrome adénocutanéomuqueux | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1068. tumeur maligne d'un testicule --- r_associated #0: 15 --> en:addison disease
    n1=tumeur maligne d'un testicule | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1069. tumeur maligne testiculaire --- r_associated #0: 15 --> en:addison disease
    n1=tumeur maligne testiculaire | n2=en:addison disease | rel=r_associated | relid=0 | w=15
  1070. Aldostérone --- r_associated #0: 10 --> en:addison disease
    n1=Aldostérone | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1071. Cortisol --- r_associated #0: 10 --> en:addison disease
    n1=Cortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1072. acromégalie --- r_associated #0: 10 --> en:addison disease
    n1=acromégalie | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1073. acétate de potassium --- r_associated #0: 10 --> en:addison disease
    n1=acétate de potassium | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1074. affection pancréatique --- r_associated #0: 10 --> en:addison disease
    n1=affection pancréatique | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1075. anémie aplasique --- r_associated #0: 10 --> en:addison disease
    n1=anémie aplasique | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1076. anémie aplasique non précisée --- r_associated #0: 10 --> en:addison disease
    n1=anémie aplasique non précisée | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1077. aplasie médullaire --- r_associated #0: 10 --> en:addison disease
    n1=aplasie médullaire | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1078. aplasie érythrocytaire --- r_associated #0: 10 --> en:addison disease
    n1=aplasie érythrocytaire | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1079. asthme --- r_associated #0: 10 --> en:addison disease
    n1=asthme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1080. bilirubinémie --- r_associated #0: 10 --> en:addison disease
    n1=bilirubinémie | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1081. cancer de l'ovaire --- r_associated #0: 10 --> en:addison disease
    n1=cancer de l'ovaire | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1082. cancer testiculaire --- r_associated #0: 10 --> en:addison disease
    n1=cancer testiculaire | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1083. diabète non insulinodépendant --- r_associated #0: 10 --> en:addison disease
    n1=diabète non insulinodépendant | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1084. diabète sucré non dépendant d'insuline --- r_associated #0: 10 --> en:addison disease
    n1=diabète sucré non dépendant d'insuline | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1085. diabète sucré non insulino dép --- r_associated #0: 10 --> en:addison disease
    n1=diabète sucré non insulino dép | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1086. diabète sucré non insulino-dépendant --- r_associated #0: 10 --> en:addison disease
    n1=diabète sucré non insulino-dépendant | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1087. défaillance du rein --- r_associated #0: 10 --> en:addison disease
    n1=défaillance du rein | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1088. défaillance rénale --- r_associated #0: 10 --> en:addison disease
    n1=défaillance rénale | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1089. déficience en hormone de croissance chez certains individus --- r_associated #0: 10 --> en:addison disease
    n1=déficience en hormone de croissance chez certains individus | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1090. en:aldosterone --- r_associated #0: 10 --> en:addison disease
    n1=en:aldosterone | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1091. en:cortisol --- r_associated #0: 10 --> en:addison disease
    n1=en:cortisol | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1092. en:hyperandrogenism --- r_associated #0: 10 --> en:addison disease
    n1=en:hyperandrogenism | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1093. en:renin --- r_associated #0: 10 --> en:addison disease
    n1=en:renin | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1094. exophtalmie --- r_associated #0: 10 --> en:addison disease
    n1=exophtalmie | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1095. fécondité féminine diminuée --- r_associated #0: 10 --> en:addison disease
    n1=fécondité féminine diminuée | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1096. glandes suprarénales --- r_associated #0: 10 --> en:addison disease
    n1=glandes suprarénales | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1097. glomérulonéphrite --- r_associated #0: 10 --> en:addison disease
    n1=glomérulonéphrite | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1098. gonade --- r_associated #0: 10 --> en:addison disease
    n1=gonade | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1099. hydrocortisone --- r_associated #0: 10 --> en:addison disease
    n1=hydrocortisone | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1100. hyperaldostéronisme --- r_associated #0: 10 --> en:addison disease
    n1=hyperaldostéronisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1101. hyperandrogénie --- r_associated #0: 10 --> en:addison disease
    n1=hyperandrogénie | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1102. hyperandrogénisme --- r_associated #0: 10 --> en:addison disease
    n1=hyperandrogénisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1103. hyperbilirubinémie des nouveau-nés --- r_associated #0: 10 --> en:addison disease
    n1=hyperbilirubinémie des nouveau-nés | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1104. hyperparathyroïdisme --- r_associated #0: 10 --> en:addison disease
    n1=hyperparathyroïdisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1105. hyperthyroïdisme --- r_associated #0: 10 --> en:addison disease
    n1=hyperthyroïdisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1106. hypogonadisme --- r_associated #0: 10 --> en:addison disease
    n1=hypogonadisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1107. hypogonadisme hypogonadotrophique --- r_associated #0: 10 --> en:addison disease
    n1=hypogonadisme hypogonadotrophique | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1108. hypométabolisme --- r_associated #0: 10 --> en:addison disease
    n1=hypométabolisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1109. hypopituitarisme --- r_associated #0: 10 --> en:addison disease
    n1=hypopituitarisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1110. hypothyroïdisme --- r_associated #0: 10 --> en:addison disease
    n1=hypothyroïdisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1111. infection virale --- r_associated #0: 10 --> en:addison disease
    n1=infection virale | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1112. infertilité de la femme --- r_associated #0: 10 --> en:addison disease
    n1=infertilité de la femme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1113. insuffisance rénale non précisée --- r_associated #0: 10 --> en:addison disease
    n1=insuffisance rénale non précisée | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1114. kyste de l'ovaire --- r_associated #0: 10 --> en:addison disease
    n1=kyste de l'ovaire | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1115. lupus erythematosus --- r_associated #0: 10 --> en:addison disease
    n1=lupus erythematosus | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1116. lupus érythémateux aigu disséminé --- r_associated #0: 10 --> en:addison disease
    n1=lupus érythémateux aigu disséminé | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1117. maladie infectieuse --- r_associated #0: 10 --> en:addison disease
    n1=maladie infectieuse | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1118. maladie virale --- r_associated #0: 10 --> en:addison disease
    n1=maladie virale | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1119. nanisme --- r_associated #0: 10 --> en:addison disease
    n1=nanisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1120. niveau élevé d'hormone folliculo-stimulante --- r_associated #0: 10 --> en:addison disease
    n1=niveau élevé d'hormone folliculo-stimulante | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1121. non précisée, insuffisance rénale --- r_associated #0: 10 --> en:addison disease
    n1=non précisée, insuffisance rénale | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1122. panhypopituitarisme --- r_associated #0: 10 --> en:addison disease
    n1=panhypopituitarisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1123. paraganglion --- r_associated #0: 10 --> en:addison disease
    n1=paraganglion | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1124. perte séquentielle des hormones trophiques de l'antéhypophyse --- r_associated #0: 10 --> en:addison disease
    n1=perte séquentielle des hormones trophiques de l'antéhypophyse | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1125. proptose --- r_associated #0: 10 --> en:addison disease
    n1=proptose | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1126. pseudohypoparathyroïdisme --- r_associated #0: 10 --> en:addison disease
    n1=pseudohypoparathyroïdisme | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1127. résistance à l'insuline --- r_associated #0: 10 --> en:addison disease
    n1=résistance à l'insuline | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1128. sclérodermie --- r_associated #0: 10 --> en:addison disease
    n1=sclérodermie | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1129. sclérodermie généralisée progressive --- r_associated #0: 10 --> en:addison disease
    n1=sclérodermie généralisée progressive | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1130. sclérose générale --- r_associated #0: 10 --> en:addison disease
    n1=sclérose générale | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1131. sel d'Epsom --- r_associated #0: 10 --> en:addison disease
    n1=sel d'Epsom | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1132. stérilité féminine --- r_associated #0: 10 --> en:addison disease
    n1=stérilité féminine | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1133. surrénales --- r_associated #0: 10 --> en:addison disease
    n1=surrénales | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1134. syndrome adéno-cutanéo-muqueux --- r_associated #0: 10 --> en:addison disease
    n1=syndrome adéno-cutanéo-muqueux | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1135. syndrome d'insuffisance rénale --- r_associated #0: 10 --> en:addison disease
    n1=syndrome d'insuffisance rénale | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1136. système immunitaire --- r_associated #0: 10 --> en:addison disease
    n1=système immunitaire | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1137. système lymphatique --- r_associated #0: 10 --> en:addison disease
    n1=système lymphatique | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1138. taux élevés d'hormone folliculostimulante --- r_associated #0: 10 --> en:addison disease
    n1=taux élevés d'hormone folliculostimulante | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1139. taux élevés d'hormone lutéinisante --- r_associated #0: 10 --> en:addison disease
    n1=taux élevés d'hormone lutéinisante | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1140. trouble du pancréas --- r_associated #0: 10 --> en:addison disease
    n1=trouble du pancréas | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1141. tumeur maligne d'un ovaire --- r_associated #0: 10 --> en:addison disease
    n1=tumeur maligne d'un ovaire | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1142. tumeur maligne du testicule --- r_associated #0: 10 --> en:addison disease
    n1=tumeur maligne du testicule | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1143. tumeur maligne ovarienne --- r_associated #0: 10 --> en:addison disease
    n1=tumeur maligne ovarienne | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1144. tumeur testiculaire maligne --- r_associated #0: 10 --> en:addison disease
    n1=tumeur testiculaire maligne | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1145. virose --- r_associated #0: 10 --> en:addison disease
    n1=virose | n2=en:addison disease | rel=r_associated | relid=0 | w=10
  1146. Addison (maladie d') --- r_associated #0: 5 --> en:addison disease
    n1=Addison (maladie d') | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1147. Insuffisance rénale --- r_associated #0: 5 --> en:addison disease
    n1=Insuffisance rénale | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1148. Insuffisance surrénale --- r_associated #0: 5 --> en:addison disease
    n1=Insuffisance surrénale | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1149. Insuffisance surrénalienne --- r_associated #0: 5 --> en:addison disease
    n1=Insuffisance surrénalienne | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1150. Maladie d'Addison --- r_associated #0: 5 --> en:addison disease
    n1=Maladie d'Addison | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1151. Maladie rare --- r_associated #0: 5 --> en:addison disease
    n1=Maladie rare | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1152. absence de complexes immuns et de lymphocytes dans le tissu thyroïdien --- r_associated #0: 5 --> en:addison disease
    n1=absence de complexes immuns et de lymphocytes dans le tissu thyroïdien | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1153. affection du pancréas --- r_associated #0: 5 --> en:addison disease
    n1=affection du pancréas | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1154. affection du testicule --- r_associated #0: 5 --> en:addison disease
    n1=affection du testicule | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1155. anémie aplastique --- r_associated #0: 5 --> en:addison disease
    n1=anémie aplastique | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1156. anémie par aplasie médullaire --- r_associated #0: 5 --> en:addison disease
    n1=anémie par aplasie médullaire | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1157. anémie par atteinte isolée de la lignée rouge --- r_associated #0: 5 --> en:addison disease
    n1=anémie par atteinte isolée de la lignée rouge | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1158. aplasie de globules rouges purs --- r_associated #0: 5 --> en:addison disease
    n1=aplasie de globules rouges purs | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1159. aplasie des globules rouges purs --- r_associated #0: 5 --> en:addison disease
    n1=aplasie des globules rouges purs | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1160. aplasie isolée de la lignée rouge --- r_associated #0: 5 --> en:addison disease
    n1=aplasie isolée de la lignée rouge | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1161. aplasie primitive de la lignée rouge --- r_associated #0: 5 --> en:addison disease
    n1=aplasie primitive de la lignée rouge | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1162. cancer du testicule --- r_associated #0: 5 --> en:addison disease
    n1=cancer du testicule | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1163. chimiorésistance à l'insuline --- r_associated #0: 5 --> en:addison disease
    n1=chimiorésistance à l'insuline | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1164. dermite herpétiforme --- r_associated #0: 5 --> en:addison disease
    n1=dermite herpétiforme | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1165. diabète de type 2 --- r_associated #0: 5 --> en:addison disease
    n1=diabète de type 2 | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1166. diabète sucré de type ii --- r_associated #0: 5 --> en:addison disease
    n1=diabète sucré de type ii | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1167. déficience en hormone adrénocorticotrope --- r_associated #0: 5 --> en:addison disease
    n1=déficience en hormone adrénocorticotrope | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1168. en:17-hydroxycorticosterone --- r_associated #0: 5 --> en:addison disease
    n1=en:17-hydroxycorticosterone | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1169. en:hypoaldosteronism --- r_associated #0: 5 --> en:addison disease
    n1=en:hypoaldosteronism | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1170. en:wolman disease --- r_associated #0: 5 --> en:addison disease
    n1=en:wolman disease | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1171. exophthalmie --- r_associated #0: 5 --> en:addison disease
    n1=exophthalmie | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1172. glomerulonéphrite --- r_associated #0: 5 --> en:addison disease
    n1=glomerulonéphrite | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1173. hyperbilirubinémie --- r_associated #0: 5 --> en:addison disease
    n1=hyperbilirubinémie | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1174. hypo-aldostéronisme --- r_associated #0: 5 --> en:addison disease
    n1=hypo-aldostéronisme | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1175. hypoaldostéronisme --- r_associated #0: 5 --> en:addison disease
    n1=hypoaldostéronisme | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1176. infection due au rétrovirus --- r_associated #0: 5 --> en:addison disease
    n1=infection due au rétrovirus | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1177. insulino-résistance --- r_associated #0: 5 --> en:addison disease
    n1=insulino-résistance | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1178. insulinorésistance --- r_associated #0: 5 --> en:addison disease
    n1=insulinorésistance | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1179. maladie de Kawasaki --- r_associated #0: 5 --> en:addison disease
    n1=maladie de Kawasaki | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1180. maladie du pancréas --- r_associated #0: 5 --> en:addison disease
    n1=maladie du pancréas | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1181. pathologie infectieuse --- r_associated #0: 5 --> en:addison disease
    n1=pathologie infectieuse | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1182. pseudo-hypoparathyroïdisme --- r_associated #0: 5 --> en:addison disease
    n1=pseudo-hypoparathyroïdisme | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1183. réponse absente ou faible à la stimulation par l'hormone de libération des gonadotrophines --- r_associated #0: 5 --> en:addison disease
    n1=réponse absente ou faible à la stimulation par l'hormone de libération des gonadotrophines | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1184. sclérodermie généralisée --- r_associated #0: 5 --> en:addison disease
    n1=sclérodermie généralisée | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1185. sclérodermie systémique --- r_associated #0: 5 --> en:addison disease
    n1=sclérodermie systémique | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1186. syndrome de Kawasaki --- r_associated #0: 5 --> en:addison disease
    n1=syndrome de Kawasaki | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1187. syndrome de fiessinger-leroy-reiter --- r_associated #0: 5 --> en:addison disease
    n1=syndrome de fiessinger-leroy-reiter | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1188. syndrome de reiter --- r_associated #0: 5 --> en:addison disease
    n1=syndrome de reiter | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1189. syndrome lymphoprolifératif avec autoimmunité --- r_associated #0: 5 --> en:addison disease
    n1=syndrome lymphoprolifératif avec autoimmunité | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1190. testostérone sérique diminuée --- r_associated #0: 5 --> en:addison disease
    n1=testostérone sérique diminuée | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1191. trouble pancréatique --- r_associated #0: 5 --> en:addison disease
    n1=trouble pancréatique | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1192. trouble testiculaire --- r_associated #0: 5 --> en:addison disease
    n1=trouble testiculaire | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1193. tuberculose --- r_associated #0: 5 --> en:addison disease
    n1=tuberculose | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1194. tumeur maligne de l'ovaire --- r_associated #0: 5 --> en:addison disease
    n1=tumeur maligne de l'ovaire | n2=en:addison disease | rel=r_associated | relid=0 | w=5
  1195. tumeur à peptide vaso-intestinal --- r_associated #0: 5 --> en:addison disease
    n1=tumeur à peptide vaso-intestinal | n2=en:addison disease | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr